Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Disease

• 129 Xenon MRI as a Biomarker for Diagnosis and Response to Therapy in Pulmonary Arterial Hypertension (PAH)
• Bioequivalence Study to Compare Metformin / Vildagliptin (850 mg/50 mg) Versus Galvumet®
• Amantadine Therapy for Cognitive Impairment in Long COVID
• Reconsolidation Blockade of Intrusive Trauma- and Cocaine-related Memories
• Post-thrombectomy Intra-arterial Tenecteplase for Acute manaGement of Non-retrievable Thrombus and No-reflow in Emergent Stroke
• Pycnogenol® in Post-COVID-19 Condition
• Responding With Evidence and Access for Childhood Headaches
• ML-004 Open-Label Extension Study in Adults and Adolescents With Autism Spectrum Disorders (ASD)
• Synaptic Imaging and Network Activity in Treatment Resistant Depression
• The Moderating Role of Baseline Oxytocin on Its Psychotherapy-facilitating Effects Among Patients With Eating Disorders
• Interest of Oxytocin as an Adjuvant Treatment of Psycho-educational Measures in Challenging Behaviors in Children With Autism Spectrum Disorders and Moderate to Severe Intellectual Disability: Feasibility and Safety Study.
• Cannabidiol as an add-on Treatment During Inpatient Alcohol Cessation in Patients With Severe Alcohol Use Disorder: a Phase ii Trial
• Study of the Effectiveness of Valbenazine on Patient- and Clinician-Reported Outcomes in Participants With Tardive Dyskinesia
• Phase 2 Clinical Trial of GH001 in Bipolar II Disorder
• Efficacy and Safety of Magnesium Vitamin B6 in First Episode Bipolar Disorder
• Intradermal Acupuncture Versus Sham Acupuncture and SSRI for Treating Adolescents With Major Depressive Disorder
• imPROving Quality of LIFe In the Long COVID Patient
• Evaluation of Radiprodil in Children With GRIN-related Disorder
• Spironolactone in Alcohol Use Disorder (SAUD)
• The Impact of AMPA Receptor Blockade on Ketamine's Anti-Suicidal Effects
• Effects of GLP-1RA on Body Weight, Metabolism and Fat Distribution in Overweight/Obese Patients With Type 2 Diabetes Mellitus
• Treating Polysubstance Use Using a Novel Digital Technology
• Oxytocin Effects on Bone Metabolism in Children With Autism Spectrum Disorder
• A Study of Different Donanemab (LY3002813) Dosing Regimens in Adults With Early Alzheimer's Disease (TRAILBLAZER-ALZ 6)
• A Study of JZP541 in Adults With Irritability Associated With Autism Spectrum Disorder
• Influence of Oxycodone on Individuals Taking an SSRI
• A Clinical Study That Will Meaure How Well SEP-363856 Works and How Safe it is in Adults With Generalized Anixety Disorder
• Cytisine for Smoking Cessation
• The Efficacy and Cerebral Mechanism of Intradermal Acupuncture for Major Depressive Disorder
• The Effects of Suvorexant on Sleep, Stress, and Cue-reactivity in Methamphetamine Use Disorder
• A Randomised, Controlled Trial of MDMA-assisted Prolonged Exposure Therapy for Comorbid Alcohol Use Disorder and Post-traumatic Stress Disorder
• Testing a Novel Therapeutic Strategy for Comorbid Post-Traumatic Stress Disorder and Alcohol Use Disorder
• Study to Evaluate TNX-601 ER Monotherapy Versus Placebo in Patients With Major Depressive Disorder (MDD)
• A Study of the Effects of Oxytocin in Adults With Obesity and Binge-eating Disorder
• Dexmedetomidine in the Treatment of Agitation Associated With Schizophrenia and Bipolar Disorder (SERENITY III)
• Guanfacine Extended Release for the Reduction of Aggression and Self-injurious Behavior Associated With Prader-Willi Syndrome
• Orexin Receptor Antagonists as Modulators of Threat Sensitivity in Individuals With Alcohol Use Disorder
• SAGE-217 Pharmacokinetics (PK) and Safety Study Pediatric Participants With Major Depressive Disorder (MDD)
• Efficacy of Botulinum Toxin in Temporomandibular Disorders
• Psilocybin in Adults With and Without Autism Spectrum Disorder
• Gut Microbiota in Mood Disorders in Lebanese Population
• OSU6162 as add-on in SSRI/SNRI-resistant Depression
• Dual Sympathetic Blocks for Patients Experiencing Sympathetically-Mediated Symptoms From Long COVID
• RCT of Glecaprevir/Pibrentasvir for the Treatment of PTSD
• Phase 3 Efficacy and Safety Study in Adults With ADHD Using CTx-1301.
• Clinical Predictors of Intravenous Ketamine Response in Treatment-Resistant Depression
• Intranasal Insulin Improves Postoperative Neurocognitive Disorders in Elderly Patients
• Behavioral Effects of Drugs (Inpatient): 43 (Opioids, Cocaine, n-Acetylcysteine)
• Efficacy and Safety of Intradermal Acupuncture for Major Depressive Disorder
• A Study of Anaprazole Sodium Enteric-coated Tablets in the Treatment of Reflux Esophagitis
• STTEPP: Safety, Tolerability and Dose Limiting Toxicity of Lacosamide in Patients With Painful Chronic Pancreatitis
• Intensified Pharmacological Treatment for Schizophrenia, Major Depressive Disorder and Bipolar Depression After a First-time Treatment Failure
• Effect of SSRIs on Response to Psilocybin Therapy
• A Trial of the Safety and Efficacy of SEP-363856 in the Treatment of Adults With Major Depressive Disorder
• Study to Evaluate the Efficacy and Safety of Ampligen in Patients With Post-COVID Conditions
• Ketamine and Stress in OCD
• Dialectical Behavioral Therapy As A Therapeutic Tool In Patients With Binge Eating Disorder
• Psilocybin for the Treatment of Veterans With Post-Traumatic Stress Disorder
• Effects of Psilocybin in Obsessive Compulsive Disorder
• Suvorexant for Opioid/Stimulant Co-use
• Defining Neurobiological Links Between Substance Use and Mental Illness
• Trial of Centanafadine Efficacy and Safety as Monotherapy or as Adjunct to SSRI in Adults With Major Depressive Disorder
• Efficacy and Safety of Sustained-release Dexamphetamine in Patients With Moderate to Severe Cocaine Use Disorder
• Multi-factor Model Constraction for Early Warning and Diagnosis of MDD
• A Bridging Study on Efficacy and Safety of [18F]Florbetaben PET for Diagnosis of Alzheimer Disease Subjects in Chinese Population
• Intradermal Acupuncture Based on Changes in Biological Specificity of Acupoints for Major Depressive Disorder
• An Open-Label Extension of XPro1595 in Patients With Alzheimer's Disease
• A Study of Aticaprant in Adult and Elderly Participants With Major Depressive Disorder (MDD)
• Smoking Cessation and Menstrual Cycle Phase: A Randomized Controlled Trial
• Naltrexone Neuroimaging Randomized Controlled Trial
• A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 5)
• An EEG Study of Intravenous Ketamine for Major Depression Disorder
• Open-label Brexpiprazole fMRI Trial in Adults With Major Depressive Disorder and Anxiety
• Chinese Longitudinal and Systematic Study of Bioplar Disorder
• Extension of AOC 1001-CS1 (MARINA) Study in Adult Myotonic Dystrophy Type 1 (DM1) Patients
• A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas
• SV2A Density Cannabis Use Disorder
• MDMA-Assisted Therapy for Stress Disorders in Healthcare Workers
• Low-dose Buprenorphine Initiation of Opioid Use Disorder
• Study of Cariprazine Oral Capsules or Solution to Assess Adverse Events and Change in Irritability Due to Autism Spectrum Disorder (ASD) in Participants Aged 5-17 Years With ASD
• Measurement-Based Care Vs. Standard Care for Major Depressive Disorder
• A Study of Zilovertamab and Ibrutinib in Patients With Relapsed or Refractory Mantle Cell Lymphoma
• Safety and Efficacy of Daratumumab in Patients With Anti-Aquaporin 4 Antibody Positive Neuromyelitis Optica Spectrum Disorders
• Psilocybin in Co-occuring Major Depressive Disorder and Borderline Personality Disorder
• A Randomized Controlled Study of Conservative Treatment of Granulomatous Lobular Mastitis Combined With Psychiatric Disorders
• A Study of a Psilocybin Analog (CYB003) in Participants With Major Depressive Disorder
• Cariprazine Versus Placebo for Social Anxiety Disorder
• Intranasal Steroid as Medical Therapy For Sleep-Disordered Breathing in Children
• A Study to Evaluate the Safety, Tolerability and Efficacy of XEN1101 in Major Depressive Disorder
• Digital Interventions as an Add-on Tool in Generalized Anxiety Disorder Treatment
• Evaluating the Effects of Tasimelteon in Individuals With Autism Spectrum Disorder (ASD) and Sleep Disturbances
• Treating Nightmares in Posttraumatic Stress Disorder With Clonidine and Doxazosin
• Acupuncture Therapy Based on Biological Specificity of Acupoints for Major Depressive Disorder
• Intradermal Needle Therapy for Major Depressive Disorder
• First-in-Human (FIH) Trial of 1A46 in Subjects With Advanced CD20 and/or CD19 Positive B-cell Hematologic Malignancies
• Cannabinol Use in Patients With Insomnia Disorder
• Evaluating the Hypothesized Mechanism of Action of N-acetylcysteine for Bipolar Disorder
• Maintenance Ketamine Infusions for Treatment-Resistant Bipolar Depression
• The Study Aims to Show Bioequivalence of the Test Product and the Reference Reference Product in a Crossover Design Study Healthy Volunteers. Additionally, the Safety Profile of Test Product Compared to Reference Product Will be Assessed.
• Semaglutide in Comorbid Schizophrenia Spectrum Disorder and Obesity
• The Study Intends to Show Bioequivalence of the Test Product and the Reference Reference Product in a Crossover Design Study Healthy Volunteers. Additionally, the Safety Profile of Test Product Compared to Reference Product Will be Evaluated.
• ERAdicate S. Aureus in Patients With Bacteremia and Endocarditis
• Effect of Propofol on Postoperative Sleep Quality in Elderly Patients With Sleep Disorders
• Study of the Safety and Feasibility of Psilocybin in Adults With Methamphetamine Use Disorder
• Study to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective Disorder
• Study to Assess the Efficacy of XPro™ in Patients With Mild Alzheimer's Disease With Biomarkers of Inflammation
• Clinical and Basic Researches Related to ZhenQi Buxue Oral Liquid in Treating Menstrual Disorders
• The Safety and Tolerability of COMP360 in Participants With Post-traumatic Stress Disorder
• Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder
• A Bioequivalence Trial of Irbesartan Tablets（0.15g） in Healthy Chinese Subjects
• Varenicline for the Treatment of Cannabis and Tobacco Use Disorders in Veterans
• A Phase 3 Efficacy and Safety in Pediatrics (6-17) With Attention-Deficit/Hyperactivity Disorder (ADHD) Using CTx-1301 (Dexmethylphenidate)
• A Study of Orelabrutinib in Patients With AQP4-IgG Positive Neuromyelitis Optica Spectrum Disorder
• Safety and Efficacy of BHV-3000 (Rimegepant) Orally Disintegrating Tablet for Acute Treatment of Temporomandibular Disorders
• Extended-Release Naltrexone and Monthly Extended-Release Buprenorphine for Cocaine Use Disorder (CURB-2)
• A Clinical Trial of PRAX-114 in Participants With Post-Traumatic Stress Disorder
• The CANabidiol Use for RElief of Short Term Insomnia
• A Clinical Study on the Effects of Inhalation of Volatile Oil of Cang-Ai Via the Nose on Patients With Depression
• Investigating the Therapeutic Effects of Psilocybin in Treatment-Resistant Post-Traumatic Stress Disorder
• Assessing Cognitive Performance Among Adults With Attention Disorders Working on Treadmill
• Compare the Impact of Xuezhikang and Atorvastatin on Glucose Metabolism in Dyslipidemia Patients With Prediabetes
• Pharmaco-Neuroimaging Studies of Approach/Avoidance Behaviors and Post-Mortem Studies: Study 1.1. (Pharmacological Manipulation)
• Postpartum MDMA Co-occurring PTSD and OUD
• Effectiveness of iPRF Injections in Temporomandibular Joints Degeneration Management
• Study to Assess the Efficacy and Safety of Adjunctive NBI-1065845 in Adults With Major Depressive Disorder (MDD)
• KAP for Depression in Abstinent Opioid Users
• A Study of JZP150 in Adults With Posttraumatic Stress Disorder
• Study to Evaluate the Efficacy Safety and Tolerability of QR-421a in Subjects With RP Due to Mutations in Exon 13 of the USH2A Gene With Early to Moderate Vision Loss (Celeste)
• Efficacy and Safety of Mebeverine + Simethicone in Patients With Functional Bowel Disorders
• Erenumab-aooe for Temporomandibular Disorders Management: TMD Cgrp Antibody RElief (TMD CARE)
• Study to Evaluate the Efficacy Safety and Tolerability of QR-421a in Subjects With RP Due to Mutations in Exon 13 of the USH2A Gene With Advanced Vision Loss (Sirius)
• A Pilot Study on Effect of add-on Sulforaphane to SSRIs and Application of Niacin Skin Flush Response Test in Major Depressive Disorder
• A Comparative Study on Efficacy and Safety of add-on Sulforaphane or rTMS to Escitalopram for Major Depressive Disorder With Poor Response to Initial Treatment
• NMDA Modulation in Antidepressant Nonresponders With Major Depressive Disorder
• Enhancing Prolonged Exposure With Cannabidiol to Treat Posttraumatic Stress Disorder in Military Veterans
• Randomized Trial of Buprenorphine Microdose Inductions During Hospitalization
• ALTO-100 in MDD and/or PTSD
• A Trial of Centanafadine Efficacy, Safety, and Tolerability in Adult Subjects With Binge Eating Disorder
• Traditional Chinese Medicine Alleviates Stigma in Patients With Functional Dyspepsia
• Stellate Ganglion Block to Augment Trauma-focused Therapy Among Veterans With PTSD
• The Study of Quadruple Therapy Intranasal Insulin, Zinc, Gabapentin, Ice Cube Stimulation for Post COVID-19 Smell and Taste Dysfunctions
• Oral Contraceptives for Treating Premenstrual Dysphoric Disorder in Bipolar Disorder
• Seroquel ® in Patients With Bipolar Disorder in Remission With Signs of Impaired Impulse Control
• Human Laboratory Study of ASP8062 for Alcohol Use Disorder
• ML-004 in Adolescents and Adults With Autism Spectrum Disorders (ASD)
• Oral Naltrexone In Pediatric Eating Disorders
• Gabapentin for Restoring GABA/Glutamate Homeostasis in Co-occurring Bipolar and Cannabis Use Disorders
• Cariprazine for Comorbid Cocaine and Opioid Use Didorder
• A Study to Assess the Safety and Efficacy of ASP8062 as an Add-on Therapy to Buprenorphine/Naloxone in Participants With Opioid Use Disorder
• Ketamine for OUD and Comorbid Depression (OUDCD)
• Cannabinoids as a Treatment for Insomnia in Major Depression
• Mind to Quit Multisite Trial
• Determining Efficacy and Safety of BXCL501 in Agitation Associated With Pediatric Schizophrenia and Bipolar Disorder
• [C-11]NPA PET-amphetamine in Cocaine Use Disorders
• Efficacy of Buprenorphine and XR-Naltrexone Combination for Relapse Prevention in Opioid Use Disorder
• Sevoflurane for Treatment-Resistant Depression
• Imaging CRF X NOP Interactions in CUD
• Phase 1 Study of OLZ/SAM in Pediatric Subjects With Bipolar I Disorder
• Comparing Standard vs. Modified Reconsolidation Blockade for the Treatment of Psychological Trauma
• Epidiolex in Obsessive Compulsive Disorder
• Flupentixol and Melitracen Tablets in the Treatment of Emotional Disorder
• A Clinical Trial of Adjunctive PRAX-114 in Participants With Major Depressive Disorder
• A Study To Assess Adverse Events and Change in Disease Activity With Oral Cariprazine When Added to Antidepressant Therapies (ADTs) Compared to Placebo in Adult Participants With Generalized Anxiety Disorder (GAD) Who Have Had an Inadequate Response
• Multi-Center Study to Evaluate the Efficacy and Safety of Sildenafil Cream (3.6%) in Premenopausal Patients With Female Sexual Arousal Disorder
• 28-Day Daily-dose Crossover Study of the Safety and Tolerability of SB-121 (Lactobacillus Reuteri With Sephadex® and Maltose) in Subjects, Ages 15 to 45 Years, Diagnosed With Autistic Disorder
• Exenatide for Treating Cocaine Use Disorder
• Dopaminergic Therapy for Frontotemporal Dementia Patients
• Naltrexone Neuroimaging
• Study to Test the Efficacy and Safety of Vafidemstat in Adult Borderline Personality Disorder Population
• Relative Bioavailability of LY03010 Compared to Listed Drug
• Study of Dextromethorphan in OCD and Related Disorders
• Cognitive Effects of Adjuvant Vortioxetine in Early Schizophrenia
• Role and Mechanism of Probiotics in Improving Motor Symptoms in Mild to Moderate Parkinson's Disease
• Intubating Conditions During Rapid Sequence Induction in Elderly With Either Suxamethonium 1.0 mg/kg or Rocuronium 1.0 mg/kg
• An Open-label, Dose Escalation and Double-masked, Randomized, Controlled Trial Evaluating Safety and Tolerability of Sepofarsen in Children (<8 Years of Age) With LCA10 Caused by Mutations in the CEP290 Gene.
• Computerized Chemosensory-Based Orbitofrontal Cortex (CBOT) for Opioid Use Disorder
• Esketamine Adjuvant Therapy for Patients With Chronic Visceral Pain Comorbid Major Depressive Disorder
• A Clinical Trial of PRAX-114 in Participants With Major Depressive Disorder
• Clonidine to Prevent Delirium After Electroconvulsive Therapy.
• XEN1101 for Major Depressive Disorder
• Effect of Sublingual Formulation of Dexmedetomidine HCl (BXCL501) - Alcohol Interaction Study
• Evaluation of Efficacy and Safety of Iloperidone in the Treatment of Bipolar I Disorder
• Young Houston Emergency Opioid Engagement System
• Pimavanserin for Insomnia in Veterans With Posttraumatic Stress Disorder: Proof of Concept
• Study of Mesenchymal Stem Cells for Pediatric Perianal Fistulizing Crohn's Disease
• A Study of the Change in Disease State and Safety of Oral Cariprazine Capsules in the Treatment of Depression in Pediatric Participants (10 to 17 Years of Age) With Bipolar I Disorder
• Treatment of Restless Legs Symptoms With Pramipexole to Improve the Outcomes of Protracted Opioid Withdrawal in OUD
• Study of Efficacy and Safety of MIJ821 in Addition to Comprehensive Standard of Care on the Rapid Reduction of Symptoms of Major Depressive Disorder in Subjects Who Have Suicidal Ideation With Intent
• Reducing Cannabis Overuse With Prazosin
• Psilocybin for Treatment of Alcohol Use Disorder: a Feasibility Study
• Long-term Safety Study of Adjunctive Troriluzole in Subjects With Obsessive Compulsive Disorder
• Antidepressant Response in Older Adults With Comorbid PTSD and MDD
• Fremanezumab, Migraine and Sleep
• Efficacy and Safety Study of Adjunctive Troriluzule in Obsessive Compulsive Disorder
• Anti-inflmmation Treatment in Mood Disorder and Deep Learning Prediction Model
• Dupilumab in CRSsNP (Liberty CRSsNP ORION)
• Effects of Ospemifene on Brain Activation Patterns in Women With Sexual Interest-arousal Disorders
• Adjunctive Celecoxib in Childhood-onset OCD Study
• Effect of Vitamin K Supplementation on Circulating Levels of Osteocalcin on the Bone Metabolism and Aging
• A Study of SLS-002 (Intranasal Racemic Ketamine) in Adults With Major Depressive Disorder at Imminent Risk of Suicide
• Evaluating the Effects of Tasimelteon vs. Placebo in Delayed Sleep-Wake Phase Disorder (DSWPD)
• Predicting Response to Naltrexone With Eye Tracking in Videogame Disorder
• Cord Blood Transplant in Children and Young Adults With Blood Cancers and Non-malignant Disorders
• Safety, Tolerability and Pharmacokinetics Study of STP1 in a Subgroup of Patients With Autism Spectrum Disorder
• Yangzheng Compound Mixture in the Treatment of Sleep Disorder in Cancer Patients
• Efficacy and Safety Study of Adjunctive Troriluzole in Obsessive Compulsive Disorder
• NMDA Modulation in Major Depressive Disorder
• N-Acetylcysteine for Smoking Cessation in Tobacco and Cannabis Co-Use
• Psilocybin Treatment of Major Depressive Disorder With Co-occurring Alcohol Use Disorder
• Oral Iron Frequency for Childhood Restless Leg Syndrome/Periodic Limb Movement Disorder
• The Safety and Efficacy of Psilocybin in Cancer Patients With Major Depressive Disorder
• Antipsychotic Response to Clozapine in B-SNIP Biotype-1 (Clozapine)
• Open-Label, Flexible-dose Study to Evaluate the Long-Term Safety and Tolerability of Cariprazine in the Treatment of Pediatric Participants With Schizophrenia or Bipolar I Disorder
• Cannabinoids for the Treatment of Anxiety Disorders: An 8-Week Pilot Study
• Neuroimaging and CBD for Heroin Use Disorder
• Role of Liquid Phase Concentrated Growth Factors vs. Hypertonic Dextrose Prolotherapy for Management of Patients With Disc Displacement Without Reduction
• Non-Invasive Vagal Nerve Stimulation in Opioid Use Disorders
• A Study of Lemborexant in Chinese Participants With Insomnia Disorder
• Naltrexone Treatment for Prolonged Grief Disorder (PGD)
• Psychotherapy for Psychosis, Adverse Events, and Substance Misuse
• А Dose-finding Study to Assess the Efficacy and Safety of CD-008-0045 in Patients With Generalized Anxiety Disorder
• CASCADE: CAnnabidiol Study in Children With Autism Spectrum DisordEr
• A Study to Evaluate EMB 001 in Subjects With Cocaine Use Disorder
• Anti-retroviral Therapy, Medications for Opioid Use Disorder, Opioids and HIV Infection - Study 1
• A Comparative Study of Sage-217 Plus an Antidepressant (ADT) Versus Placebo Plus an ADT in Adults With Major Depressive Disorder
• A Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Food Effect of RO6953958 in Healthy Participants
• Feasibility Trial of Pregnenolone for Posttraumatic Stress Disorder and Alcohol Use Disorder
• Leflunomide for the Treatment of Relapsed or Refractory CD30+ Lymphoproliferative Disorders
• Locomotor Training With Testosterone to Promote Bone and Muscle Health After Spinal Cord Injury
• An Open Label Study of FT218 in Subjects With Narcolepsy
• Treating Nightmares in Posttraumatic Stress Disorder With Dronabinol
• A Study to Assess the Effect of a Single Dose of ASP8062 on the Multiple Dose Safety, Tolerability and Pharmacokinetics of Buprenorphine/Naloxone in Participants With Opioid Use Disorder
• A Study to Evaluate the Efficacy of Sage-217 in the Treatment of Adult Participants With Major Depressive Disorder (MDD)
• eIMPACT-DM Pilot Trial: Depression Treatment to Reduce Diabetes Risk
• Brain Hippocampal Volume Relationship With Anxious Symptoms in Major Depressive Patients
• Pilot Trial of Visual Healing® in Psilocybin-assisted Therapy for Alcohol Use Disorder
• FAAH Availability in Psychiatric Disorders: A PET Study
• Study of Desvenlafaxine in Treating Major Depressive Disorder.
• Lofexidine Combined With Buprenorphine for Reducing Symptoms of PTSD and OU Relapse in Veterans
• Extended-Release Buprenorphine vs. Sublingual Buprenorphine for the Treatment of Opioid Use Disorder
• EXHIT ENTRE Comparative Effectiveness Trial
• Allogeneic Hematopoietic Stem Cell Transplant for People With Primary Immunodeficiency Diseases
• Use of Analgesic Treatment to Reduce Signs of Pain in Patients With Disorders of Consciousness.
• Rituximab Treatment for Psychosis and/or Obsessive Compulsive Disorder With Probable Immune System Involvement
• Pregabalin Trial for the Treatment of Alcohol Use Disorder
• Melatonin in ADHD and Sleep Problems
• Evaluate Efficacy and Safety of Endoxifen in Bipolar I Disorder Patients
• Effects of Tofacitinib vs Methotrexate on Rheumatoid Arthritis Interstitial Lung Disease
• Cognitive Outcomes After Dexmedetomidine Sedation in Cardiac Surgery Patients
• Clinical Trial Evaluating Lumateperone Monotherapy in the Treatment of Bipolar Depression or Major Depressive Disorder
• Binge Eating & Birth Control
• Dexmedetomidine in the Treatment of Agitation Associated With Bipolar Disorder
• Treatment of Adults With Generalized Anxiety Disorder Using Glutamine
• The Activation on Prefrontal Cortex With Acupuncture and Moxibustion for Major Depressive Disorder: A Study of Functional Near Infrared Spectroscopy
• Dexmedetomidine in the Treatment of Agitation Associated With Schizophrenia
• MDMA-Assisted Psychotherapy in Veterans With Combat-Related, Refractory PTSD
• Brexpiprazole in Treatment of Children and Adolescents With Irritability Associated With Autism Spectrum Disorder for Subjects That Have Completed Participation in 331-201-00148
• Rituximab at Low dosE for neuromyelitiS optiCa spectrUm disordEr (RESCUE)
• Phthalates Exposure in Type 2 Diabetic Patients and Diuretic Therapy
• Riboflavin for Glutamate Reduction in Alcohol Withdrawal
• Effect of Regulated Add -on Sodium Chloride Intake on Stabilization of Serum Lithium Concentration in Bipolar Disorder
• MeDiGes Study: Metformine Use in Gestational Diabetes
• Vortioxetine in Patients With Depression Coexisting With General Anxiety Disorder (GAD)
• 1H Magnetic Resonance Spectroscopy in Migraine Patients
• Definitive Selection of Neuroimaging Biomarkers for the Diagnosis and Treatment to Common Mental Disorders
• Neuroimmune Dysfunction in Alcohol Use Disorder
• Aripiprazole Lauroxil for Preventing Psychotic Relapse After an Initial Schizophrenia Episode
• Use of a GLP-1R Agonist to Treat Opioid Use Disorder
• Pimavanserin for Insomnia In Veterans With Posttraumatic Stress Disorder
• Role of the Melanocortin-4 Receptor in Hypoactive Sexual Desire Disorder
• Ketamine for the Treatment of Opioid Use Disorder and Depression
• Brexpiprazole in Treatment of Children and Adolescents With Irritability Associated With Autism Spectrum Disorder
• Brexpiprazole as Combination Therapy With Sertraline in the Treatment of Adults With Post-traumatic Stress Disorder
• Brain Indices of Stimulant Treatment in Drug-Naive Youth at Risk for Substance Use Disorder
• Daily Vitamin D for Sickle-cell Respiratory Complications
• Safety and Preliminary Efficacy of ANS-6637 to Reduce Drug Craving and Harm in People With Opioid Use Disorder
• Citalopram and Self Emotional Processing
• Varenicline and Bupropion for Alcohol Use Disorder
• Citalopram and Stress Reactivity
• Adjunctive Effects of Psilocybin and Buprenorphine
• MAP4343 Treatment for Alcohol Use Disorder
• A Study of the Safety and Activity of Eculizumab in Pediatric Participants With Relapsing Neuromyelitis Optica Spectrum Disorder
• Idebenone for the Preventive Treatment of Migraine
• A Phase I Clinical Trial of BAT4406F Injection in Patients With Neuromyelitis Optica Spectrum Disorders
• Vivitrol Treatment for Cannabis Use Disorder
• Evidence of Spreading Vasoconstriction in Human Gingiva
• Evaluating a New Iloperidone Titration Scheme in Bipolar I Disorder or Schizophrenia
• EnBrace HR for PMS With Prominent Mood Symptoms or Menstrual Related Mood Disorders
• Effective Mechanisms of Wu-Chu-Yu Tang on Gastroesophageal Disorder
• Bazedoxifene -Treatment for Women With Schizophrenia
• Clinical Outcome of a Patented Pharmaceutical Composition (KT-110) to Treat Alcohol Use Disorder While Avoiding Major Side Effects
• CLE-100 as an Oral Therapy in Addition to Standard Antidepressant Drug for Major Depressive Disorder - CLEO Study
• Study to Evaluate AD04 in Adults With Alcohol Use Disorder (AUD) and Selected Serotonin Transporter Polymorphisms
• A Trial of Brexpiprazole in the Treatment of Borderline Personality Disorder
• Ketamine for Mood Disorders With Suicidal Ideation
• Feasibility of Emergency Department Initiated Extended-Release Naltrexone for the Treatment of Alcohol Use Disorder
• Estradiol as add-on to Antipsychotics
• A Prospective, Randomized Trial of the Effect of Standard of Care Reduced Dose Versus Full Dose Buprenorphine/Naloxone in the Perioperative Period on Pain Control and Post-Operative Opioid Use Disorder Symptoms
• The Antidiabetic Metformin as a Novel Adjunct to Antidepressants in Major Depressive Disorder Patients
• CHI-902 for Treatment of Social Anxiety Disorder
• A Study of TAK-503 in Children and Teenagers With Attention Deficit Hyperactivity Disorder (ADHD)
• Memory Enhancement by Gamma-hydroxybutyrate vs. Trazodone in Major Depressive Disorder.
• Open-label, Single-dose Trial to Assess the Pharmacokinetics of Centanafadine Extended-release Capsules in Pediatric Subjects With Attention-deficit Hyperactivity Disorder
• Does Treatment of Androgen Excess Using Spironolactone Improve Ovulatory Rates in Girls With Androgen Excess?
• Intranasal Neuropeptide Y in Clinical Trial in Level Two Trauma Patients for PTSD and Acute Stress Disorder
• The Phosphodiesterase-3 Inhibitor Cilostazol as an Adjunctive to Antidepressants in Patients With Major Depressive Disorder.
• Efficacy of Naproxen-codeine, Naproxen+Dexamethasone, and Naproxen on Myofascial Pain
• Brexpiprazole in Alcohol Use Disorder
• Near-infrared Spectroscopy Neurofeedback as a Treatment for Children With Attention Deficit Hyperactivity Disorder
• SUBLOCADE Rapid Initiation Extension Study
• Treatment of Social and Language Deficits With Leucovorin for Young Children With Autism
• Early Treatment of Language Impairment in Young Children With Autism Spectrum Disorder With Leucovorin Calcium
• Oxytocin, Stress, Craving, Opioid Use Disorder
• Therapy for Migraine Prevention in Children 6-11 Years of Age
• A Study to Investigate the Pharmacokinetics, Safety, and Tolerability of Balovaptan in Children With Autism Spectrum Disorder
• Safety and Efficacy of NYX-783 in Subjects With Post-Traumatic Stress Disorder
• A Study to Evaluate the Efficacy and Safety of Fremanezumab for Preventive Treatment of Migraine in Patients With Major Depressive Disorder
• Vortioxetine for the Treatment of Hoarding Disorder
• add-on Low Dose Memantine in Middle-to-old Aged Bipolar II Disorder Patients
• The Analgesic Efficacy of Continuous Sub-fascial Bupivacaine Infusion and Lidocaine Patches in Post-cesarean Patients With Opiate Use Disorder: A Comparative Efficacy Analysis
• Repeated Ketamine Infusions for Comorbid PTSD and MDD in Veterans
• A Trial of Multiple-doses of Aripiprazole in Adults With Schizophrenia or Bipolar 1 Disorder
• A Trial of AXS-05 in Patients With Major Depressive Disorder
• Trial of Naproxen Sodium for the Treatment of OCD in Children With PANDAS
• The Effects of Kynurenine Aminotransferase Inhibition in People With Schizophrenia
• Novel Pharmacotherapy Approaches in Smokers With Serious Mental Illness
• A Study to Evaluate SAGE-217 for Prevention of Relapse in Adult Subjects With Major Depressive Disorder
• Umbilical Cord Blood vs Personalized Treatments for Improving Autistic Disorder
• Treatment of REM Sleep Behavior Disorder (RBD) With Sodium Oxybate
• Multi-modal Assessment of Gamma-aminobutyric Acid (GABA) Function in Psychosis
• Extension Study of Pimavanserin in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Treatment
• Study to Evaluate the Efficacy and Safety of Adjunctive Pimavanserin in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Treatment (CLARITY-2)
• Smell Changes & Efficacy of Nasal Theophylline
• Rituximab for Obsessive-compulsive Disorder. (RITS-PO-2019)
• Rituximab for Schizophrenia Spectrum Disorder (RITS-PS-2019)
• UH3 Varenicline for Cannabis Use Disorder
• the Efficacy and Safety of Agomelatine in the Patients With Parkinson's Disease
• Serotonin in Impulse Control Disorders in Parkinson's Disease
• HLAB-002 of ANS-6637 for Alcohol Use Disorder
• Study to Evaluate the Efficacy and Safety of Adjunctive Pimavanserin in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Treatment (CLARITY-2)
• Neurobehavioral Mechanisms of Choice in Opioid Use Disorder
• The Role of Neuroactive Steroids in Stress, Drug Craving and Drug Use in Cocaine Use Disorders
• Slow-Release Oral Morphine for the Treatment of Opioid Use Disorder
• Cognitive-Behavioral and Pharmacologic (LDX) Treatment of Binge-Eating Disorder and Obesity: Medication Change for Non-Responders
• Outcomes Mandate National Integration With Cannabis as Medicine for Prevention and Treatment of COVID-19
• Effects of Intranasal Insulin on Neuroimaging Markers and Cognition in Patients With Psychotic Disorders
• Adjunctive D-Cycloserine in Major Depressive Disorder
• UNLOCKED: A Phase 2, Open-label Trial With KB195 in Subjects With a Urea Cycle Disorder
• Nitrous Oxide for Major Depressive Disorder
• Cognitive-Behavioral and Pharmacologic (LDX) Treatment of Binge-Eating Disorder and Obesity: Maintenance Treatment
• A Study of Escitalopram in the Treatment of Children and Adolescents With Generalized Anxiety Disorder
• Cognitive-Behavioral and Pharmacologic (LDX) Treatment of Binge-Eating Disorder and Obesity: Acute Treatment
• Overcoming Psychomotor Slowing in Psychosis (OCoPS-P)
• Medication Treatment for Opioid Use Disorder in Expectant Mothers
• Brain Insulin Resistance in Mood Disorders
• A Study to Evaluate Efficacy, Safety, Tolerability and Exposure After a Repeat-dose of Sepofarsen (QR-110) in LCA10 (ILLUMINATE)
• Extension Study to Study PQ-110-001 (NCT03140969)
• Medication Treatment for Opioid Use Disorder in Expectant Mothers: Infant Neurodevelopmental Outcomes Sub-study
• Medication Treatment for Opioid Use Disorder in Expectant Mothers: Conceptual Model Assessments Sub-study
• Cannabidiol for Alcohol Use Disorder
• COMT Inhibition Among Individuals With Comorbid AUD/ADHD
• Citalopram Titration in Early Non-responder Patients With Major Depressive Disorders
• Study on the Effect of PRKCB1 Modulating Inflammatory Factors and the Role for Developing Major Depressive Disorder
• Pilot Human Lab Study of Lacosamide in Alcohol Use Disorder (AUD)
• Suvorexant in the Management Comorbid Sleep Disorder and Alcohol Dependence
• Manipulating Ghrelin Signaling Via GOAT Inhibition in Alcohol Use Disorder
• Prazosin Use in Adults With Anxiety Disorders
• Definitive Selection of Neuroimaging Biomarkers in Anxiety Disorder and Obsessive-compulsive Disorder: A Longitudinal Functional Magnetic Resonance Imaging （fMRI） Study With Paroxetine Treatment
• Biolab Zolpidem Orodispersible 1.0 mg, 1.75 mg and 3.5 mg to Treat Maintenance Insomnia Disorder.
• Intranasal Oxytocin for the Treatment of Alcohol Use Disorder
• Persistence Targeted Smoking Cessation in Schizophrenia
• Trial to Assess the Bioavailability of Quetiapine Versus Seroquel® in Subjects With Schizophrenia or Bipolar Disorder
• Single Ascending Dose Study in Participants With LCA10
• The Role of Neuroactive Steroids in Stress, Alcohol Craving and Alcohol Use in Alcohol Use Disorders
• Nitrous Oxide for the Treatment of Major Depressive Disorder
• A Study of Psilocybin for Major Depressive Disorder (MDD)
• A Study to Evaluate SAGE-217 in Adult Participants With Major Depressive Disorder (MDD)
• Effects of Acute Prucalopride Administration in Healthy Volunteers
• Intraoperative Ketamine Versus Saline in Depressed Patients Undergoing Anesthesia for Non-cardiac Surgery
• An Open-Label Pilot Study of Sublocade as Treatment for Opiate Use Disorder
• Memantine Effects on Sensorimotor Gating and Neurocognition in Schizophrenia
• Clozapine Versus Olanzapine as Treatment for Comorbid Psychotic Disorder and Substance Use Disorder
• Study of Rapastinel as Monotherapy in Major Depressive Disorder (MDD)
• A Trial of Single- and Multiple-doses of Aripiprazole in Adult Subjects With Schizophrenia or Bipolar I Disorder
• Kappa Opioid Receptor Antagonism for the Tx of AUD and Comorbid PTSD
• Safety and Tolerability of Cannabidivarin (CBDV) in Children and Young Adults With Autism Spectrum Disorder
• Estradiol Patch as add-on to Antipsychotics in Patients With Schizophrenia, Schizoaffective or Schizophreniform Disorder
• Using Non-invasive Brain Stimulation (tDCS) With Varenicline for Treating Tobacco Dependence
• Effect of a Wide Spectrum Nutritional Supplement on Mitochondrial Function in Children With Autism Spectrum Disorder
• A Study of the Safety of REN001 in Patients With Fatty Acid Oxidation Disorders
• Efficacy, Safety, and Tolerability Study of Oral Full-Spectrum MicrobiotaTM (CP101) in Subjects With Autism Spectrum Disorder and Associated GI Symptoms (SPROUT)
• Autologous Transplant To End NMO Spectrum Disorder
• Randomized Trial of Adult Subjects With Generalized Anxiety Disorder
• Treating Smokers With Mental Illness
• XIENCE 28 USA Study
• The Effects of Sedatives on Tobacco Use Disorder
• Varenicline for Smoking Cessation in Hospitalized Patients With Psychiatric Disorders
• The Use of Dexmedetomidine for EEG Sedation in Children With Behavioural Disorders
• Vitamin B6 and B12 in the Treatment of Movement Disorders Induced by Antipsychotics
• Identification of Multi-modal Bio-markers for Early Diagnosis and Treatment Prediction in Schizophrenia Individuals
• Cannabidiol as Adjunctive Treatment for Opioid Use Disorder
• Mild-Intensity Whole Body Hyperthermia (WBH) for Major Depressive Disorder
• Dose-Finding Clinical Trial to Evaluate the Efficacy and Safety of LY03005 Extended-release Tablets in the Treatment of Major Depressive Disorder (MDD)
• A 14 Week, Randomized, Placebo-Controlled Cross-Over Study of Methylphenidate Hydrochloride Controlled Release Capsules in Adult ADHD With and Without Anxiety Disorder Comorbidity
• Study to Evaluate Safety and Tolerability of QR-421a in Subjects With RP Due to Mutations in Exon 13 of the USH2A Gene
• A Study to Evaluate the Safety, Tolerability, and Efficacy of SAGE-217 Compared to Placebo in Adult Subjects With Comorbid Major Depressive Disorder and Insomnia
• Extension Study Evaluating The Safety And Tolerability Of Flexible Doses Of Oral Ziprasidone In Children And Adolescents With Bipolar I Disorder
• Natural Treatments for the Management of Emotional Dysregulation in Youth With Non-verbal Learning Disability (NVLD) and/or Autism Spectrum Disorders (ASD)
• A Study to Determine Pharmacokinetic Characteristics of LY03010 Versus INVEGA SUSTENNA® in Schizophrenia Patients
• Xenon Inhalation Therapy for Major Depressive Disorder and Bipolar Disorder
• The Role of Estrogen in the Neurobiology of Eating Disorders
• The Object of This Study is to Evaluate the Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD) Who Have Had an Inadequate Response to Antidepre
• Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD) Who Have Had an Inadequate Response to Antidepressants Alone
• A Long-Term Study of Brexpiprazole in Patients With Major Depressive Disorder
• Nitrous Oxide- Suicidal Ideation
• Altering Memories That Increase Risk of Relapse in Alcohol Use Disorders
• Add-on Low Dose Dextromethorphan and Memantine in Patients With Amphetamine-type Stimulants Use Disorder
• AGN-241751 in the Treatment of Major Depressive Disorder
• Ketamine for Major Depressive Disorder
• Effect of Changing Physiological Conditions on Myogenic Oscillations: Pilot Study
• Subcutaneous Hydrocortisone Children With Congenital Adrenal Hyperplasia
• The Clinical Utility of Measuring the Circadian Clock in Treatment of Delayed Sleep-Wake Phase Disorder
• Efficacy and Safety of Bumetanide Oral Liquid Formulation in Children Aged From 2 to Less Than 7 Years Old With Autism Spectrum Disorder.
• Brain Connectivity in Attention Deficit Hyperactivity Disorder (ADHD)
• N-Acetylcysteine for Adolescent Alcohol Use Disorder
• A Study of Brexpiprazole in Patients With Major Depressive Disorder
• A Study of Efficacy and Safety of Sepranolone (UC1010) in Patients With Premenstrual Dysphoric Disorder (PMDD)
• A Study to Evaluate SAGE-217 in Subjects With Bipolar I/II Disorder With a Current Major Depressive Episode - Part A
• Sexual Penetration Pain in Postmenopausal Women: A Topical Botanical Drug Treatment
• GABA Pathways in Autism Spectrum Disorder (ASD)
• Study of Rapastinel as Monotherapy in Patients With Major Depressive Disorder (MDD)
• A Study to Evaluate the Efficacy of SAGE-217 in the Treatment of Adult Subjects With Major Depressive Disorder
• A Study to Evaluate the Safety and Efficacy of IPX203 in Parkinson's Disease Patients With Motor Fluctuations
• A Study to Assess the Effects of RO6889450 (Ralmitaront) in Participants With Schizophrenia or Schizoaffective Disorder and Negative Symptoms
• Study of Adjunctive or Monotherapy Rapastinel Treatment in Patients With Major Depressive Disorder (MDD)
• Leveraging Biomarkers for Personalized Treatment of Alcohol Use Disorder Comorbid With PTSD
• A Study to Investigate the Efficacy, Safety, and Tolerability of JNJ-42165279 in Adolescent and Adult Participants With Autism Spectrum Disorder
• Allogeneic Hematopoietic Cell Transplantation for Disorders of T-cell Proliferation and/or Dysregulation
• Trial to Evaluate the Long-term Efficacy of Oral Aripiprazole in the Treatment of Pediatric Participants With Tourette's Disorder
• Adult Attention Deficit Hyperactivity Disorder (ADHD) Study With Amphetamine Sulfate
• Acceptable Hemodynamic Changes in Dexmedetomidine for Single Intravenous Bolus Injection
• A Trial to Measure the Difference in All-cause Hospitalizations for Participants Who Are Using Abilify MyCite Versus Virtual Matched Controls in Adults With Schizophrenia, Bipolar 1 Disorder, and Major Depressive Disorder
• A Study in Patients With Major Depressive Disorder
• Suvorexant: A Dual Orexin Receptor Antagonist for Treating Sleep Disturbance in Posttraumatic Stress
• Lorcaserin for Cannabis Use Disorder
• Oxytocin Treatment for Alcohol Use Disorders
• Imaging 5HT7 Antagonist Effects in Bipolar Disorder
• Metformin for Treatment of Psoriasis Combined With Disorders of Glucose and Lipid Metabolism
• Study of ABX-1431 in Adult Patients With Tourette Syndrome or Chronic Motor Tic Disorder
• Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - Second Study
• TCR Alpha Beta T-cell and CD19 B-cell Depleted Peripheral Blood Stem Cell Transplantation Using the CliniMACS System for Patients With Non-Malignant Hematologic Disorders From Matched or Mismatched, Related or Unrelated Donors
• Study of Monotherapy Rapastinel in the Prevention of Relapse in Patients With Major Depressive Disorder (MDD)
• Oxytocin and Stress Response in Alcohol Use Disorder
• A Long Term Study of ALKS 5461 in the Treatment of Refractory Major Depressive Disorder (MDD)
• A Trial Evaluating the Long-term Safety and Tolerability of Centanafadine Sustained-release Tablets in Adults With Attention-Deficit/Hyperactivity Disorder
• A Trial to Evaluate the Efficacy, Safety, and Tolerability of Centanafadine Sustained-release Tablets in Adults With Attention-deficit/Hyperactivity Disorder
• Safety and Efficacy of Cariprazine As Adjunctive Therapy In Major Depressive Disorder
• A Trial Evaluating the Efficacy, Safety, & Tolerability of Centanafadine Sustained-release Tablets in Adults With Attention-deficit/Hyperactivity Disorder
• Optimal Treatment of Veterans With PTSD and Comorbid OUD
• Study of CAR-T Cells Expressing CD30 and CCR4 for r/r CD30+ HL and CTCL
• Pacritinib in Relapsed/Refractory Lymphoproliferative Disorders
• Co Morbid Attention Deficit and Hyperactivity Disorder(ADHD) and Developmental Co Ordination Disorder (DCD)
• Modulation of the Brain Excitatory/Inhibitory (E/I) Balance in Autism Spectrum Disorder (ASD)
• Ibudilast for the Treatment of Alcohol Use Disorder
• Study to Investigate the Effect of AB-101 in Breast Cancer Survivors
• Study of Neuroimaging Biomarkers of Social Cognition Deficits in Adolescents (Age 13-17) With Autism Spectrum Disorder and Effects of Gabapentin
• NBTXR3 Activated by Radiotherapy for Patients With Advanced Cancers Treated With An Anti-PD-1 Therapy
• AGN-241751 in the Treatment of Major Depressive Disorder
• Vortioxetine Monotherapy for Major Depressive Disorder in Type 2 Diabetes
• Study Of Nivolumab Alone, Or In Combination With Vinblastin In Patients With Classical Hodgkin Lymphoma
• A 6-week Study to Evaluate the Safety and Efficacy of Quillichew ERCT in 4-5 Year Old Children With ADHD.
• A Cariprazine Study in the Prevention of Relapse in Bipolar I Disorder Patients Whose Current Episode is Manic or Depressive, With or Without Mixed Features
• Study of Adjunctive Ganaxolone Treatment in Children and Young Adults With CDKL5 Deficiency Disorder
• Effects of Seven Day Prucalopride Administration in Healthy Volunteers
• Efficacy, Safety, and Tolerability of Levomilnacipran ER in Pediatric (7-17 Years) With Major Depressive Disorder
• A Trial to Explore Acceptance and Performance of Using a Digital Medicine System With Healthcare Professionals and Adults With Schizophrenia, Schizoaffective Disorder, or First Episode Psychosis on an Oral Atypical Antipsychotic
• Evaluating the Efficacy and Safety of Yi-Gan San in Children and Adolescents With Tourette's Disorder
• Research Into Antipsychotic Discontinuation and Reduction Trial
• The Study of Mindfulness-based Cognitive Therapy and Major Depressive Disorder
• Role of Pentoxifylline as an Adjuvant Therapy for Adult Patients With Major Depressive Disorder
• Psilocybin - Induced Neuroplasticity in the Treatment of Major Depressive Disorder
• Memantine for the Treatment of Social Deficits in Youth With Disorders of Impaired Social Interactions
• Study of Clonidine Efficacy for the Treatment of Impulse Control Disorders in Parkinson's Disease:
• Cannabidiol for the Treatment of Anxiety Disorders: An 8-Week Pilot Study
• Study to Assess the Efficacy and Safety of ACT-541468 in Adult and Elderly Subjects With Insomnia Disorder
• Efficacy and Mechanisms of Naltrexone+Bupropion for Binge Eating Disorder
• A Trial to Evaluate the Efficacy, Safety & Tolerability of Brexpiprazole in the Maintenance Treatment of Adults With Major Depressive Disorder
• A Double-Blind, Placebo-Controlled Safety and Efficacy Study of NA-831
• Improving Driving in Young People With Autism Spectrum Disorders
• Shifting Brain Excitation-Inhibition Balance in Autism Spectrum Disorder
• Combinatorial Pharmacogenomics Testing in Treatment-Naïve Major Depressive Disorder
• Brexpiprazole Study
• Treatments for Anxiety: Meditation and Escitalopram
• Combination Probiotic: BB-12 With LGG (Different Doses) in Treating Children With Autism Spectrum Disorder
• Study to Evaluate Improvements of the Quality of Sleep With NOVANUIT® Triple Action in Healthy Volunteers With Sleep Disorders
• Sodium Benzoate and/or N-Acetylcysteine Added to TAU in Patients With Early Schizophrenia Spectrum Disorder.
• A Study of Balovaptan in Adults With Autism Spectrum Disorder With a 2-Year Open-Label Extension
• Bioequivalence Study of Paroxetine Tablets and Paxil® Under Fasting and Fed Conditions in Chinese Healthy Volunteers
• Aripiprazole Oral Solution in the Treatment of Children and Adolescents With Autistic Disorder
• The Safety and Efficacy of Brexpiprazole as Adjunctive Therapy in the Treatment of Major Depressive Disorder
• Substance Misuse To Psychosis for Stimulants
• Substance Misuse To Psychiatric Disorders for Cannabis
• Effectiveness of Methylphenidate Late Formula to Reduce Cannabis Use in Young Cannabis-Related Patients and Attention Deficit Disorder Hyperactivity
• Haploidentical Allogeneic Peripheral Blood Transplantation: Examining Checkpoint Immune Regulators' Expression
• Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic Malignancies
• A Trial of TTA-121 on Autism Spectrum Disorder
• BP101 for Adults With Female Sexual Dysfunction
• A Clinical Trial of Oral Ganaxolone in Women With Postpartum Depression
• A Study to Evaluate the Efficacy and Safety of MIN-117 in Adult Patients With Major Depressive Disorder
• Intranasal Ketamine With Dexmedetomidine for the Treatment of Children With Autism Spectrum Disorder
• A Pilot Study of Buspirone for the Treatment of Anxiety in Youth With Autism Spectrum Disorders
• Cariprazine Effects on Brain and Behavior in Cocaine Use Disorder
• Effects of Intranasal Naloxone on Gambling Urges and Craving in Gambling Disorder
• Psilocybin vs Escitalopram for Major Depressive Disorder: Comparative Mechanisms
• Randomized Clinical Trial Evaluating BP1.3656 Versus Placebo For Alcohol Use Disorder Treatment
• Modafinil for the Treatment of Alcohol Use Disorders
• Study to Assess the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Intermittent Explosive Disorder
• Topical Bimatoprost in the Treatment of Migraine
• Brexpiprazole in Borderline Personality Disorder
• Effect of GET73 on MRS Measures of Central Glutamate and GABA in Individuals With Alcohol Use Disorder
• Glasdegib in Refractory Patients With Sclerotic Chronic Graft-Versus-Host Disease
• NMDA Modulation in Major Depressive Disorder in Late- Life
• To Determine the Effect of GLP1 on Cognitive Function, Brain Glucose Metabolism and Neuroplasticity.
• Microbiota Transfer Therapy for Adults With Autism Spectrum Disorder (ASD) Who Have Gastrointestinal Disorders
• CAE Plus LAI in Individuals With Bipolar Disorder at Risk for Treatment Non-adherence (BD-CAEL)
• MGTA-456 in Patients With Inherited Metabolic Disorders Undergoing Hematopoietic Stem Cell Transplantation (HSCT)
• Venetoclax and Decitabine in Treating Participants With Relapsed/Refractory Acute Myeloid Leukemia or Relapsed High-Risk Myelodysplastic Syndrome
• A Study of Duloxetine (LY248686) in the Treatment of Japanese Children and Adolescents With Depressive Disorder
• Ketamine in Borderline Personality Disorder
• Fatty Acid Amide Hydrolase (FAAH) Inhibitor Treatment of Cannabis Use Disorder (CUD)
• A 12-weeks Study to Evaluate the Dietary Fiber and Probiotics Treatment in Prevention and Intervention of Weight-gain and Cognitive Impairment of Schizophrenia or Bipolar Disorder
• Zonisamide Outpatient Study
• Exploring Nitrous Oxide Effects for Post Traumatic Stress Disorder (PTSD)
• A Study to Evaluate the Efficacy, Safety, and Tolerability of JNJ-42847922 in Participants With Insomnia Disorder
• A Study to Investigate the Antidepressant Mechanism-of-action of JNJ-42847922 in Participants With Major Depressive Disorder
• Chidamide Combined With R-GDP in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL)
• Alpha-Amino-3-Hydroxy-5-Methyl-4- Isoxazole Propionic Acid Receptor Components of the Anti-Depressant Ketamine Response
• A Trial of Directly Observed and Long-term Varenicline
• XIENCE 28 Global Study
• Bioequivalence (BE) Study Comparing Azithromycin 250 mg Tablet Manufactured in China and in the United States
• A Study of Rapastinel for Rapid Treatment of Depression and Suicidality in Major Depressive Disorder
• Tocilizumab vs Azathioprine in Neuromyelitis Optica Spectrum Disorders
• Tolcapone in Obsessive Compulsive Disorder
• [11C]NOP-1A and Cocaine Use Disorders
• Glutamatergic Modulation to Facilitate the Behavioral Treatment of Cocaine Use Disorders
• Evaluation of the Effect and Safety of Lisdexamfetamine in Children Aged 6-12 With ADHD and Autism
• Study of Glycerol Phenylbutyrate & Sodium Phenylbutyrate in Phenylbutyrate Naïve Patients With Urea Cycle Disorders
• Gabapentin for Bipolar & Cannabis Use Disorders
• Simplified Cognitive Behavioral Therapy for Generalized Anxiety Disorder and Depression
• Safety, Tolerability and Pharmacokinetics of SHP465 in Children Aged 4 to 5 Years With Attention-Deficit/Hyperactivity Disorder (ADHD)
• Safety and Tolerability Study of SHP465 in Children Aged 4 to 12 Years Diagnosed With Attention-deficit/Hyperactivity Disorder (ADHD)
• Efficacy and Safety of SHP465 at 6.25 mg in the Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in Children Aged 6-12 Years
• The Safety and Efficacy of OPC-64005 in the Treatment of Adult Attention-deficit/Hyperactivity Disorder
• A Study to Compare the Efficacy, Safety, and Tolerability of JNJ-42847922 Versus Quetiapine Extended-Release as Adjunctive Therapy to Antidepressants in Adult Participants With Major Depressive Disorder Who Have Responded Inadequately to Antidepress
• Effects of Erythropoietin on Cognition and Neural Activity in Mood Disorders
• A Study of Duloxetine (LY248686) in Japanese Children and Adolescents With Depressive Disorder
• Cannabidiol as an Adjunctive Treatment for Bipolar Depression
• Psilocybin for Treatment of Obsessive Compulsive Disorder
• BHV-4157 in Adult Subjects With Obsessive Compulsive Disorder
• Trial to Assess the Pharmacokinetics, Safety, Tolerability of Oral Brexpiprazole in Children (6 to <13 Years Old) With Central Nervous System Disorders
• A Proof of Concept Study to Evaluate the Effects of Tasimelteon and Placebo in Travelers With Jet Lag Disorder
• A Trial to Evaluate the Safety and Tolerability of Brexpiprazole in the Treatment of Participants With Bipolar I Disorder.
• Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
• Inhaled Nitrous Oxide for Treatment-Resistant Depression: Optimizing Dosing Strategies
• Effects of Intranasal Naloxone on Gambling Urges in Gambling Disorder
• Psycho-biological Substrates of Therapeutic Benefit of Thermal Cure on Generalized Anxiety Disorders
• Allogeneic HUman Mesenchymal Stem Cell InfusioN Versus Placebo in Subjects With Alcohol Use Disorder and Major DepreSsion.
• Safety and Efficacy Study in Preschool Children Aged 4-5 Years With Attention-deficit/Hyperactivity Disorder (ADHD)
• A Trial to Assess Brexpiprazole Versus Placebo for the Treatment of Acute Manic Episodes Associated With Bipolar I Disorder
• A Trial to Assess Brexpiprazole Versus Placebo for the Treatment of Acute Manic Episodes, Associated With Bipolar I Disorder
• Pregabalin as Treatment for Alcohol Use Disorder
• Effects of Cannabidiol in Alcohol Use Disorder
• Buprenorphine Physician-Pharmacist Collaboration in the Management of Patients With Opioid Use Disorder: CTN 0075
• Cannabidiol as a Treatment for AUD Comorbid With PTSD
• Minocycline for Alcohol Use Disorder
• Study to Investigate Whether AFQ056 Reduces Cocaine Use in Patients Diagnosed With Cocaine Use Disorder (CUD)
• Impact of Combined Medication and Behavioral Treatment for ASD & ADHD
• Effects of Ondansetron in Obsessive-compulsive and Tic Disorders
• A Study to Evaluate the Efficacy and Safety of Dasotraline in Children 6 to 12 Years Old With Attention-Deficit Hyperactivity Disorder (ADHD) in a Simulated Classroom Setting.
• A Clinical Trial of Intravenous Ganaxolone in Women With Postpartum Depression
• A Study to Evaluate the Efficacy and Safety of JNJ-42847922 as Adjunctive Therapy to Antidepressants in Adult Participants With Major Depressive Disorder Who Have Responded Inadequately to Antidepressant Therapy
• Imaging GABAergic/Glutamatergic Drugs in Bipolar Alcoholics Alcoholics
• Multi-Dimensional Diagnosis,Individualized Therapy,and Management Technique for Major Depressive Disorder:Based on Clinical and Pathological Characteristics
• Cognitive and Psychophysiological Effects of Delta-9-Tetrahydrocannabinol in Bipolar Disorder
• Medication Development for Opioid and Alcohol Abuse
• Cannabidivarin (CBDV) vs. Placebo in Children With Autism Spectrum Disorder (ASD)
• Study to Evaluate the Long-term Safety, Tolerability, and Durability of Treatment Effect of ALKS 3831
• Methylene Blue Injection for Nonneoplastic Epithelial Disorders of Vulva
• The Preventive Treatment of Migraine With Low-Dose Naltrexone and Acetaminophen Combination
• BTRX-246040 Administered Once Daily to Patients With Major Depressive Disorder
• A Double Blind Randomised Placebo-controlled Trial to Assess the Role of Iron Repletion in Glucose Homeostasis.
• Brain Dopaminergic Signaling in Opioid Use Disorders
• A Study of ALKS 5461 for Treatment Refractory Major Depressive Disorder (MDD)
• Study to Evaluate the Efficacy of ALKS 3831 on Body Weight in Young Adults Who Have Been Recently Diagnosed With Schizophrenia, Schizophreniform, or Bipolar I Disorder
• Study to Evaluate the Efficacy and Safety of 3 Fixed Doses of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Pediatric Partici
• Oxytocin in Spectrum Autism Disorders
• Effects of Psilocybin in Major Depressive Disorder
• The Study of Mindfulness Based Cognitive Therapy and Obsessive-Compulsive Disorder
• Effect of Deep Versus Moderate Neuromuscular Block During Sevoflurane Anesthesia on Intraoperative Surgical Conditions.
• Lorcaserin in Combination With XR-Naltrexone for Relapse Prevention in Opioid Use Disorder
• Clinical Trial of Efficacy and Safety of Tenoten for Children in the Treatment of Specific Developmental Disorders of Scholastic Skills in Children
• Saxenda® in Obese or Overweight Patients With Stable Bipolar Disorder (Investigator Initiated)
• The BIO-K Study: A Single-Arm, Open-Label, Biomarker Development Clinical Trial of Ketamine for Non-Psychotic Unipolar Major Depression and Bipolar I or II Depression.
• A Study of Bumetanide for the Treatment of Autism Spectrum Disorders
• LSD Treatment in Persons Suffering From Anxiety Symptoms in Severe Somatic Diseases or in Psychiatric Anxiety Disorders
• Attention Deficit Hyperactivity Disorder (ADHD) Prediction of Treatment Response
• Salicylic Augmentation in Depression
• Posttraumatic Stress Disorders in Police, Correctional Service Officers, and 911 Operators
• The Trauma of Betrayal: Treating Adjustment Disorder With Reconsolidation Blockade Under Propranolol
• Drug Interaction and Subjective Effects of Compounds for Opioid Use Disorder
• Phase I Functional Magnetic Resonance Imaging (fMRI) Pharmacodynamic Studies of Compounds for Opioid Use Disorder and Cocaine Use Disorder
• A Study to Assess the Wakefulness Promoting Effect, Safety, Tolerability, and Pharmacokinetics (PK) of LML134 in Shift Work Disorder
• Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders
• Escitalopram in the Treatment of Adolescents With Major Depressive Disorder or Anxiety Disorders
• Efficacy and Safety of Duloxetine Among Individuals With Depressive Disorder in a 12 Weeks Trial
• ELEKT-D: Electroconvulsive Therapy (ECT) vs. Ketamine in Patients With Treatment Resistant Depression (TRD)
• Continuation With Vortioxetine in Child and Adolescent Patients With Major Depressive Disorder (MDD) From 7 to 17 Years of Age
• A Study to Evaluate a Drug (Dasotraline) on the Safety, Effectiveness and How Well the Body Tolerates it, in Adults With Moderate to Severe Binge Eating Disorder
• Cannabidiol Pharmacotherapy for Adults With Cannabis Use Disorder
• 54135419SUI3002: A Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Participa
• A Study to Evaluate the Safety and Efficacy of TS-121 as an Adjunctive Treatment for Major Depressive Disorder
• TOnicity of Perioperative Maintenance SoluTions
• A Study of the Efficacy of Botox in the Treatment of Social Anxiety Disorder
• Accelerated Development of Additive Pharmacotherapy Treatment (ADAPT-2) for Methamphetamine Use Disorder
• Effectiveness and Acceptability of Stellate Ganglion Block for Posttraumatic Stress Disorder Symptoms - Effectiveness
• Z-Drugs for Sleep Disorders in Alzheimer's Disease
• Randomized Clinical Trial of a Mindfulness Based Intervention in Generalized Anxiety Disorder
• Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder
• Safety and Efficacy Study of VY-AADC01 for Advanced Parkinson's Disease
• Clonazepam Effects on Brain Oscillations and Cognition in Schizophrenia
• Sofosbuvir/Velpatasvir in Postpartum Women With Opioid Use Disorder and Chronic Hepatitis C Infection
• Study to Validate the Questionnaire Called IDSIQ™ in Patients With Insomnia Disorder
• N-Acetylcysteine for Youth Cannabis Use Disorder
• Open Label Ketamine Treatment for Major Depressive Disorder in Veterans
• Safety, Tolerability, PK Profile, and Symptom Response of a 7-Day Dosing With 25 mg or 50 mg Daily of REL-1017 in MDD
• A Phase I, Two-part Study to Determine the Recommended Dose and Evaluate the Safety and Tolerability of a Novel Oral Arsenic Trioxide Formulation (ORH-2014) in Subjects With Advanced Hematological Disorders
• Efficacy of Prazosin in Preventing Post-traumatic Stress Disorder
• Raloxifene Augmentation in Patients With a Schizophrenia Spectrum Disorder
• Study to Treat Major Depressive Disorder With a New Medication
• 54135419SUI3001: A Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Participa
• Human Laboratory Study of Varenicline for Alcohol Use Disorder
• Nalmefene, Baclofen and Impulsivity in Subjects With Alcohol Use Disorder and Healthy Control Subjects
• A Study of Flexible Dose Brexpiprazole as Monotherapy or Combination Therapy in the Treatment of Adults With Post-traumatic Stress Disorder
• Topiramate Treatment of Alcohol Use Disorders in African Americans
• Study to Evaluate the Efficacy and Safety of Adjunctive Pimavanserin in Major Depressive Disorder (CLARITY)
• Acute Anxiolytic Effects of Riluzole on Subjects With Social Anxiety Disorder
• Umbilical Cord Blood Transplantation From Unrelated Donors
• Ebselen as an add-on Treatment in Hypo/Mania
• Lanreotide in the Treatment of Small Bowel Motility Disorders
• A Feasibility Study of N-acetylcysteine for Self-injurious Behavior in Children With Autism Spectrum Disorder
• Lorcaserin in the Treatment of Cocaine Use Disorder
• Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
• Study of Lemborexant for Irregular Sleep-Wake Rhythm Disorder and Mild to Moderate Alzheimer's Disease Dementia
• Movantik for Opioid-Related Esophageal Disorders
• NMDA Receptor Antagonist Nitrous Oxide Targets Affective Brain Circuits
• Closed Loop Vagal Nerve Stimulation for Patients With Posttraumatic Stress Disorder
• A Study of Oxytocin for the Treatment of Social Impairment in Individuals With High Functioning Autism Spectrum Disorder
• Analysis of the Effects of the Osteopathic Manipulative Treatment in Carriers of Temporomandibular Disorders
• Goal Achievement After a Change to Vortioxetine in Adults With Major Depressive Disorder
• N-Acetyl Cysteine Supplementation in Therapy Refractory Major Depressive Disorders
• Use of Psychotropic Medications Among Pregnant Women With Bipolar Disorder
• Clinical Trial for Alcohol Use Disorder and Post Traumatic Stress Disorder (PTSD)
• Intranasal Inhalations of Bioactive Factors Produced by M2 Macrophages in Patients With Organic Brain Syndrome
• Acceptance and Commitment Therapy in SSRI-Resistant Obsessive Compulsive Disorder
• Long-term Study of Lemborexant in Insomnia Disorder (SUNRISE 2)
• A Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
• Methylphenidate in Adults With Attention Deficit/Hyperactivity Disorder
• Prednisolone Addition for Patients With Recent-onset Psychotic Disorder
• A Promising Tool for Predicting Consciousness Evolution in Prolonged Disorders of Consciousness
• A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
• A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-02)
• Neural and Behavioral Effects of Oxytocin in Autism Spectrum Disorders
• Evaluation of Nalmefene in Impulse Control Disorders in Parkinson's Disease: A Prospective Open Label Study
• A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-01)
• Use of a Mobile Health Sensor in an Open Label Trial of Lorcaserin for the Treatment of Cannabis Use Disorder
• Pentosan Polysulfate Sodium and Meclofenamic Acid as Treatments in Patients With Psychotic Disorders
• Safety and Efficacy of SJP-0035 Ophthalmic Solution in Patients With Moderate to Severe Corneal Epithelial Disorders
• A Study to Evaluate the Effects of a Single-Dose and Repeat-Administration of Intranasal Esketamine on On-Road Driving in Participants With Major Depressive Disorder
• Study of the Efficacy and Safety of Initial Administration of 17 mg Vortioxetine Intravenously With 10 mg/Day Vortioxetine Orally in Patients With Major Depressive Disorder
• Oxytocin and Social Cognitive Skills Groups
• Aripiprazole for Bipolar Disorder and Alcohol Use Disorder
• Cost- Effectiveness and Quality of Life Assessment in Bipolar Disorder Depressive Episode
• NAC for Treating Comorbid PTSD and SUD
• Sulforaphane for the Treatment of Young Men With Autism Spectrum Disorder
• Efficacy and Tolerability of Ecopipam in Adults With Childhood Onset Fluency Disorder (Stuttering).
• A Study to Investigate the Safety, Tolerability, and Pharmacodynamics of JNJ-54175446 in Participants With Major Depressive Disorder
• Study Investigating the Effect of Lu AF35700 on Cardiac Repolarization in Men and Women With Schizophrenia and Schizoaffective Disorder
• A Study to Investigate the Efficacy and Safety of Balovaptan (RO5285119) in Participants With Autism Spectrum Disorder (ASD)
• Zonisamide Treatment of Alcohol Use Disorder: an Evaluation of Efficacy and Mechanism of Action
• Open-Label Treatment Extension Study
• Longitudinal Comparative Effectiveness of Bipolar Disorder Therapies
• Efficacy and Safety of Bortezomib as add-on Treatment in Relapsing Neuromyelitis Optica Spectrum Disorder
• Collaborative Care for Alcohol Use Disorders in the Patient-centered Medical Home
• A Study of Delayed and Extended Release Formulation of Dextroamphetamine Sulfate (HLD100) in Children With ADHD
• The UTHealth Ketamine Project
• Eye Tracking as a Predictor of Methylphenidate Response in Autism With ADHD
• Open-label Study of Nelotanserin in Lewy Body Dementia With Visual Hallucinations or REM Sleep Behavior Disorder
• Trial of Propranolol in Children and Youth With Autism Spectrum Disorder and Predictors of Response
• Cost- Effectiveness and Quality of Life Assessment in Mood Disorder
• Treatment Outcome in Major Depressive Disorder
• A Trial of Dextromethorphan for Treatment of Major Depressive Disorder
• Interest of Cryotherapy or Cortisone Aerosol Therapy in Early Post-operative Swallowing Disorders Following Total Thyroidectomy
• Long Term Treatment of Panic Disorder With Clonazepam or Paroxetine
• Treatment With Quetiapine for Youth With Substance Use Disorders and Severe Mood Dysregulation
• Milk Thistle in Body Dysmorphic Disorder
• Efficacy and Safety of ACT-541468 in Elderly Subjects With Insomnia Disorder
• Leucovorin for the Treatment of Language Impairment in Children With Autism Spectrum Disorder
• Efficacy and Safety of ACT-541468 in Adult Subjects With Insomnia Disorder
• Oxytocin on Irritability/Emotional Dysregulation of Disruptive Behavior and Mood Disorders
• Inositol for Comorbid Anxiety in Children and Adolescents With Bipolar Disorder
• Treatment of Temporo-Myofascial Disorder of Muscular Origin Using Botulinum Toxin: A Prospective Study
• Mycophenolate Mofetil Treatment With Neuromyelitis Optica Spectrum Disorders in Chinese Patients
• Mazindol Controlled Release in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
• Early Interventions in Children With Attention Deficit/Hyperactivity Disorder
• Treatment of Cannabis Use Disorder Among Adults With Comorbid Attention-Deficit/Hyperactivity Disorder
• Study of the What the Body Does to the Drug in Subjects With Mild, Moderate, and Severe Liver Dysfunction
• Effectiveness of Vitamin B in Reducing Temporomandibular Joint Disorder Pain
• Multimodal Imaging for Surveillance in Patients With Oral Potentially Malignant Disorders
• Using Reconsolidation Blockade to Treat Trauma Related Disorders After Paris Attacks: an Effectiveness Study
• Efficacy and Safety of Melatonin PR and Clonazepam in Patients With REM Sleep Behavior Disorder in Parkinson Disease
• The Effectiveness of Aerobic Exercise in the Treatment of Adults With Attention Deficit Hyperactivity Disorder (ADHD)
• Effectiveness of a Personalized Neurofeedback Training Device (ADHD@Home) in Attention-Deficit/Hyperactivity Disorder
• Efficacy and Safety of NFC-1 in Adolescents With Genetic Disorders Impacting mGluR and ADHD
• Study of the Pharmacokinetics and Safety of Tasimelteon in Children and Adolescents
• PPARγ Agonist Treatment for Cocaine Dependence
• Targeting Anhedonia in Cocaine Use Disorder
• Nitrous TRD Bipolar Depression
• Study of the Efficacy and Safety of NPC-15 for Sleep Disorders of Children With Neurodevelopmental Disorders
• Verification of the Efficacy of NPC-15 for Sleep Disorders of Children With Autism Spectrum Disorders
• Personalized Indications for CBT and Antidepressants in Treating Depression
• Nalmefene in Alcohol Dependence and Borderline Personality Disorder
• The Staged Treatment in Early Psychosis Study
• The Relationship Among Changes in Brain Network Activation in Adult Outpatients With Major Depressive Disorder
• Oxytocin Suppresses Substance Use Disorders Associated With Chronic Stress
• A Study to Assess the Efficacy and Safety of AXS-05 in Subjects With Treatment Resistant Major Depressive Disorder
• Effects of 800mg of Rhodiola Rosea in Attention in Adults With Attention-Deficit/Hyperactivity Disorder
• Rhodiola Rosea in Adults With Attention Deficit/Hyperactivity Disorder
• Choline Supplementation as a Neurodevelopmental Intervention in Fetal Alcohol Spectrum Disorders
• A Study to Evaluate the Efficacy and Safety of Dasotraline in Children 6 to 12 Years of Age With Attention-Deficit Hyperactivity Disorder (ADHD) in a Simulated Classroom Setting.
• Imaging SV2A in Mood Disorders
• Botulinum Toxin A for Emotional Stabilization in Borderline Personality Disorder (BPD)
• A Longitudinal Observational Cohort Study of NSI-189, With Out-Patients With Major Depressive Disorder
• Exploratory Trial to Assess the Functionality of an Integrated Call Center for the Digital Medicine System
• Active Reference (Fluoxetine) Fixed-dose Study of Vortioxetine in Paediatric Patients Aged 12 to 17 Years With Major Depressive Disorder (MDD)
• Active Reference (Fluoxetine) Fixed-dose Study of Vortioxetine in Paediatric Patients Aged 7 to 11 Years With Major Depressive Disorder (MDD)
• A Controlled Trial of Losartan in Posttraumatic Stress Disorder
• Study Evaluating Nelotanserin for Treatment of REM Sleep Behavior Disorder in Subjects With Dementia (DLB or PDD)
• Minocycline and Celecoxib as Adjunctive Treatments of Bipolar Depression
• The Effect of Methylphenidate on Primary Enuresis in Children With Attention Deficit Hyperactivity Disorder
• Evaluating Naltrexone for Use in Conjunction With Buprenorphine in Adults With Opioid Use Disorder Transitioning From Buprenorphine Maintenance Prior to First Dose of VIVITROL
• Study of NSI-189 for Major Depressive Disorder
• Dasotraline Binge Eating Disorder Extension Study
• Sulforaphane in a New Jersey (NJ) Population of Individuals With Autism
• Combination Probiotic: BB-12 With LGG (Different Doses) in Treating Children With Autism Spectrum Disorder
• Long-Term Safety Study of Buprenorphine (CAM2038) in Adult Outpatients With Opioid Use Disorder
• Oxytocin Administration in BDD and OCD
• The Exploratory Study to Investigate the Effect of Ramelteon for Insomnia Patients With Major Depressive Disorder by Using Actigraphy
• A Six Week, Randomized, Double-Blind Placebo-Controlled, Suvorexant Augmentation Study of Antidepressant Treatment of Major Depressive Disorder With Residual Insomnia
• Administration of T Lymphocytes for Prevention of Relapse of Lymphomas
• Ketamine for Relapse Prevention in Recurrent Depressive Disorder
• Tocilizumab Augmentation in Treatment-Refractory Major Depressive Disorder
• Lisdexamfetamine in Binge Eating Disorder (BED): fMRI Effects
• Phentermine/Topiramate Extended Release in Binge Eating Disorder (BED)
• Ketamine as an Alternative Treatment to ECT in Major Depressive Disorder
• Translational Approach to the Understanding and Treatment of Obsessive-Compulsive Disorder (OCD). Can D-Cycloserine Enhance and Stabilize the Treatment-response in Relapsed and Non-responding OCD-patients?
• Remifentanil Requirement for Acceptable Intubating Condition
• A Policy Relevant US Trauma Care System Pragmatic Trial for PTSD and Comorbidity
• Single-agent Cobimetinib for Adults With Histiocytic Disorders
• Risk and Benefit Assessment of Hypnotic Agents for Sleep Disorders Among Elderly
• Treatment of Young Adults With Comorbid AUD/MDD: A Pilot Medication Trial
• Vortioxetine for Posttraumatic Stress Disorder
• A Study of Aripiprazole Lauroxil in Subjects With Schizophrenia or Schizoaffective Disorder
• Shire SCT: Lisdexamfetamine Treatment for ADHD and SCT
• Disruption of Memory Reconsolidating as a Treatment for Panic Disorder
• Efficacy of Memantine add-on in the Treatment of Bipolar Disorder (Type I) Nonresponders or Partial Responders Patients
• DB/Maintenance of Equetro (Carbamazepine) in Children With Acute Manic or Mixed Bipolar 1 Disorder
• Attention-deficit/Hyperactivity Disorder Translational Center for Identifying Biomarkers
• Feasibility Study of PH94B Nasal Spray for Acute Treatment of Social Anxiety Disorder (SAD)
• Neural Basis of Meal Related Interoceptive Dysfunction in Anorexia Nervosa
• Study of Intranasal Ketamine for Social Impairment in Autism Spectrum Disorder
• Safety and Efficacy Study of SHP465 in Adults Aged 18-55 Years With Attention-deficit/ Hyperactivity Disorder (ADHD)
• Exploratory Study To Assess the Efficacy and Safety of a Triple Combination for Acute Pain Treatment in Patients With Temporomandibular Joint Disorders (TMJD).
• Deep Brain Stimulation of NAc/ALIC to Prevent Treatment-Refractory Obsessive Compulsive Disorder
• Phone-based Safety Monitoring of Baclofen Prescriptions for Alcohol Use Disorder
• Integrating Psychotropic Medication Into the Care of People With Mental Disorders in a Prayer Camp in Ghana
• The Role of Orexin in Human Panic Disorder
• Effect of Ketamine vs. Active Placebo on Suicidal Ideation in Depressed Inpatients With Major Depressive Disorder or Bipolar Depression.
• Medication-Assisted Treatment for Youth With Substance Use Disorders
• Tideglusib vs. Placebo in the Treatment of Adolescents With Autism Spectrum Disorders
• Clinical Medication Development for Bipolar Disorder and Alcohol Use Disorders
• Antipsychotics and Risk of Hyperglycemic Emergencies
• Augmentation of Brief Habit Reversal Training With D-cycloserine or Placebo
• Pilot Trial of Allogeneic Blood or Marrow Transplantation for Primary Immunodeficiencies
• Ketamine Infusion for Adolescent Depression and Anxiety
• Ketamine Infusions for PTSD and Treatment-Resistant Depression
• Study to Evaluate the Efficacy and Safety of SST-6007, a Topical Sildenafil Cream, Compared to Placebo in Women With Female Sexual Arousal Disorder
• Cognitive Behavioral Therapy for Adolescents With Attention-Deficit / Hyperactivity Disorder
• Olfaction Disorders in Patients Included in The Trauma Brain Injury (TBI) Database at Trondheim University Hospital
• Dasotraline Binge Eating Disorder Study
• Clozapine Versus Other Atypical Antipsychotics for Bipolar Disorder
• Sulforaphane Treatment of Children With Autism Spectrum Disorder (ASD)
• Pharmacokinetics, Safety, and Tolerability of Depot Buprenorphine at Three Different Molecular Weights in Treatment-Seeking Subjects With Opioid Use Disorder
• Effect of Deep Neuromuscular Block on Surgical Conditions in Morbidly Obese Patients
• Folinic Acid in Children With Autism Spectrum Disorders
• Impact of CArdiopulmonary Bypass Flow on Renal Blood Flow, Function and OXygenation
• Safety and Efficacy Study of Centanafadine Sustained-Release (CTN SR) in Adults With Attention-Deficit Hyperactivity Disorder (ADHD)
• Depth of Neuromuscular Blockade and the Perioperative Conditions in Laparoscopic Surgery in Pediatric Population
• Oxytocin and Affect Processing in Posttraumatic Stress Disorder
• Predictors of Treatment Response in Late-onset Major Depressive Disorder
• Drug Interaction and Self Administration Studies of Compounds for Cocaine Use Disorder
• Naltrexone for Use in Conjunction With Buprenorphine in Adults With Opioid Use Disorder Prior to First Dose of VIVITROL® (Naltrexone for Extended-Release Injectable Suspension)
• Minocycline Augmentation of Clozapine for Treatment Resistant Schizophrenia
• Vortioxetine for Binge Eating Disorder
• Efficacy of Suvorexant to Treat Insomnia Related to Bipolar Disorder
• Treating Insulin Resistance as a Strategy to Improve Outcome in Refractory Bipolar Disorder
• Evaluating Safety and Efficacy of Cannabis in Participants With Chronic Posttraumatic Stress Disorder
• A Dose-Escalation Study to Determine the Maximum Tolerated Dose of Arbaclofen Placarbil in Subjects With Alcohol Use Disorder
• Safety and Tolerability Study of Depot Buprenorphine in Treatment Seeking Subjects With Opioid Use Disorder
• Emotional Processing and Oxytocin Mechanisms in Premenstrual Dysphoric Disorder: A Pilot Study
• Role Functioning Changes NOS
• CAP: Doxazosin in the Treatment of Co-Occurring PTSD and Alcohol Use Disorders
• An Efficacy, Safety and Tolerability Study of JNJ-42165279 in Participants With Major Depressive Disorder With Anxious Distress
• CAP: Doxazosin in the Treatment of Co-Occurring PTSD and Alcohol Use Disorders
• International Substudy Enigma2 on Postoperative Cognitive Disorders
• Pilot Study of Sleep Therapy and Biomarkers in Children With Autism Spectrum Disorders
• Rapid Infusion Rituximab, Hematologic, Oncologic, and Rheumatologic Disorders
• Neuroimaging Study of Risk Factors for Adolescent Bipolar Disorder
• Effects of Expectation, Medication and Placebo on Objective and Self-rated Performance
• Initial Severity and Antidepressant Efficacy for Anxiety Disorders: an Individual Patient Data Meta-analysis
• A Safety, Efficacy and Biomarker Study of JNJ-42847922 in Participants With Major Depressive Disorder
• The Serotonin Transporter Availability for Prognosing Major Depressive Disorder (MDD) Treatment and Detecting MDD
• An Efficacy and Safety Study of Sirukumab in Participants With Major Depressive Disorder
• Prediction of Clinical Response to SSRI Treatment in Bipolar Disorder Using Serotonin 1A Receptor PET Imaging
• The Role of Ursodeoxycholic Acid in Treatment of Gallstones in Hemolytic Disorders
• Noradrenergic Activity, Cognition and Major Depressive Disorder
• Safety and Efficacy Study of SHP465 in Children and Adolescents Aged 6-17 Years With Attention-Deficit Hyperactivity Disorder (ADHD)
• Safety and Tolerability Study of SPD489 in Preschool Children Aged 4-5 Years, Diagnosed With Attention-deficit/Hyperactivity Disorder
• Ketamine for the Rapid Treatment of Major Depressive Disorder and Alcohol Use Disorder
• eIMPACT Trial: Modernized Collaborative Care to Reduce the Excess CVD Risk of Older Depressed Patients
• Effect of Oxcarbazepine on Serum Brain Derived Neurotrophic Factor (BDNF) in Bipolar Disorder
• Controlled Trial of Valproate Versus Risperidone in Young Children With Bipolar Disorder
• Vortioxetine in Patients With Major Depressive Disorder and Coronary Artery Disease
• Clock and Narcolepsy Genetic Variants and the Effects of Stalevo® (Levodopa/Carbidopa/Entacapone) on Sleep Disorders in Parkinson's Disease
• Using Ferumoxytol-Enhanced MRI to Measure Inflammation in Patients With Brain Tumors or Other Conditions of the CNS
• Effect of Quetiapine on Brain Activity Patterns in Patients With Heightened Risk of Bipolar Disorder
• A Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
• A Study of the Safety, Tolerability, and Pharmacokinetics of Multiple-Ascending Dose Basimglurant in Healthy Subjects and in Patients With Major Depressive Disorder (MDD)
• A Safety and Efficacy Study of JNJ-42165279 in Participants With Social Anxiety Disorder
• Pharmaco(Epi)Genetic Study of Obsessive-Compulsive Disorder
• Safety and Efficacy of Levomilnacipran ER in Adolescent Participants With Major Depressive Disorder
• Ketamine Treatment for Pediatric-Refractory Obsessive-Compulsive Disorder (OCD)
• Open Label Extension Safety and Efficacy Study of TNX-102 SL Tablets in Military Related PTSD and Related Conditions
• Effects of Intranasal Administration of a Single Dose of Oxytocin Using a Novel Device in Adults With Autism Spectrum Disorder
• Iloperidone in Mixed States of Bipolar Disorder
• Clinical Registry of Patients Under Treatment With Atypical Antipsychotics
• A Multi-level Life-span Characterization of Adult-depression and Effects of Medication and Exercise
• Laboratory Studies on Oxytocin for Treatment of Alcohol Use Disorder
• Single and Multiple Rising Dose Study of Safety and PK of Metyrapone/Oxazepam Combination (EMB-001)
• Safety, Tolerability, Pharmacokinetic, and Efficacy Study of SPD489 in Preschool Children With Attention-deficit/Hyperactivity Disorder
• Hydrocortisone for Prevention of Post-Traumatic Stress Disorder
• Evaluation of the Safety of Adjunct Brexpiprazole in Elderly Patients With Major Depressive Disorder and an Inadequate Response to Antidepressant Treatment
• Targeting Cognition in Bipolar Disorder With Pramipexole
• A 10-Week, Open-Label, Flexible Dose Adaptive Study Evaluating the Efficacy of Vortioxetine in Subjects With Panic Disorder
• COMPOUND (INN): HOE490O - GLIMEPIRIDE / METFORMIN HCl (Amaryl® M)0 (Glimepiride/Metformin Hydrochloride Immediate Release Combination Tablet) in Fed Conditions in Healthy Male and/or Female Subjects.
• A Phase 3 Study of Lu AA21004 in Patients With Major Depressive Disorder
• A Trial of Sertraline in Young Children With Autism Spectrum Disorder
• Trial of Oral SNC-102 in Subjects With Combat-Related Posttraumatic Stress Disorder
• An Interdisciplinary Approach to the Treatment of Encopresis in Children With Autism Spectrum Disorders
• Pharmacovigilance in Gerontopsychiatric Patients
• Safety and Efficacy of Vilazodone in Pediatric Patients With Major Depressive Disorder (VLZ-MD-22)
• Vortioxetine, 5, 10, and 20 mg, Relapse Prevention Study in Adults With Major Depressive Disorder (MDD)
• Relative Bioavailability Study in Healthy Subjects Comparing 2 Dry Powder Oral Suspensions of Rivaroxaban Under Fasting and 20 mg of an Oral Suspension of Rivaroxaban Under Fed Conditions to 10 mg of an Immediate Release Tablet Under Fasting Conditi
• Biomarkers of Neuroinflammation and Anti-Inflammatory Treatments in Major Depressive Disorder
• Treatment Seeking Participants With Opioid Use Disorders Assessing Tolerability of Depot Injections of Buprenorphine
• Open-Label Study of N-Acetylcysteine in Children and Adolescents 5-17 With Bipolar Spectrum Disorders
• Pharmacogenetic Study of Ondansetron in Alcohol Use Disorder
• Nitrous Oxide as a Putative Novel Dual-Mechanism Treatment for Bipolar Disorder
• Study to Evaluate the Effect of 2 Dosage Strengths of Lemborexant (E2006) on a Multiple Sleep Latency Test in Participants With Insomnia Disorder
• Does Clinical Treatment of Mitochondrial Dysfunction Impact Autism Spectrum Disorder (ASD)?
• Neurochemical, Metabonomics and Neuroimaging Characterization of TCM Diagnostic Subtypes of Major Depression Disorder
• The Characteristics of Prepulse Inhibition in Children and Adolescents Suffering From Attention Deficit Disorder
• Characterization of the Prosocial and Prosexual Effects of GHB
• 2. Study to Evaluate the Efficacy/Safety of Bremelanotide in Premenopausal Women With Hypoactive Sexual Desire Disorder
• A Policy Relevant US Trauma Care System Pragmatic Trial for PTSD and Comorbidity Pilot
• Melatonin in Youth: N-of-1 Trials in a Stimulant-treated Attention Deficit Hyperactivity Disorder (ADHD) Population
• 1. Study to Evaluate the Efficacy/Safety of Bremelanotide in Premenopausal Women With Hypoactive Sexual Desire Disorder
• Ramelteon in the Prevention of Post-operative Delirium
• Prazosin and Naltrexone (PaN) Study for Veterans With Alcohol Use Disorders
• EGb 761® (Tanakan®) Effectiveness in the Treatment of Patients of Middle Age and Younger With Psycho-emotional Symptoms, Added to Cognitive Disorders
• Treatment of Binge Eating Disorder in Obesity: Naltrexone/ Bupropion Combination Versus Placebo
• Music Therapy in Obsessive Compulsive Disorder
• Effect of Clonazepam on REM Sleep Behavior Disorder in Patients With Parkinsonism
• POC Study in Partially Responsive Generalized Anxiety Disorder
• Evaluation of the Necessity of Long-term Pharmacological Treatment With Antipsychotics in Schizophrenic Patients
• SAD/MAD Study of a New Formulation of Nebulised RPL554 in Healthy Subjects and COPD Subjects
• Tipepidine in Children With Attention Deficit/Hyperactivity Disorder (AD/HD): a Double-blind, Placebo-controlled Trial
• Vortioxetine Versus Placebo in Major Depressive Disorder Comorbid With Social Anxiety Disorder
• Mephedrone and Alcohol Interactions in Humans
• A Multicenter, Relapse Prevention Study With Levomilnacipran Extended Release (ER) in Participants With Major Depressive Disorder
• Atomoxetine in Veterans With Comorbid ADHD/PTSD
• Phase I Single Dose, Open-Label Pharmacokinetic Study and Single-Blind, Placebo-Controlled Dose Escalation Study of NFC-1 in Adolescents With Attention-Deficit Hyperactivity Disorder
• The Gut Microbiota in Obsessive-Compulsive Disorder
• Efficacy of Vortioxetine on Cognitive Dysfunction in Working Patients With Major Depressive Disorder
• Efficacy of Vortioxetine on Cognitive Dysfunction in Patients With Partial or Full Remission of Major Depressive Disorder
• Safety and Efficacy Study of TNX-102 SL in Subjects With Military-Related PTSD and Related Conditions
• Randomized，Controlled and Open-label Study of Buspirone add-on Treatment in Patients With Major Depression Disorder
• Efficacy of Vortioxetine Versus Escitalopram on Cognitive Function in Patients With Inadequate Response to Current Antidepressant Treatment of Major Depressive Disorder
• A New Treatment Approach for Major Depressive Disorder Based Upon Targeting Monoamine Oxidase A (MAO-A)
• Tagraxofusp (SL-401) in Patients With CMML or MF
• Open Label Trial of Rapastinel (Formerly GLYX-13) in Individuals With Obsessive-Compulsive Disorder
• Pharmacokinetics, Safety and Tolerability of Tamsulosin Hydrochloride in Children With Voiding Disorders
• Minocycline as an Adjunct for the Treatment of Depressive Symptoms: Pilot Randomized Controlled Trial
• HORIZANT (Gabapentin Enacarbil Extended-Release Tablets) for the Treatment of Alcohol Use Disorder
• Investigating the Impact of Methylphenidate on Neural Response in Disruptive Behavioral Disorder
• A Study of the Safety, Efficacy and Pharmacokinetics of Glycerol Phenylbutyrate in Pediatric Subjects Under 2 Years of Age With Urea Cycle Disorders
• Effect of Neuromuscular Reversal With Sugammadex on Postoperative Recovery Profile
• Semi-replicate Crossover Bioequivalence Study of Dirithromycin in Healthy Subjects Under Fed Conditions
• Semi-replicate Crossover Bioequivalence Study of Dirithromycin of (Abdi İbrahim İlaç San. Ve Tic. A. Ş., Turkey) in Healthy Subjects Under Fasting Conditions
• A Trial of Intranasal Ketamine for the Treatment of Obsessive-Compulsive Disorder
• Food-Effect Study in Healthy Participants
• Study to Evaluate the Efficacy of Duloxetine in Outpatients With Major Depressive Disorder and Pain
• An Exploratory Open Label Study of EPI-743 (Vincerinone TM) in Children With Autism Spectrum Disorder
• Prazosin Augmentation of Outpatient Treatment of Alcohol Use Disorders in Active Duty Soldiers With and Without PTSD
• The Effect of Oxytocin Administration on Interpersonal Cooperation in Borderline Personality Disorder Patients and Healthy Adults
• Dopamine Receptor Imaging to Predict Response to Stimulant Therapy in Chronic TBI
• Fast-Fail Trials in Mood and Anxiety Spectrum Disorders; Kappa Opioid Receptor Phase 2a
• A Study of ALKS 5461 for the Treatment of Major Depressive Disorder (MDD) - FORWARD-5 Study
• Brexpiprazole (OPC 34712) Trial in the Treatment of Adults With Major Depressive Disorder and Irritability
• Cortical Metrics in Intervention Trials With Autism Spectrum Disorders
• Efficacy of Cognitive Behavioral Therapy in Treatment of Adults With Attention Deficit Hyperactivity Disorder
• Pharmacological Treatment of Comorbid Alcohol and Marijuana Withdrawal and Dependence
• Randomized Controlled Trial of Intranasal Ketamine vs. Intranasal Midazolam in Individuals With OCD
• Botox for Treatment of TMJ Disorder With Bruxism
• N-MOmentum: A Clinical Research Study of Inebilizumab in Neuromyelitis Optica Spectrum Disorders
• An Open-Label Study to Evaluate the Efficacy of High-Dose Gammaplex in Children on the Autism Spectrum
• Study of the Safety and Efficacy of Fixed-dose Brexpiprazole (OPC-34712) as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder With and Without Anxious Distress
• Study to Evaluate the Efficacy, Safety and Tolerability of Bupropion Hydrochloride Extended-release Tablet, and Escitalopram Oxalate Capsule in Subjects With Major Depressive Disorder
• The Measurement-based Care in Patients With Depressive Disorder: A Randomized Controlled Trial
• Treatment of Pediatric Anxiety Disorders by Predicting Treatment Response Through Biocellular Markers and Sleep
• Fixed Dose Intervention Trial of New England Enhancing Survival in SMI Patients
• An Randomized Open-Label PK Study of LY03004 Compared to Risperdal® Consta® in Stable Patients With Schizophrenia or Schizoaffective Disorder
• Efficacy Study of Abdominal Massage Therapy to Treat Generalized Anxiety Disorder of Deficiency of Both Heart and Spleen Type
• Bioequivalence Pilot Study of Dirithromycin of (Abdi İbrahim İlaç San.Ve.Tic.A.Ş,Turkey) in Healthy Subjects Under Fed Condition
• Bioequivalence Pilot Study of Dirithromycin of (Abdi İbrahim İlaç San.Ve.Tic.A.Ş,Turkey) in Healthy Subjects Under Fasting Condition
• Double-blind Pilot Trial of Mirtazapine for the Treatment of Co-occurring AD/MDD.
• Biomarkers for Post-Transplant Lymphoproliferative Disorders in Children
• Mifepristone Treatment of Alcohol Use Disorder
• Hematopoietic Stem Cell Transplant for High Risk Hemoglobinopathies
• MT2013-31: Allo HCT for Metabolic Disorders and Severe Osteopetrosis
• Safety, Tolerability, and Pharmacokinetics of Multiple Rising Doses of TAK-137 in Adults With Attention-Deficit/Hyperactivity Disorder.
• A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder
• A Study of ALKS 5461 for the Treatment of Major Depressive Disorder (MDD) - the FORWARD-3 Study
• A Study of ALKS 5461 for the Treatment of Major Depressive Disorder (MDD) - the FORWARD-4 Study
• Efficacy, Safety, and Tolerability Study of AVP-786 as an Adjunctive Therapy in Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment
• Study to Treat Major Depressive Disorder (MDD) With a New Medication
• Examining Dose-Related Effects of Oxytocin on Social Cognition Across Populations
• Lurasidone and Cognition in Bipolar I Disorder
• Follow up Treatment of Children With Attention Deficit Hyperactivity Disorder (ADHD)
• Validation of DaTscan for Detection of Parkinson Disease Related Disorders
• Efficacy and Safety of A-prexa Compared to Zyprexa in Patients With Schizophrenia
• Creatine Augmentation for Adolescent Females With Treatment-Resistant Major Depressive Disorder
• A Double-blind Study to Assess the Efficacy and Safety of Intranasal Esketamine for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Participants Who Are Assessed to be at Imminent Risk for Suicide
• Efficacy and Safety of Bupropion Hydrobromide in Adolescents and Children With Major Depressive Disorder
• OnabotulinumtoxinA as Treatment for Major Depressive Disorder in Adult Females
• Comparative Efficacy of Phenylbutyrate (PBA) vs. Benzoate in Urea Cycle Disorders
• Safety and Efficacy Study of SJP-0035 Ophthalmic Solution in Patients With Moderate to Severe Corneal Epithelial Disorders
• Lybridos in Pre-and Postmenopausal Women With Hypoactive Sexual Desire Disorder
• Effects of Magnesium Sulfate on Onset and Duration of Low Dose Rocuronium
• Trial of Low-Dose Xenon For The Treatment Of Obsessive-Compulsive Disorder
• A Novel Drug for Borderline Personality Disorder
• Methylphenidate ER Liquid Formulation in Adults With ASD and ADHD
• Parallel Group, Multiple Dose Pharmacokinetics Study of Five Antipsychotic Medications in Psychiatric Participants
• Trazodone Once a Day in Major Depression Disorder
• A Study of Different Titration Schedules of ALKS 5461 in Adults With Major Depressive Disorder (MDD)
• Ketamine Infusion for Social Anxiety Disorder
• TRI102 in the Treatment of Children With Attention Deficit Hyperactivity Disorder (ADHD)
• Ondansetron for Bipolar Disorder and Alcohol Use Disorders
• Inositol Hexaphosphate: A Novel Treatment Strategy for Bipolar Disorder?
• Pilot Study of Riluzole for Drug-Refractory Irritability in Autism Spectrum Disorders
• Validation of Subjective Rating Scales Used to Assess Surgical Conditions in Abdominal Surgery
• Efficacy and Safety Trial of Flexible Doses of Oral Ziprasidone in Children and Adolescents With Bipolar I Disorder
• RCT of Methotrexate Added to Treatment As Usual in Schizophrenia
• Cannabinoid Control of Fear Extinction Neural Circuits in Post-traumatic Stress Disorder
• Study of Intravenous NRX-1074 in Patients With Major Depressive Disorder
• A Study to Investigate the Effect of JNJ-42847922 on Polysomnography Measures in Patients With Major Depressive Disorder With Insomnia Who Are Stably Treated With Antidepressants
• Dose Timing of D-Cycloserine to Augment CBT for Social Anxiety Disorder
• Methylphenidate vs. Risperidone for the Treatment of Children and Adolescents With ADHD and Disruptive Disorders
• Effect of Early Oral Triple Viable Bifidobacterium Intestinal Flora in Preterm
• Oxytocin Suppresses Substance Use Disorders Associated With Chronic Stress
• Safety, Tolerability and Activity of SRX246 in Adults With Intermittent Explosive Disorder
• Pharmacokinetic and Safety Study of LY03004 in Stable Patients With Schizophrenia or Schizoaffective Disorder
• Beta-arrestins and Response to Venlafaxine in Major Depressive Disorder (MDD) (DEPARRESTCLIN)
• Intuniv vs Placebo in the Treatment of Childhood Intermittent Explosive Disorder
• Assess the Efficacy and Safety of ASC-01 in Patients With Major Depressive Disorder
• Development of Ivermectin for Alcohol Use Disorders
• Multiple Dose Study of Blockade of Opioid Effects by Injections of Buprenorphine in Participants With Opioid Disorder
• Cocaine Opioid Oxytocin Option - Limited
• Efficacy of Exposure and Response Prevention(ERP) and SSRIs in Chinese OCD Patients
• Efficacy and Safety of Mitoxantrone in Patients With Refractory Neuromyelitis Optica and Spectrum Disorders
• Monoamine Contributions to Neurocircuitry in Eating Disorders
• A Study to Assess Bioequivalence of a New Tapentadol Extended-Release Tablet With Respect to a Tapentadol Extended Release Tablet Under Fasted Conditions in Healthy Subjects
• Safety and Efficacy Study Comparing ETS6103 With Amitriptyline in the Treatment of Major Depressive Disorder (MDD)
• Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety Symptoms
• Brexpiprazole as Adjunctive Therapy With Major Depressive Disorder and an Inadequate Response to Previous Adjunctive Therapy
• Evaluate the Maintenance of Efficacy of SPD489 in Adults Aged 18-55 Years With Moderate to Severe Binge Eating Disorder
• Oxytocin in Adolescents With Autism Spectrum Disorders
• A Study of GWP42003 as Adjunctive Therapy in the First Line Treatment of Schizophrenia or Related Psychotic Disorder
• Smoking Cessation for Depression and Anxiety Treatment
• Vilazodone for Separation Anxiety Disorder
• Simvastatin Addition for Patients With Recent-onset Schizophrenia
• Electrophysiologic Parameters and Biomarkers Predicting Treatment Response in Patients With Major Depressive Disorder
• Comparing Intubating Conditions Using Succinylcholine or Rocuronium for Rigid Bronchoscopy
• Pregnant Women Taking Lamictal for Bipolar Disorder
• Control of Cognition (Naltrexone, Methylphenidate, and ADHD Study (NMAS))
• Brexpiprazole as an Adjunctive Treatment to Paroxetine or Sertraline in Adult Patients Suffering From Post-traumatic Stress Disorder (PTSD)
• A Long-Term Study of SM-13496 in Patients With Bipolar I Disorder.
• Effects of Corticorelin Administration on Dopamine Transmission, Craving, and Mood in Cocaine Dependence
• Accelerated Development of Additive Pharmacotherapy Treatment for Methamphetamine Use Disorder
• Adherence to Treatment, Safety and Tolerability Study of the Medical Information Device #1 (MIND1) in Subjects With Schizophrenia or Bipolar I Disorder
• D-Cycloserine Augmentation of Cognitive Behavioral Therapy for Delusions
• Study of Icariin for Bipolar Disorder and Co-Occurring Substance Use Disorders
• A Study of Sustained-Release Desvenlafaxine Hydrochloride for the Treatment of Major Depressive Disorder
• Antidepressant Response in the Treatment of Depressive Symptoms and Frailty Characteristics in Older Adults
• Behavioral and Neural Response to Memantine in Adolescents With Autism Spectrum Disorder
• Efficacy of Extended-release Quetiapine (Seroquel XR) as Adjunctive Therapy to Cognitive Behavioral Therapy in the Treat
• A Pilot Treatment Study of Insulin-Like Growth Factor-1 (IGF-1) in Autism Spectrum Disorder
• Investigator Initiated Study - Asenapine Early Psychosis
• Targeting GABA-A for the Treatment of Social Disability in Young Adults With Autism Spectrum Disorders: A Phase II Proof of Mechanism Trial
• Targeting Circadian and Cognitive Dysfunction in Bipolar Disorder With Modafinil
• Cannabis, Schizophrenia and Reward: Self-Medication and Agonist Treatment?
• Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT
• Identifying Characteristic Signature of Attention Deficit / Hyperactivity Disorder (ADHD) and Ritalin Treatment
• A Study to Investigate Evoked Potentials as Markers of Ketamine-induced Cortical Plasticity in Patients With Major Depressive Disorder
• Effects of Methylphenidate, Modafinil, and MDMA on Emotion-processing in Humans: A Pharmaco-fMRI Study
• Long-term Safety and Tolerability Study of Brexpiprazole as Adjunctive Treatment in Patients With Major Depressive Disorder
• Study of Brexpiprazole as Adjunctive Treatment of Irritability in Patients With Major Depressive Disorder and an Inadequate Response to Antidepressant Therapy
• A Comparison of Medication Augmentation and PST in the Treatment of Depression in Older Adults
• Comparison of Surgical Conditions in Cesarean Section Under General Anesthesia With Deep Neuromuscular Blockade Versus Succinylcholine
• A Study of Combination Therapy in Children With ADHD
• A Phase 3 Study of Fluvoxamine (SME3110) in Pediatric/Adolescent Patients With Obsessive Compulsive Disorder
• A Long Term Post-Marketing Study on the EffIcacy and Safety of Osmotic Release Oral System (OROS) Methylphenidate on the Cognitive Functions of Attention Deficit Hyperactivity Disorder (ADHD) Participants
• Optimizing Surgical Conditions During Gynecologic Laparoscopic Surgery With Deep Neuromuscular Blockade
• Open-Label Study of Latuda for the Treatment of Mania in Children and Adolescents 6-17 Years Old
• An Open-Label Trial of Oxytocin in Adolescents With Autism Spectrum Disorders
• Lithium for Suicidal Behavior in Mood Disorders
• Adjunctive Curcumin for Symptomatic Adolescents With Bipolar Disorder: Brain and Body Considerations
• Oral Multiple-dose Study in Patients With Major Depressive Disorder
• Different Doses of Oral Melatonin Supplements in Chronic Kidney Disease (CKD)-Associated Sleep Disorders
• A Comparison of Methylphenidate and Cognitive Behavioural Therapy for the Treatment of Binge Eating Disorder
• Comparison of Plasma Concentration Changes Between Two Types of Tablets of FK949E Administration to Patients With Major Depressive Disorder
• Iloperidone for Symptoms of Arousal in Post Traumatic Stress Disorder (PTSD)
• Efficacy and Safety of Paroxetine Controlled Release for Major Depressive Disorder in Irritable Bowel Syndrome Patients
• A Randomized, Controlled Trial of Intranasal Oxytocin as an Adjunct to Behavioral Therapy for Autism Spectrum Disorder
• Antipsychotic Effects on Brain Function in Schizophrenia
• Clinical Research Study to Evaluate Selegiline in the Treatment of Borderline Personality Disorder
• Gene-environment Interactions and Brain Functional Connectivity in Attention Deficit Hyperactivity Disorder
• Add-On Study of MSI-195 (S-Adenosyl-L-Methionine, SAMe) for Patients With Major Depressive Disorder (MDD)
• Remifentanil Versus Sufentanil for Intubation Condition Without Myorelaxant
• Bioequivalence Study of FLURBIPROFEN 100 mg FAMOTIDINE 20 mg MULTI-LAYER TABLET in Healthy Subjects Under Fasting Conditions
• Comparing Treatments for HIV-Infected Opioid and Alcohol Users in an Integrated Care Effectiveness Study
• Study to Evaluate Safety and Tolerability of FK949E in Elderly Patients With Major Depressive Disorder
• Treating Emotional Disorders in Primary Care With Psychological Techniques
• Muscle Relaxation for Short Procedures
• Epidemiological Study to Evaluate Personality Disorders in Prison Populations in Treatment for Hepatitis C
• Ifenprodil Tartrate Treatment of Adolescents With Post-traumatic Stress Disorder: a Double-blind, Placebo-controlled Trial
• Escitalopram, Placebo and tDCS in Depression: a Non-inferiority Trial
• Pilot Study of Cognitive Behavioral Therapy for Anxiety and Bipolar I Disorder
• Maintenance of Efficacy With Risperidone Long Acting Injectable (R-LAI) in Patients With Schizophrenia or Schizoaffective Disorder
• A Phase II, Adaptive Trial Design Examining the Pharmacokinetic and Pharmacodynamic Effects of Modified Release Amphetamine (HLD100, Formulations B, C and E)) in Adolescents and Children With Attention-Deficit Hyperactivity Disorder (ADHD)
• A Study of UX007 (Triheptanoin) in Participants With Long-Chain Fatty Acid Oxidation Disorders (LC-FAOD)
• PET and MRI Brain Imaging of Bipolar Disorder
• Prospective Cytochrome P450 Genotyping and Clinical Outcomes in Patients With Psychosis
• Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder
• An Open-Label Study of Naltrexone in Adults With Attention Deficit Hyperactivity Disorder.
• Study to Evaluate Safety and Tolerability of FK949E in Patients With Major Depressive Disorder
• A Study to Evaluate the Impact of Escitalopram on Quality of Life and Social Functionality in Patients With Major Depressive Disorder With Anxiety Symptom
• Mirtazapine for Sleep Disorders in Alzheimer's Disease
• Naltrexone for Antipsychotic-Induced Weight Gain
• Olanzapine Compared to Lamotrigine in the Prevention of Depressive Episode in the Patients With Bipolar Disorder
• Lisdexamfetamine Dimesylate in the Treatment of Adult ADHD With Anxiety Disorder Comorbidity
• Efficacy of Amoxicilline/Clavulanic Acid in Patients Affected by Tic Disorder Colonized by Group A Streptococcus
• Phase 1b/2a Unblinded Study of Responses in Premenopausal Women With HSDD to Lorexys Evaluating Efficacy and Safety
• Effect of Oxytocin Nasal Sprays on Social Behavior in Social Anxiety Disorder
• An Efficacy and Safety Study of Risperidone Long-Acting Microspheres in Participants With Schizophrenia, Schizophreniform or Schizoaffective Disorders
• An Open-Label Trial of Buspirone for the Treatment of Anxiety in Youth With Autism Spectrum Disorders
• Phase II Clinical Trial of NPB-01 in Patients With Anti-aquaporin 4 Antibody Positive Neuromyelitis Optica Spectrum Disorder Not Provided Adequate Effect of Therapy to Steroids Plus Therapy.
• Safety, Efficacy and Tolerability of Vilazodone in (GAD) Generalized Anxiety Disorder
• Betaine and Peroxisome Biogenesis Disorders
• Long-term Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy in Patients With Major Depressive Disorder
• Brexpiprazole as Adjunctive Treatment in Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment
• Efficacy and Safety of Brexpiprazole as Adjunctive Treatment in Elderly Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment
• NT0102 in the Treatment of Children With Attention Deficit Hyperactivity Disorder (ADHD)
• Effectiveness and Safety Study of Solifenacin Succinate and Solifenacin Succinate + Estrogen to Treat OAB in Postmenopausal Women
• Influence of Stimulant Medication on Brain Processes for Decision Making in Attention Deficit Hyperactivity Disorder
• Efficacy, Safety, and Tolerability of Eslicarbazepine Acetate in the Recurrence Prevention of Bipolar I Disorder
• Treatment of Overweight Induced by Antipsychotic Medication in Young People With Autism Spectrum Disorders (ASD)
• Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) in Acute Manic Episodes Associated With Bipolar I Disorder
• Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) in Acute Manic Episodes Associated With Bipolar I Disorder
• Agomelatine Treatment of Depression in Schizophrenia (AGOPSYCH)
• Immune Disorder HSCT Protocol
• An Interventional Study to Assess the Efficacy and Safety of Buprenorphine in Korean Patients With Spinal Disorders
• An Efficacy and Safety Study of Escitalopram Long-Term Treatment in Major Depressive Disorder With Associated Anxiety Symptoms
• An Interventional Study to Assess the Efficacy and Safety of Oxycodone/Naloxone in Korean Patients With Spinal Disorders
• The Effect of Minocycline on Relapse After Successful Intravenous Ketamine/Minocycline-induced Symptoms Response in Subjects With Depression
• A Study of Fluoxetine in Major Depressive Disorder (MDD) Long-Term Dosing
• A Study of Fluoxetine in Major Depressive Disorder (MDD) Short-Term Dosing
• The Effect of Methylphenidate Versus Placebo on State Anxiety in Children With Attention Deficit Hyperactivity Disorder.
• N-Acetyl Cysteine and Aspirin as an Adjunctive Treatment for Bipolar Disorder
• A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
• INtranasal OXyTocin for the Treatment of Autism Spectrum Disorders
• A Phase Ib/II Dose-finding Study to Assess the Safety and Efficacy of LDE225 + INC424 in Patients With MF
• Neurobiological Bases of Placebo Response in Major Depressive Disorder
• Omega-3 Dietary Supplements in Schizophrenia
• Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder
• Algorithm Guided Treatment Strategies for Major Depressive Disorder
• Lithium Augmentation for Hyperarousal Symptoms of Post Traumatic Stress Disorder: Pilot Study
• CURES: The Effect of Deep Curarisation and Reversal With Sugammadex on Surgical Conditions and Perioperative Morbidity
• Iron Treatment of Sleep Disorders in Children With Autism Spectrum Disorder
• Lybridos in Pre- and Postmenopausal Women With Hypoactive Sexual Desire Disorder Due to Maladaptive Activation of Sexual Inhibitory Systems
• Double-Blind Treatment of Major Depressive Disorder With Vilazodone
• Efficacy and Safety Study of ABT-436 in Major Depressive Disorder
• Comparison of Aripiprazole Versus Higher Metabolic Risk Antipsychotic Drugs on Adiposity Using MRI
• Long-term Study of FK949E in Elderly Bipolar Disorder Patients
• Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents
• A Study of Flexible-dose Brexpiprazole as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder, the Delphinus Trial
• Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
• Study Evaluating the Safety and Efficacy of Fixed-dose Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
• A Study to Evaluate the Efficacy of FK949E in Bipolar Disorder Patients With Major Depressive Episodes
• Study to Evaluate the Effect and Safety of Quetiapine Extended Release (XR) (FK949E) in Major Depressive Disorder
• Study of the Efficacy and Safety of LY2940094 in Participants With Major Depressive Disorder (MDD)
• A Double-Blind Comparison of Naltrexone and Placebo in Adults With Attention Deficit Hyperactivity Disorder
• Neurobiology of a Mutation in Glycine Metabolism in Psychotic Disorders
• SPD489 in Adults Aged 18-55 Years With Moderate to Severe Binge Eating Disorder
• SPD489 in Adults Aged 18-55 Years With Moderate to Severe Binge Eating Disorder
• Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
• Study of Vilazodone to Treat Social Anxiety Disorder
• Sensitivity of Short and Long Allele Carriers of the 5-HTTLPR to Environmental Threat Post Hydrocortisone Administration
• Kuvan in People With Schizophrenia and Schizoaffective Disorder
• Open Label Extension Study of STX209 (Arbaclofen) in Autism Spectrum Disorders
• Role of Inflammation Factors and Insulin Resistance in Major Depressive Disorder
• Aripiprazole (Abilify®) as an Adjunctive Treatment for Inadequate Response in Major Depressive Disorder
• Omega-3 Fatty Acids for Hyperactivity Treatment in Autism Spectrum Disorder
• Adult Attention Deficit Hyperactivity Disorder
• PET Imaging of mGLuR5 With Drug Challenge
• A Safety and Efficacy Study of Ramelteon Tablets for Sublingual Administration (TAK-375SL) in the Maintenance Treatment of Bipolar 1 Disorder
• D-cycloserine Augmented CBT for Panic Disorder
• Safety and Efficacy Study of Ramelteon (TAK-375) Tablets for Sublingual Administration (SL) in Adults With Bipolar 1 Disorder
• A Study of Bitopertin (RO4917838) in Combination With Selective Serotonin Reuptake Inhibitors (SSRIs) in Participants With Obsessive-Compulsive Disorder (OCD)
• Safety and Efficacy Study of ELND005 as an Adjunctive Maintenance Treatment in Bipolar I Disorder
• Phase 1 Study to Assess the Safety/Tolerability of Brexpiprazole as Adjunctive Therapy in Elderly Subjects With Major Depressive Disorder
• Efficacy Mechanism of N-acetylcysteine in Patients With Posttraumatic Stress Disorder
• Comparison of Quetiapine and Trazodone Treatment for Insomnia in Dually Diagnosed Veterans
• Open Label Extension in Adults With Binge Eating Disorder (BED)
• NWP09 in Children With Attention Deficit Hyperactivity Disorder (ADHD)
• The Impact of Triptan and Doxycycline on Neuroinflammatory Biomarkers in Acute Migraine
• Study of Placebo Without Deception Versus Standard Antidepressant for Major Depressive Disorder
• A Study to Compare the Actions in the Body of Healthy Subjects of Three Modified Release Formulations of YM178 Under Fasted and Fed Conditions With One Immediate Release Formulation of YM178 Under Fasted Conditions
• EPI-743 for Metabolism or Mitochondrial Disorders
• Pilot Study of Pharmaceutical and Behavioral Interventions to Treat Anxiety Disorders
• Safety, Efficacy and Tolerability of Vilazodone in Generalized Anxiety Disorder
• Reduced-Intensity Hematopoietic Stem Cell Transplant for High Risk Lysosomal and Peroxisomal Disorders
• A Study to Evaluate the Efficacy and Safety of Risperidone (R064766) in Children and Adolescents With Irritability Associated With Autistic Disorder
• A Study to Examine the Progression of Attention-Deficit Hyperactivity Disorder (ADHD) Drug Treatment and to Analyze Associated Factors
• A Long-term, Extended Treatment Study of Aripiprazole in Pediatric Patients With Autistic Disorder
• A Short Treatment Study of Aripiprazole in Pediatric Patients With Autistic Disorder
• Nutrition, Exercise, and Wellness Treatment (NEW Tx) for Bipolar Disorder
• Tandospirone Citrate in the Treatment of Patients With Generalized Anxiety Disorder
• Ketamine and Scopolamine Infusions for Treatment-resistant Major Depressive Disorder
• Efficacy and Safety of TBS-2 Testosterone Gel in Women With Acquired Female Orgasmic Disorder
• A Retrospective And Multicenter Survey To Investigate The Dosage, Efficacy And Safety Of Sertraline In Posttraumatic Stress Disorder Patients
• Evaluation of the Potential Effects of SSR149415 on the Hypothalamic-pituitary-adrenal Axis in Outpatients With Major Depressive Disorder
• Non-interventional Study of Patients Using Norditropin® for Growth Hormone Deficiency or Turner Syndrome
• Lamotrigine Phase III Study in Bipolar I Disorder
• Randomized Double Blind Placebo Control Study in Patients With Schizophrenia
• A Folinic Acid Intervention for Autism Spectrum Disorders
• Effects of HQK-1001 in Patients With Sickle Cell Disease
• Dose-Ranging Trial of Creatine Augmentation for Adolescent Females With Treatment-Resistant Major Depressive Disorder
• An Open-Label Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
• Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
• Withdrawal Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified Previously Treated With Memantine
• Sequential Multiple Assignment Treatment for Bipolar Disorder
• An Open Label Pilot Study of Adjunctive Asenapine for the Treatment of Posttraumatic Stress Disorder
• Proof-of-Concept Safety Study of CPP-109 (Vigabatrin) for Treatment Refractory Tourette's Disorder
• Ketamine Infusion for Treatment-resistant Major Depressive Disorder
• This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder
• Safety and Efficacy of Vilazodone in Major Depressive Disorder
• Rapid Sequence Intubation With Magnesium-rocuronium Compared With Succinylcholine - A Randomised Clinical Study
• Study of Vortioxetine (Lu AA21004) in Major Depressive Disorder in Asian Countries
• Use of Prokinetics in Early Enteral Feeding in Preterm Infants
• Major Depressive Disorder - Understanding The Link Between The Brain And The Heart
• Clinical Trial on Binge Eating Disorder, Treatment With Naloxone Spray
• Zonisamide for Heavy Drinkers With Bipolar Disorder
• Efficacy of Lu AA21004 on Cognitive Dysfunction in Major Depressive Disorder
• Evaluating Acceptance of New Liquid Somatropin Formulation in Children With Growth Hormone Deficiency
• Bioequivalence of NovoSeven® and a NovoSeven® Formulation Stable at Room Temperature in Healthy Male Subjects
• Pioglitazone in Patients With Mood Disorders
• Estimate the Efficiency of the Association of an Injection of Ketamine and the Venlafaxine in the Severe Major Depressive Disorder for Six Weeks
• Efficacy Study of add-on Therapy With N-Acetylcysteine in Resistant Obsessive-compulsive Disorder
• Optimization of Treatment and Management of Schizophrenia in Europe (OPTIMISE): Substudy Site Copenhagen
• Perioperative Propranolol in Patients With Post Traumatic Stress Disorder (PTSD)
• Safety and Efficacy of MK-6096 as Adjunctive Therapy in Participants With Major Depressive Disorder And Partial Response to Antidepressant Monotherapy (MK-6096-022)
• The Effect of Methylphenidate Treatment in Familial Attention Deficit/Hyperactivity Disorder (ADHD)
• Effectiveness of Vyvanse Compared to Concerta in Adolescents With Attention-deficit/Hyperactivity Disorder
• Effectiveness of Vyvanse Compared to Concerta in Adolescents With Attention-deficit/Hyperactivity Disorder
• Effects of Quetiapine on Ultrastructural Hippocampal and Neurochemical Changes in Patients With Bipolar Disorder: Searching for Antidepressant and Mood Stabilising Neurophysiology
• Escitalopram Trial for Irritable Bowel Syndrome (IBS) Patients With Panic Disorder
• Guanfacine in Children With Tic Disorders
• Safety and Efficacy of Long-term Somatropin Treatment in Children
• Neural Correlates for Therapeutic Mechanisms of Lithium in Bipolar Disorder
• Neuroimaging Study of Bupropion Treatment in Patients With Major Depressive Disorder
• Plasma Glucose Levels With Dexamethasone as Adjuvant to Interscalene Block
• Desvenlafaxine vs. Placebo Treatment of Chronic Depression
• Efficacy and Safety Study of Combination of Ginkgo Extract and Ginseng Extract in Children With ADHD(Attention Deficit Hyperactivity Disorder)
• Efficacy and Tolerability of Propiverine Hydrochloride in Patients With Neurogenic Detrusor Overactivity
• Decreasing the Use of Unmodified Electroconvulsive Therapy (ECT) in an Indian Hospital
• Pharmacologic and Clinical Testing of a D1 Agonist for Cognitive Enhancement in Neuropsychiatric Disorders
• Imipramine Treatment for Patients With Multi-organ Bodily Distress Syndrome
• Omega-3 and Therapy Study for Childhood Bipolar Disorder- Not Otherwise Specified
• Intranasal Ketamine In the Treatment of Pediatric Bipolar Disorder
• Phase III Study of 5LGr to Treat Tic Disorder
• A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
• Glucomannan for the Treatment of Abdominal Pain-related Functional Gastrointestinal Disorders in Childhood
• Pilot Study of PRX-03140 to Assess Safety for Use in Adult Subjects With Post Traumatic Stress Disorder
• Open-label, Long-term Safety Extension Study of AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias
• Evaluation of the Efficacy and Safety of Modified Release AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias
• Pharmacokinetics and Tolerability of Vortioxetine (Lu AA21004) in Child and Adolescent Patients With Depressive or Anxiety Disorder
• RP5063 in Subjects With Schizophrenia or Schizoaffective Disorder
• Intubating Conditions During Propofol-remifentanil Anesthesia With Topical Lidocaine
• Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD)
• Cardiovascular Effects of Agomelatine and Escitalopram in Patients With Major Depressive Disorder (MDD)
• A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
• Selective Estrogen Receptor Modulators (SERMs) - A Potential Treatment for Psychotic Symptoms of Schizophrenia in Men?
• Comparison of Methods to Facilitate Rapid Sequence Intubation
• Interventional Study of Wellbutrin XL in Major Depressive Disorder With Atypical Features
• Multimodal Assessment of Neurobiological Markers for Psychiatric Disorders
• NORSPAN Transdermal Patches Phase III Study In Non-Cancer Pain
• Safety, Efficacy, and Tolerability of Vilazodone in Major Depressive Disorder
• Safety and Efficacy of Vilazodone in Major Depressive Disorder
• Safety & Efficacy of TC-5619 in Adults With Inattentive-predominant Attention Deficit/Hyperactivity Disorder (ADHD)
• SPD503 in Subjects Aged 6-17 Years With Generalized Anxiety Disorder (GAD), Separation Anxiety Disorder (SAD), or Social Phobia (SoP)
• Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder
• Neurocognition and Work Productivity in Major Depressive Disorder (MDD)
• Randomized Double Blinding Controlled Study on" Jia Wei Xiao Yao Jiaonang" Treating Mild to Moderate Major Depressive Disorder
• Efficacy and Safety of Ramelteon Sublingual as Adjunctive Therapy for Maintenance Treatment of Bipolar I Disorder
• Study of Donepezil in Female Breast Cancer Survivors With Cognitive Dysfunction
• Clinical Testing of a D1 Agonist for Cognitive Enhancement in Schizotypal Personality Disorder
• Iloperidone Augmentation of SSRIs for Patients With Major Depressive Disorder With Residual Anger and Irritability
• Decision-Making in Bipolar Disorder
• Compassionate Use of Triheptanoin (C7) for Inherited Disorders of Energy Metabolism
• Asenapine in the Treatment of Older Adults With Bipolar Disorder
• Magnetic Resonance Imaging Study of Cognitive-Behavior Therapy for Major Depressive Disorder
• Sequential Treatment of CD20-positive Posttransplant Lymphoproliferative Disorder (PTLD)
• A Study of TD-9855 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)
• ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
• Analisis of Facors Involved in Antidepressant Treatment Response of Major Depressive Disorder
• Rapamycin as a Means of Interference With Reconsolidation of Posttraumatic Stress Disorder-related Traumatic Memory
• Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
• Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
• MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy
• SPD489 Adult Major Depressive Disorder (MDD) Open-label Safety and Tolerability Rollover Extension Study
• Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
• Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
• SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
• Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) in Adult Outpatients With Major Depressive Disorder (MDD)
• Wake Therapy in the Treatment of Depression
• Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
• Melatonin Versus Placebo for Benzodiazepine Discontinuation in Patients With Schizophrenia
• Withdrawal Study to Demonstrate the Maintenance Effect in the Treatment of Non-24-Hour Sleep-Wake Disorder
• Tasimelteon for the Treatment of Non-24-hour Sleep-Wake Disorder (N24HSWD) in Blind Individuals With no Light Perception
• Melatonin Agonist Effects of Tasimelteon Versus Placebo in Patients With Major Depressive Disorder
• Treatment of Sleep Related Breathing Disorders in Patients With Pulmonary Hypertension
• Trial to Evaluate the Effects of OPC-34712 on QT/QTc in Subjects With Schizophrenia or Schizoaffective Disorder
• Major Depressive Disorder With Mixed Features - Extension
• Major Depressive Disorder With Mixed Features
• Efficacy Study of Vortioxetine on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder
• Major Depressive Disorder (MDD) With Mixed Features - Flexible Dose
• Efficacy & Safety Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder (TD)
• Efficacy & Safety Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
• Safety and Tolerability Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
• Pharmacokinetics - Pharmacodynamic Study of HT-2157 in Healthy Subjects and in Patients With Major Depressive Disorder
• Study Using Pregnenolone to Treat Bipolar Depression
• Topiramate for Alcohol Use in Posttraumatic Stress Disorder
• Buprenorphine for Treatment Resistant Depression
• Predicting Medication Response in Obsessive Compulsive Disorder
• Study to Determine Whether Ramelteon Helps People With REM Sleep Behavior Disorder
• Phase II, Randomized, Placebo-controlled Trial in Patients With Charcot-marie-tooth Disease Type 1A
• Bioequivalence of Two Somatropin Products (Norditropin® Versus Genotropin®) in Healthy Adult Volunteers
• Efficacy and Safety of Asenapine in the Prevention of Recurrence of Mood Episodes in Participants With Bipolar 1 Disorder (P06384)
• Long-Term Safety Extension Trial of Asenapine in Bipolar 1 Disorder Participants Who Completed Protocol P05691 (P05692)
• Double-blind Trial of Buspirone for the Treatment of Anxiety in Youth With Autism Spectrum Disorders
• Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder
• Comparing Treatment With Melatonin to Treatment With Stimulants (Methylphenidate) in Children With Attention Deficit Hyperactivity Disorder and Sleep Difficulties
• Post T-plant Infusion of Allogeneic Cytokine Induced Killer (CIK) Cells as Consolidative Therapy in Myelodysplastic Syndromes/Myeloproliferative Disorders
• Pharmacological Interaction Between Doxazosin and Methylenedioxymethamphetamine (MDMA)
• Evaluation of the Efficacy and Safety of AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias
• Bremelanotide in Premenopausal Women With Female Sexual Arousal Disorder and/or Hypoactive Sexual Desire Disorder
• Safety and Pharmacodynamic Study of ABT-436 in Major Depressive Disorder
• Bioequivalence Study of Doxycycline Monohydrate Tablets Under Fed Conditions
• Bioequivalence Study of Doxycycline Monohydrate Tablets Under Fasting Conditions
• Bioavailability Study of Dronabinol Capsules 10 mg Under Fasting Conditions
• Safety and Efficacy of Levomilnacipran ER (Levomilnacipran SR) in Major Depressive Disorder
• Naltrexone for Medication Compliance Among HIV-infected Men With Alcohol Use Disorder
• Special Drug Use Investigation for PAXIL Tablet (Pediatric Panic Disorder)
• Does Hydroxyzine Decrease Anxiety in Underweight Patients Diagnosed With an Eating Disorder
• Intravenous Ketamine in the Treatment of Obsessive-Compulsive Disorder
• A Study of LY2216684 in Participants With Major Depression Disorder
• Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adults With Major Depressive Disorder (the Orion Trial)
• Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial)
• Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)
• A Long-Term Study on Safety of JNS001 in Adults With Attention-Deficit Hyperactivity Disorder
• Efficacy Study of Vortioxetine (Lu AA21004) for Treatment of Major Depressive Disorder
• Study of Paroxetine and Fluconazole for the Treatment of HIV Associated Neurocognitive Disorder
• SGN-35 in CD30-positive Lymphoproliferative Disorders (ALCL), Mycosis Fungoides (MF), and Extensive Lymphomatoid Papulosis (LyP)
• A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
• Safety and Efficacy Study of Botox in the Treatment of Forward Head Posture With Associated Episodic Headache Disorder
• Extension Study of Asenapine [P06107 (NCT01244815)] for Pediatric Bipolar Disorder (P05898)
• Clinical Characteristics of Spinal Levobupivacaine: Hyperbaric Compared With Isobaric Solution
• Ketamine Infusion for Obsessive-Compulsive Disorder
• Study of the Safety, Pharmacokinetics and Efficacy of HPN-100, in Pediatric Subjects With Urea Cycle Disorders (UCDs)
• The Effect of N-Acetyl Cysteine on Cortical Erosion in Early Stage Schizophrenia
• Intranasal Oxytocin for the Treatment of Autism Spectrum Disorders
• Study of Probiotic GanedenBC30 for Irritable Bowel Syndrome and Major Depressive Disorder
• A Study of Memantine Hydrochloride (Namenda®) for Cognitive and Behavioral Impairment in Adults With Autism Spectrum Disorders
• Effect of Propranolol on the Autonomic Nervous System and Muscle Pain
• Antiglucocorticoid Therapy for Cognitive Impairment in Late-life Anxiety Disorders
• Comparative Effectiveness Study for Bipolar Disorder
• Lisdexamfetamine Dimesylate 2-year Safety Study in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD)
• Usability and Tolerability of the Norditropin NordiFlex® Injection Device in Children Never Previously Treated With Growth Hormone
• Open-label Safety Extension Study of 15 and 20 mg of Vortioxetine (Lu AA21004) in Long-term Treatment of Major Depressive Disorder in Adults
• An Efficacy and Safety Study for JNS001 in Adults With Attention-Deficit Hyperactivity Disorder
• A Study of HQK-1001 in Patients With Sickle Cell Disease
• Minocycline, Acetylsalicylic Acid or Pramipexole vs Placebo in Patients With Schizophrenia or Schizoaffective Disorder
• A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine
• Topical Sodium Nitrite for Chronic Leg Ulcers in Adult Patients With Blood Disorders
• 12-Week Study of Pristiq (Desvenlafaxine) Social Anxiety Disorder
• Omega-3 Fatty Acids in Tourette's Disorder
• Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in Major Depressive Disorder (MDD)
• A Clinical Trial to Study the Effects of Sensoril® for Patients With Generalized Anxiety Disorder
• Comparison of Tianeptine Versus Escitalopram Patients Major Depressive Disorder
• Long-Term Safety Of DVS-233 SR In Patients With Major Depressive Disorder
• Safety During Use of Paediatric Triple Chamber Bag Formulas
• Mirtazapine Treatment of Anxiety in Children and Adolescents With Pervasive Developmental Disorders
• Cipralex® for Anxiety Disorders in Adolescents
• Ziprasidone Switching in Response to Adherence and Psychotropic-Related Weight Gain Concerns Among Patients With Bipolar Disorder (Zip Ad)
• Forced-dose Titration of SPD489 in Adults With Binge Eating Disorder
• Study of Arbaclofen for the Treatment of Social Withdrawal in Subjects With Autism Spectrum Disorders
• A Study to Assess the Safety and Effect of TC-5214 in Patients With Major Depressive Disorder.
• The Comparative Clinical Study of Gamisoyosan on Anxiety of Generalized Anxiety Disorder According to Dosage Form
• Intravenous Immunoglobulin for PANDAS
• Raloxifene in Treatment of Schizophrenia and Schizoaffective Disorder
• Clozapine/Paliperidone Versus Clozapine/Placebo in Resistant Schizophrenia
• Efficacy and Safety Study of Low-Dose Ondansetron For Adjunctive Therapy In Adult Patients With Obsessive-Compulsive Disorder
• Safety and Efficacy of RX-10100 to Treat Major Depressive Disorder
• Pharmacogenomics of Mood Stabilizer Response in Bipolar Disorder (PGBD)
• Pharmacological Interaction Between Carvedilol and Methylenedioxymethamphetamine (MDMA)
• Efficacy Of Bupropion For Attention Deficit Hyperactivity Disorder (ADHD) In Adults
• To Evaluate the Safety and Metabolic Profile of Vyvanse for the Treatment of ADHD in Euthymic Adults With Bipolar I/II Disorder
• A Study of LY2216684 in Major Depressive Disorder in Patients Taking Selective Serotonin Reuptake Inhibitors
• Investigation of Memantine in the Treatment of Memory, Concentration or Attention Problems
• A Single-Center, Open-Label, Randomized, 3-Treatment Crossover Bioavailability Study of Single Oral Doses of E5501 Old Tablet Formulation Under Fasted Conditions and a New Tablet Formulation Under Fed and Fasted Conditions in Healthy Subjects
• To Evaluate the Safety of Long-term Use of HPN-100 in the Management of Urea Cycle Disorders (UCDs)
• Efficacy and Safety Study of Vortioxetine (Lu AA21004) for Treatment of Major Depressive Disorder
• Safety and Efficacy of Levomilnacipran ER (F2695 SR) in Adults With Fatigue Associated With Major Depressive Disorder
• Optimization of Treatment and Management of Schizophrenia in Europe
• Omega-3 Fatty Acids Monotherapy in Children and Adolescents With Autism Spectrum Disorders
• Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder (P06107 Has an Extension [P05898; NCT01349907])(P06107)
• Efficacy and Safety of Extended-release Guanfacine Hydrochloride in Children and Adolescents Aged 6-17 Years With Attention-Deficit/Hyperactivity Disorder (ADHD)
• "The Effects of Oxytocin on Patients With Borderline Personality Disorder"
• Emotional Memory Reactivation in Posttraumatic Stress Disorder
• Guanfacine for the Treatment of Hyperactivity in Pervasive Developmental Disorder
• Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
• MK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Leukemia
• Cost-Effectiveness Study Of The Treatment Of Attention Deficit/Hyperactivity Disorder In Brazil
• Corticotropin-Releasing Hormone Receptor 1 (CRH1) Antagonism in Anxious Alcoholics^
• Phase IV Long-term Maintenance Study of Aripiprazole in the Treatment of Irritability Associated With Autistic Disorder
• Bendamustine and Rituximab As Salvage Therapy In Patients With Chronic Lymphoproliferative Disorders
• Adjunctive Quetiapine in the Treatment of Refractory Social Anxiety Disorder in Adults
• Prevention of Posttraumatic Stress Disorder (PTSD) With Diazepam
• Carvedilol Versus Placebo for Treatment in Post Traumatic Stress Disorder (PTSD)
• Safety Study of Tasimelteon for Treatment of Non-24-Hour-Sleep-Wake Disorder in Blind Individuals With No Light Perception
• Intranasal PH80 Spray for Acute Management of the Symptoms of Premenstrual Dysphoric Disorder
• Effects of Omega-3 EPA/DHA for Soldiers at Risk for Mood Disorders
• Effect of Digene Total (Buffered Pantoprazole) on 24 Hour Gastric Potential Hydrogen (pH) in Patients From Acid Peptic Disorder After Single and Repeated Dosing.
• Preliminary Trial of the Effect of Glucocorticoid Receptor Antagonist on Borderline Personality Disorder (BPD)
• Oxytocin Add-on for Stable Depressed Patients
• Paliperidone Palmitate Efficacy and Safety in Bipolar Disorder Complicated by Alcoholism
• Study Comparing Three Doses of MDMA Along With Psychotherapy in Veterans With Posttraumatic Stress Disorder
• Efficacy of Atomoxetine for ADHD in Adolescents and Young Adults With SUD
• A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Sublingual Asenapine in a Pediatric Population With Schizophrenia or Bipolar I Disorder (P06522 AM1)
• Safety Study of Escitalopram in Children 7 to 11 Years of Age With Major Depressive Disorder
• Efficacy of Quetiapine XR Versus Placebo as Concomitant Treatment to Mood Stabilizers in the Control of Subsyndromal Symptoms of Bipolar Disorder
• A Study to Assess the Efficacy and Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder.
• Quetiapine Sr as Adjunctive Treatment In Mixed States of Bipolar Disorder
• A Study to Evaluate the Efficacy of Paliperidone Palmitate in the Prevention of Relapse of the Symptoms of Schizoaffective Disorder
• Safety and Efficacy Study of Citalopram and Lithium for the Treatment of Depressive Mood Disorder Symptoms
• Effects of Seroquel XR on Sleep Architecture in Patients With Major Depressive Disorder
• Enhancing Extinction Learning in Post Traumatic Stress Disorder (PTSD)
• Medications Development for Drug Abuse Disorders
• Add-on Dextromethorphan in Bipolar Disorders
• Series Studies of Bipolar Disorder-Valproate add-on Memantine
• A Study of Flexible or Fixed Dose LY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment
• A Study in Participants With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor
• Multidimensional Measurement of Psychopharmacological Treatment Response
• A Study to Assess the Efficacy and Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder
• Safety and Efficacy Study of Vortioxetine (Lu AA21004) in Adults With Major Depressive Disorder
• A Study of ND0801 in Attention Deficit/Hyperactivity Disorder (ADHD)
• A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
• Ziprasidone in Bipolar Disorder With Comorbid Lifetime Panic or Generalized Anxiety Disorder(GAD)
• N-acetylcysteine (NAC) for Pediatric Obsessive-Compulsive Disorder
• Predictors of Response to Augmentation With Ziprasidone (Geodon®) in Major Depressive Disorder
• Efficacy and Safety Study of Vortioxetine (Lu AA21004) in Adults With Major Depressive Disorder
• Efficacy and Safety of Tasimelteon Compared With Placebo in Totally Blind Subjects With Non-24-Hour Sleep-Wake Disorder
• Brain Markers of Anxiety Disorders and SSRI/CBT Treatment in Children and Adolescents
• A Study to Assess the Efficacy and Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder (MDD)
• Open-label Long Term (52 Weeks) Safety and Tolerability of Agomelatine Sublingual Tablets in Major Depressive Disorder (MDD)
• Effect of Guanfacine Extended-Release on Attention Deficit Hyperactivity Disorder (ADHD)-Associated Insomnia
• A Safety Study in Participants With Major Depressive Disorder
• A Study to Assess the Efficacy and Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder
• Safety and Efficacy of Vortioxetine (Lu AA21004) in Adults With Major Depressive Disorder
• A Study to Assess the Long- Term Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder
• Postnatal Choline Supplementation in Children With Prenatal Alcohol Exposure
• Lisdexamfetamine Dimesylate in Residual Symptoms and Cognitive Impairment in Major Depressive Disorder.
• Efficacy and Tolerability of Escitalopram and Duloxetine in Outpatients With Major Depressive Disorder
• Developing Adaptive Treatment Strategies for Children and Adolescents With Obsessive-compulsive Disorder.
• 6-week Study Treatment to Evaluate the Safety and Effectiveness of AZD2066 in Patients With Major Depressive Disorder
• Study to Assess Brincidofovir Treatment of Serious Diseases or Conditions Caused by Double-stranded DNA Viruses
• A Study of Subjects Switched to Lurasidone for the Treatment of Schizophrenia or Schizoaffective Disorder
• A Study Evaluating Lurasidone for The Treatment of Schizophrenia or Schizoaffective Disorder in Subjects Switched From Other Antipsychotic Agents
• Trazodone for Sleep Disorders in Alzheimer's Disease
• Tetrahydrobiopterin Treatment in Children With Idiopathic Cognitive Developmental Disorders
• Randomised Placebo-controlled Duloxetine-referenced Study of Efficacy and Safety of 15 and 20 mg of Vortioxetine (Lu AA21004) in Acute Treatment of Major Depressive Disorder in Adults
• A Fixed Dose Study of 323U66 SR in the Treatment of Major Depressive Disorder (MDD)
• Pharmacological Interaction Between Clonidine and Methylenedioxymethamphetamine (MDMA)
• A Study in Myeloproliferative Disorders
• Interventions for Children With Attention and Reading Disorders
• Naltrexone in the Treatment of Dissociative Symptoms in Patients With Borderline Personality Disorder
• Event-related Potentials in Management of Children With Attention-deficit/Hyperactivity Disorder
• A Novel Treatment For Chronic Posttraumatic Stress Disorder (PTSD) Using Post-Reactivation Propranolol
• Safety And Tolerability Of Flexible Doses Of Oral Ziprasidone In Children And Adolescents With Bipolar I Disorder (Manic Or Mixed)
• To Assess the Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Patients With Major Depressive Disorder (MDD)
• Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.
• Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) In The Treatment Of Peri- And Postmenopausal Women With Major Depressive Disorder (DVS 3364)
• A Study of Duloxetine in Elderly Generalized Anxiety Disorder
• Safety And Efficacy Of Ziprasidone In Children And Adolescents With Bipolar I Disorder (Manic Or Mixed) (Protocol A1281196)
• Sirolimus, Tacrolimus, Thymoglobulin and Rituximab as Graft-versus-Host-Disease Prophylaxis in Patients Undergoing Haploidentical and HLA Partially Matched Donor Hematopoietic Cell Transplantation
• Study to Evaluate the Efficacy, Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Patients With Major Depressive Disorder (MDD)
• Study to Evaluate the Efficacy, Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD)
• Study to Evaluate the Efficacy, Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD)
• Efficacy, Safety and Tolerability of Agomelatine Sublingual Tablets in the Treatment of Major Depressive Disorder (MDD)
• Efficacy, Safety and Tolerability of Agomelatine Sublingual Tablets in the Treatment of Major Depressive Disorder
• Pioglitazone as an Adjunct for Moderate to Severe Depressive Disorder
• Efficacy of Agomelatine in Patients With Obsessive-Compulsive Disorder
• Hydrocortisone in the Treatment of Intrusions in Patients With Posttraumatic Stress Disorder
• Neural and Pharmacological Correlates of Intrusions in Patients With Posttraumatic Stress Disorder
• Study of Memantine for Gait Disorders And Attention Deficit In Parkinson's Disease
• Comparison of Lisdexamfetamine Dimesylate With Atomoxetine HCl in Attention-Deficit/Hyperactivity Disorder (ADHD) Subjects With an Inadequate Response to Methylphenidate
• Pramipexole for Binge Eating Disorder
• Selective Serotonin Reuptake Inhibitors (SSRIs) in Borderline Personality Disorder
• A Trial to Determine Whether Two Differing Strength Tablets (3 x 5 mg Versus 1 x 15 mg) of Sublingually Org 5222 (Asenapine) Are Safe and Equal in Subjects With Schizophrenia or Schizoaffective Disorder (P05937)
• Antimicrobial Solution or Saline Solution in Maintaining Catheter Patency and Preventing Catheter-Related Blood Infections in Patients With Malignancies
• Pilot Study of Ketamine in Adults With Obsessive-Compulsive Disorder (OCD)
• Carnitine as an Adjunct to Methylphenidate for the Treatment of Attention Deficit Hyperactivity Disorder
• ALK33-101: A Study of RDC-0313 (ALKS 33) in Adults With Binge Eating Disorder
• A Drug Interaction Study of Valproic Acid and Paliperidone Extended-Release (ER) in Patients With Schizophrenia, Bipolar I Disorder, or Schizoaffective Disorder
• Marinol in Trichotillomania or Obsessive Compulsive Disorder
• Brain Imaging Study of Adults With Autism Spectrum Disorders
• Efficacy Study of Lisdexamfetamine to Treat Binge Eating Disorder
• Observational Study of Somatropin Treatment in Children
• D-Cycloserine and Social Skills Training in Autism Spectrum Disorders
• Relapse-Prevention Study With Levomilnacipran ER (F2695 SR) in Patients With Major Depressive Disorder
• Effects of Pravastatin on Cholesterol, Inflammation and Cognition in Schizophrenia
• Maintenance of Efficacy of Extended-Release Guanfacine HCl in Children and Adolescents With Attention-deficit/Hyperactivity Disorder (ADHD)
• Dose-optimization in Adolescents Aged 13-17 Diagnosed With Attention-deficit/Hyperactivity Disorder (ADHD) Using Extended-release Guanfacine HCl
• Memantine in Adult Autism Spectrum Disorder
• Safety Study of Depakote Versus Lithium in African Americans With Bipolar Disorder
• Study of the Safety and Efficacy of OPC-34712 as a Complementary Therapy in the Treatment of Adult Attention Deficit/Hyperactivity Disorder
• Electrophysiological Effects of Guanfacine Extended Release in Attention Deficit Hyperactivity Disorder (ADHD)
• Glivec/Gleevec Pediatric (Age 1 to Less Than 4) PK Study in CML, Ph+ ALL Patients and Other Glivec/Gleevec® Indicated Hematological Disorders.
• Concerta and Strattera on the Executive Function in Attention Deficit Hyperactivity Disorder (ADHD) Children
• An Open Label Extension Study of STX209 in Subjects With Autism Spectrum Disorders
• An Efficacy Study of Osmotic Release Oral System (OROS) Methylphenidate in Participants With Attention-Deficit/Hyperactivity Disorder (ADHD)
• Long-term Safety and Tolerability of Cariprazine for Bipolar I Disorder
• Safety and Efficacy of Cariprazine for Bipolar I Disorder
• Naltrexone for Impulse Control Disorders in Parkinson's Disease
• Study of the Safety and Efficacy of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder
• A Study to Evaluate the Safety and the Effects of Risperidone Compared With Other Atypical Antipsychotic Drugs on the Growth and Sexual Maturation in Children
• Allogeneic Bone Marrow Transplant for Inherited Metabolic Disorders
• The Efficacy of a Single Dose of Intranasal Oxytocin in the Prevention of Post Traumatic Stress Disorder (PTSD)
• An Open Label Trial of Memantine in the Treatment of Bulimia Nervosa and Body Dysmorphic Disorder
• Safety and Efficacy of Levomilnacipran ER (F2695 SR) in Major Depressive Disorder
• Safety Study of F2695 SR in Major Depressive Disorder
• Melatonin CR for the Treatment of Impaired Sleep Maintenance in 4-8 Year Old Children With Autism Spectrum Disorders
• Efficacy Study of Transcranial Direct Current Stimulation to Treat Major Depressive Disorder
• N-methyl Glycine (Sarcosine) for the Treatment of Obsessive Compulsive Disorder (OCD)
• First Time in Human Study
• Efficacy of an Early Antipsychotic Switch in Case of Poor Initial Response to the Treatment of Schizophrenia
• FMRI Brain Activation of Aripiprazole Treatment in Autism Spectrum Disorders
• Open Trial of Escitalopram Treatment for Male Subjects With Posttraumatic Stress Disorder
• Evaluation of GSK561679 in Women With Post-Traumatic Stress Disorder
• Treatment of Alcohol Dependence and Comorbid Bipolar Disorder
• Lisdexamfetamine Dimesylate (LDX) Pilot Cognition Study to Evaluate the Utility of a Standardized Battery of Tests in Adults With Attention-Deficit Hyperactivity Disorder (ADHD)
• Varenicline Treatment for Smoking Cessation in Patients With Bipolar Disorder
• Neuroprotective/Neurotrophic Effect of Lexapro® in Patients With Posttraumatic Stress Disorder
• A Study of Duloxetine in Major Depressive Disorder (MDD) and Associated Painful Symptoms
• Orvepitant (GW823296) in Adult Post Traumatic Stress Disorder
• Juvenile Bipolar Disorder Outpatient Program
• Tolerability and Efficacy of AM and PM Once Daily Dosing With Extended-release Guanfacine Hydrochloride in Children 6-12 With Attention-Deficit/Hyperactivity Disorder (ADHD) (The ADHD Tempo Study)
• A Randomized, Double-Blind, Placebo-Controlled Trial of Flumazenil for the Treatment of Obsessive Compulsive Disorder
• A Study of Pregabalin (Lyrica) Augmentation in Serotonin Reuptake Inhibitor-Refractory Obsessive Compulsive Disorder
• Methemoglobinemia in Young Patients With Hematologic Cancer or Aplastic Anemia Treated With Dapsone
• Adjunctive Pregnenolone in Post-Traumatic Stress Disorder (PTSD) and Depression in Operations Enduring Freedom and Iraqi Freedom (OEF/OIF) Veterans
• Study of HQK-1004 and Valganciclovir to Treat Epstein-Barr Virus (EBV) - Positive Lymphoid Malignancies or Lymphoproliferative Disorders
• Efficacy and Safety of HPN-100 for the Treatment of Adults With Urea Cycle Disorders
• Augmentation Trial of Prazosin for Post-Traumatic Stress Disorder (PTSD)
• Interaction Between Duloxetine and 3,4-Methylenedioxymethamphetamine (MDMA, Ecstasy)
• A Pharmacokinetic Study of Risperidone and Topiramate Administered Alone and in Combination in Patients With Bipolar Disorder or Schizoaffective Disorders
• A Pharmacokinetic Study of Lithium Before and During Topiramate Dosing in Bipolar Disorder Patients
• SPD489 in Adults With Persistent Executive Function Impairments (EFI) and Partial or Full Remission of Recurrent Major Depressive Disorder
• A Study of Patients With Major Depressive Disorder and Residual Apathy
• Study of Droxidopa Treatment in Adults With Attention Deficit Hyperactivity Disorder With Co-administration of Carbidopa
• Effects of Delta-9-THC and Iomazenil in Healthy Humans
• Study in Adolescents With Schizophrenia or Bipolar Disorder
• Duloxetine for Treatment of Painful Temporomandibular Joint Disorder
• Efficacy and Safety of Circadin for Non-24 Hour Sleep-Wake Disorder in Totally Blind Subjects
• Safety and Efficacy of Levomilnacipran ER (F2695 SR) in Major Depressive Disorder
• A Long Term Follow-Up Study for Asian Adult Patients With Attention Deficit Hyperactivity Disorder
• Safety and Efficacy of Levomilnacipran ER (F2695 SR) in Major Depressive Disorder
• Study of Phenethyl Isothiocyanate in Lymphoproliferative Disorders
• A Study of Pediatric Participants With Attention Deficit/Hyperactivity Disorder
• Atomoxetine to Treat Asian Adult Patients With Attention-Deficit/Hyperactivity Disorder
• An Open Label Trial of Duloxetine in the Treatment of Irritable Bowel Syndrome and Comorbid Generalized Anxiety Disorder
• A Duloxetine Dosing Strategy Study in Korean Patients With Major Depressive Disorder
• D-amino Acid Oxidase Inhibition (DAAOI-1) add-on Treatment for Chronic Schizophrenia
• Observational Prospective Study on Patients Treated With Norditropin®
• Mood Stabilizer (MS)+ Antidepressant vs MS + Placebo in Maintenance of Bipolar Disorder.
• Memantine Augmentation in Treatment-Resistant Adults With Obsessive-Compulsive Disorder
• Atomoxetine/Attention Deficit/ Hyperactive Disorder (ADHD)/Substance Use Disorder (SUD)in a Residential Treatment Facility
• Umbilical Cord Blood Transplant for Congenital Pediatric Disorders
• Study of the Safety and Tolerability of HPN-100 Compared to Sodium Phenylbutyrate in Children With Urea Cycle Disorders
• Study of the Safety of HPN (Hyperion)-100 for the Long-Term Treatment of Urea Cycle Disorders (Treat UCD)
• A Study to Determine the Relative Oral Bioavailability of Single Dose Administration of TMC207, Under Fed and Fasted Conditions in Healthy Participants
• Cannabis and Schizophrenia: Self-Medication and Agonist Treatment
• Homeopathic Medication and Nutritional Oriented Diet to Treat Overweight Pregnant Women With Mental Disorder
• Pilot Study of Duloxetine in Adult Attention Deficit Hyperactivity Disorder(ADHD)
• Treatment of Smoking Among Individuals With PTSD
• Adult Study / OROS Methylphenidate Hydrochloride (HCL) (OROS MPH) in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
• A Protocol Based Treatment for Debilitating Fibrosing Skin Disorders With (Anti-CD 20), Rituximab, Evaluating Safety and Efficacy
• Bupropion for ADHD in Adolescents With Substance Use Disorder
• Study of Fluconazole in Children With Autism Spectrum Disorder
• Citalopram Versus Citalopram Plus Pindolol in Major Depressive Disorder
• Role of Anti-Inflammatory Agents in Patients With Schizophrenia
• The Safety and Efficacy of SPD465 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
• Effect of Antidepressants on the Treatment for Korean Major Depressive Disorder Patients
• A Study of Pediatric Patients With Attention Deficit/Hyperactivity Disorder
• A 5-Week Trial Of PD 0332334 And Alprazolam Extended Release Compared To Placebo In Patients With Generalized Anxiety Disorder
• Campath/Fludarabine/Melphalan Transplant Conditioning for Non-Malignant Diseases
• Treosulfan and Fludarabine Phosphate Before Donor Stem Cell Transplant in Treating Patients With Nonmalignant Inherited Disorders
• Impact of Strattera and Behavior Therapy on the Home and School Functioning of Children With ADHD
• Effects of Erythropoietin on Depressive Symptoms and Neurocognitive Deficits in Depression and Bipolar Disorder
• Dehydroepiandrosterone (DHEA) Treatment in Women and Men Experiencing Hypoactive Sexual Desire Disorder
• Study of Methylphenidate to Treat Gait Disorders And Attention Deficit In Parkinson's Disease (PARKGAIT-II)
• Quetiapine Augmentation for Primary Anxiety Disorder or Mood Disorders With Co-morbid Anxiety Symptoms
• Treating Sleep/Wake Cycle Disturbances in Basal Ganglia Disorders With Ramelteon
• Chantix in Adult Smokers With Attention Deficit Hyperactivity Disorder (ADHD)
• Exploratory Study of SPD489 in Adults With Major Depressive Disorder (MDD) as Augmentation Therapy to an Antidepressant
• Quillivant Oral Suspension (Quillivant XR) in the Treatment of Attention Deficit Hyperactivity Disorder (ADHD)
• Escitalopram in Patients With Generalized Anxiety Disorder
• Escitalopram in Patients With Social Anxiety Disorder
• Studying Fentanyl in Patients With Cancer
• Functional MRI Before and After Treatment for Depression
• Safety and Efficacy Study in Patients With Major Depressive Disorder
• Pharmacological Interaction Between Pindolol and MDMA (3,4-Methylenedioxymethamphetamine)
• Identifying Very Early Response to Seroquel Extended Release (XR) Augmentation for Major Depressive Disorder
• A Study of the Effect of Carbamazepine on the Pharmacokinetics of Paliperidone Extended Release (ER) in Patients With Schizophrenia or Bipolar I Disorder
• Effect of Prazosin on Neurophysiology and Cognition in Post-Traumatic Stress Disorder (PTSD)
• A Study to Evaluate Pharmacokinetics, Safety and Tolerability After a Single Dose Administration of JNJ-31001074 in Pediatric Patients (12-17 Years) With Attention Deficit Hyperactivity Disorder (ADHD)
• A Study to Evaluate Pharmacokinetics, Safety and Tolerability After a Single Dose Administration of of JNJ-31001074 in Children (6-11 Years) With Attention Deficit Hyperactivity Disorder (ADHD)
• Desvenlafaxine Succinate (DVS) for Major Depressive Disorder (MDD) in Midlife Men and Women
• Treatment Effects of Escitalopram (Lexapro®) on Generalized Anxiety Disorder in Patients With HIV and AIDS
• Relapse Prevention Study Of Desvenlafaxine Succinate Sustained Release In Outpatients With Major Depressive Disorder
• Interaction Between Reboxetine and 3,4-Methylenedioxymethamphetamine: Pharmacodynamics (PD) and Pharmacokinetics (PK)
• Long-Term Administration Study of Aripiprazole as an Adjunctive Therapy in Patients With Major Depressive Disorder
• Seroquel Extended Release (XR) for the Management of Borderline Personality Disorder (BPD)
• A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Fixed Dose Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
• A Study to Evaluate 3 Different Doses of JNJ-31001074 in the Treatment of Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)
• A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
• Bioequivalence Study of Ramipril 10 mg Capsules Under Fed Conditions
• Bioequivalence Study of Ramipril 10 mg Capsules Under Fasting Conditions
• Safety and Efficacy of Vyvanse in Adults With Attention-Deficit/Hyperactivity Disorder
• Study of Aripiprazole as an Adjunctive Therapy in Patients With Major Depressive Disorder
• Imaginal Exposure & D-Cycloserine (DCS) for Posttraumatic Stress Disorder (PTSD)
• Buspirone in the Treatment of 2-6 Year Old Children With Autistic Disorder
• Identifying Brain and Genetic Markers of Sertraline Treatment Response in People With Social Anxiety Disorder
• Study of Aripiprazole in the Treatment of Pervasive Developmental Disorders
• Transcranial Direct Current Stimulation (tDCS) Augmentation by D-Cycloserine as a Treatment for Depression
• Bortezomib and Rituximab in Treating Patients With Post-Transplant Lymphoproliferative Disorders
• Quetiapine Extended Release (XR) Treatment of Major Depressive Disorder With Comorbid Generalized Anxiety Disorder
• Treatment of Psychotic Major Depression With Mifepristone
• Community-based Study Comparing Extended-release Methylphenidate and Atomoxetine in Children With Attention-deficit Hyperactivity Disorder
• Controlled-release Paroxetine in Major Depressive Disorder (Double-blind, Placebo-controlled Study)
• D-Cycloserine Augmentation of Therapy for Pediatric Obsessive-Compulsive Disorder
• Study Evaluating Desvenlafaxine Succinate Sustained Release In Adults With Major Depressive Disorder
• International Study to Predict Optimised Treatment in Attention Deficit/Hyperactivity Disorder
• Trial Comparing the Effects of Aripiprazole With Those of Standard of Care on Non-HDL Cholesterol in Patients With Schizophrenia or Bipolar I Disorder Who Have Metabolic Syndrome
• Safety & Efficacy Study of Study Drug (Eszopiclone) in Children and Adolescents With Attention-deficit/Hyperactivity Disorder - Associated Insomnia
• Autonomic Correlates of Impulsivity for Preschool Children With Attention Deficit Hyperactivity Disorder (ADHD)
• Long Term Safety and Tolerability of SR58611 in Patients With Major Depressive Disorder
• Effectiveness and Safety of Atypical Antipsychotic Agents in Augmenting SSRI-Refractory Obsessive-Compulsive Disorder
• Cytidine and Omega-3 Fatty Acids in Bipolar Disorder
• Safety and Efficacy of Cariprazine As Adjunctive Therapy In Major Depressive Disorder
• Sapropterin as a Treatment for Autistic Disorder
• A Study in the Treatment of Children and Adolescents With Major Depressive Disorder
• A Study in the Treatment of Children and Adolescents With Major Depressive Disorder
• Open-Label Study of the Safety and Tolerability of STX209 in Subjects With Autism Spectrum Disorders
• Metabolic Effects of Switching to Aripiprazole in Patients With Bipolar Disorders
• Safety of Org 34517 900 mg in Patients Who Received Org 34517 in a Previous Trial (Study 28133/P05842)
• Atomoxetine, Placebo and Parent Management Training in Autism
• Duloxetine in Patients With Diabetic in Peripheral Neuropathic Pain With or Without Co-morbid Major Depressive Disorder
• D-Cycloserine Augmentation of Behavior Therapy for Individuals With Body Dysmorphic Disorder
• Genetic Polymorphism and OROS-Methylphenidate Treatment in Attention Deficit Hyperactivity Disorder(ADHD)
• A Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
• Randomised Placebo-controlled Venlafaxine-referenced Study of Efficacy and Safety of 5 and 10 mg of Vortioxetine (Lu AA21004) in Acute Treatment of Major Depressive Disorder in Adults
• BRL29060A (Paroxetine Hydrochloride Hydrate) in Posttraumatic Stress Disorder
• Efficacy Study of RX-10100 to Treat Major Depressive Disorder (MDD)
• A Study to Evaluate the Efficacy and Safety of Flexible Dose of Quetiapine Fumarate (Seroquel) Switching From Other Drugs in the Treatment of Acute Manic Patients With Bipolar Disorder
• Fixed Dose Study of PD 0332334 and Paroxetine for the Treatment of Generalized Anxiety Disorder
• Treatment Trial for Psychogenic Nonepileptic Seizures
• Comparing Treatments for Self-Injury and Suicidal Behavior in People With Borderline Personality Disorder
• Omega-3 Fatty Acids (Lovaza) for Second Generation Antipsychotic-Associated Hypertriglyceridemia
• Imaging Lymphatic Function in Normal Subjects and in Persons With Lymphatic Disorders
• Study Evaluating Long-Term Safety of Desvenlafaxine Succinate Sustained Release With Japanese Adult Subjects in Major Depressive Disorder (MDD)
• Pantoprazole 20/40 mg in the Treatment of Symptomatic Reflux Disease With Focus on Sleep Disorders
• Effects of Using Betahistine to Treat Adults With Attention Deficit Hyperactivity Disorder
• Dopamine D2 and D3 Receptor Occupancy and Clinical Response in Older Patients With Schizophrenia
• Study Evaluating Desvenlafaxine Succinate Sustained Release In Outpatients With Major Depressive Disorder
• YAZ Premenstrual Dysphoric Disorder (PMDD) in China
• An Eight-week Study of SSR411298 as Treatment for Major Depressive Disorder in Elderly Patients
• Randomised Placebo-controlled Duloxetine-referenced Study of Efficacy and Safety of 5 mg of Vortioxetine (Lu AA21004) in Acute Treatment of Major Depressive Disorder in Elderly Patients
• Early Versus Delayed Switch in Medication in Patients With Major Depressive Disorder
• AZD7325 Proof of Concept in Patients With Generalized Anxiety Disorder (GAD)
• Proof of Concept in Patients With Generalized Anxiety Disorder (GAD)AZD7325
• Short-term Study of Combination Treatment of Escitalopram and Gaboxadol in Major Depressive Disorder
• Effect of Vyvanse on Sleep in Children Aged 6-12 Years With Attention Deficit Hyperactivity Disorder (ADHD)
• Double-Blind Placebo-Controlled Trial of Riluzole in Pediatric Bipolar Disorder
• Efficacy of Aerobic Exercise Added to Alprazolam in Panic Disorder Treatment
• Duloxetine for the Treatment of Generalized Anxiety Disorder
• Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) in the Treatment of Major Depressive Disorder
• A Study to Assess the Effect of Single and Multiple Doses Org 50081 and a Single Dose of Zopiclone on Next-day Driving Ability and Psychomotor Performance in Healthy Volunteers. (P05794) (COMPLETED)
• Study of the Safety and Efficacy of OPC-34712 as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
• Ondansetron in Treatment Resistant Obsessive Compulsive Disorder (OCD)
• A Safety and Pharmacokinetic Study of ER OROS Paliperidone in Pediatric Patients With Schizophrenia, Schizoaffective Disorder, or Schizophreniform Disorder
• A Study in Adult Patients With Major Depressive Disorder
• Effectiveness of Combined Medication Treatment for Aggression in Children With Attention Deficit With Hyperactivity Disorder (The SPICY Study)
• A Controlled Trial of Serotonin Reuptake Inhibitors Added to Stimulant Medication in Youth With Severe Mood Dysregulation
• Exposure, D-Cycloserine Enhancement, and Genetic Modulators in Panic Disorder
• Study of Cerebral Function in Patients With Chronic Hepatitis C Infection (HCV/CNS)
• Relapse-prevention Study With Lu AA21004 (Vortioxetine) in Patients With Generalized Anxiety Disorder
• Bipolar Disorder in Late Life
• Study to Evaluate the Efficacy and Quality of Life of Long-Acting Methylphenidate in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
• AZD6765 Severe Major Depressive Disorder (MDD) IV
• Aripiprazole for Prevention of Relapse to Cocaine Use in Methadone-Maintenance Patients
• Bioequivalence Study of Sertraline Hydrochloride 100mg Tablets Under Fasting Conditions
• Bioequivalence Study of Cefprozil Tablets, USP 500 mg Under Fasting Conditions
• Bioequivalence Study of Gabapentin 400 mg Capsules Under Fed Conditions
• Bioequivalence Study of Metformin Hydrochloride 1000mg Tablets Under Fed Conditions
• Bioequivalence Study of Metformin Hydrochloride 1000mg Tablets Under Fasting Conditions
• Bioequivalence Study of Gabapentin 800 mg Tablets Under Fasting Conditions
• Bioequivalence Study of Gabapentin 400 mg Capsules Under Fasting Conditions
• Bioequivalence Study of Cefprozil Tablets, USP 500 mg Undef Fed Conditions
• Bioequivalence Study of Gabapentin 800 mg Tablets Under Fed Conditions
• Bioequivalence Study of Amoxicillin Dispersible 600 mg Tablets Under Fasting Conditions
• Bioequivalence Study of Cyclobenzaprine Hydrochloride 10 mg Tablets, USP Under Fasting Conditions
• Bioequivalence Study of Fluoxetine HCL 40 mg Capsules Under Fasting Conditions
• Bioequivalence Study of Fosinopril Sodium/ Hydrochlorothiazide 20/ 12.5 mg Tablets Under Fasting Conditions
• Bioequivalence Study of Hydrochlorothiazide 50mg Tablets Under Fasting Conditions
• Bioequivalence Study of Loratadine Orally Disintegrating Tablets 10 mg Under Fed Conditions
• Bioequivalence Study of Cetirizine Hydrochloride 10mg Tablets Under Fasting Conditions
• Bioequivalence Study of Cetirizine Hydrochloride 10mg Tablets Under Fed Conditions
• Efficacy and Safety of Dex-Methylphenidate Extended Release 30 mg Versus 20 mg in Children (6-12 Years) With Attention-Deficit/Hyperactivity Disorder (ADHD) in a Laboratory Classroom Setting.
• Bioequivalence Study of Carvedilol 12.5mg Tablets Under Fed Conditions
• A Randomized, Double-blind, Two-arm Study Comparing the Efficacy and Safety of Trazodone Contramid® OAD and Placebo in the Treatment of Unipolar Major Depressive Disorder.
• The Role of Adverse Environment Factors, Family Functioning and Parental Psychopathology in the Response to Treatment With Methylphenidate in Children and Adolescents With Attention Deficit/Hyperactivity Disorder
• Placebo-Controlled Pilot Trial of Mecamylamine for Treatment of Autism Spectrum Disorders
• Pharmacokinetics of Two Extended-Release Formulations of Methylphenidate in Children With Attention Deficit Hyperactivity Disorder (ADHD)
• Thalidomide in Treating Patients With Relapsed or Progressive Systemic Mastocytosis
• Topiramate for Binge Eating Disorder Among Adolescents
• Changes of Cerebral Glucose Metabolism and After 12 Weeks of Escitalpram Treatment in Panic Disorder
• Changes of Cerebral Glucose Metabolism After 12 Weeks of Paroxetine Treatment in Panic Disorder
• Efficacy and Safety of Lu AA34893 in Patients With Major Depressive Disorder
• Effects of Paliperidone in Posttraumatic Stress Disorder (PTSD)
• Fixed-dose Safety and Efficacy Study of Asenapine for the Treatment of Acute Manic or Mixed Episode in Bipolar 1 Disorder (P05691)
• Sensoril(Ashwaganhda)for Bipolar Disorder
• Open-label Safety Extension Study of 5 and 10 mg of Vortioxetine (Lu AA21004) in Long-term Treatment of Major Depressive Disorder in Adults
• Comparison of Slow and Fast Transition From Stimulants to Atomoxetine in Children and Adolescents With Attention Deficit/Hyperactivity Disorder(ADHD)
• Hyperbaric Oxygen Therapy (HBOT) in Chronic Traumatic Brain Injury (TBI)/Post Concussion Syndrome (PCS) and TBI/Post-Traumatic Stress Disorder (PTSD)
• Comparison of Two KADIAN 10 mg Capsules to a KADIAN 20 mg Capsule Under Fed Conditions
• Comparison of Two KADIAN 10 mg Capsules to a KADIAN 20 mg Capsule Under Fasted Conditions
• Study of Antidepressant Efficacy of a Selective, High Affinity Enkephalinergic Agonist in Anxious Major Depressive Disorder (AMDD)
• Comparison of One Morphine Sulfate Sustained-Release 200mg Capsule With Two 100 mg KADIAN Capsules Under Fed Conditions
• Naltrexone SR and Fluoxetine Combination Therapy in Subjects With Obsessive-Compulsive Disorder
• Sinusitis and Facial Pain Disorders Anti-Depression Trial
• Cardiovascular Study of Lisdexamfetamine in Healthy and Hypertensive Attention Deficit Hyperactivity Disorder Adults
• Twenty-six Week Extension Trial of Org 50081 (Esmirtazapine) in Outpatients With Chronic Primary Insomnia (176003/P05721/MK-8265-007)
• Ketamine as a Rapid Treatment for Post-traumatic Stress Disorder (PTSD)
• Intranasal Administration of Neuropeptide Y in Healthy Male Volunteers
• An Open-Label, Extension Study Evaluating the Safety, Toleration, and Efficacy of Sildenafil in Women With Sexual Arousal Disorder
• Ramelteon for Sleep Initiation Insomnia in Individuals With Panic Disorder Who Are Also on Escitalopram for Anxiety
• Efficacy and Tolerability of Ramelteon in Patients With Rapid Eye Movement (REM) Behavior Disorder and Parkinsonism
• Reduced Intensity Conditioning for Umbilical Cord Blood Transplant in Pediatric Patients With Non-Malignant Disorders
• Efficacy and Safety of Vortioxetine (Lu AA21004) for Treatment of Generalized Anxiety Disorder in Adults.
• Prazosin for Treatment of Patients With Alcohol Dependence (AD) and Post Traumatic Stress Disorder (PTSD).
• To Evaluate the Efficiency and Safety of Quetiapine Fumarate in the Treatment of Acute Manic Patients With Bipolar Disorder.
• Efficacy and Safety of Galantamine for Improving Dysfunction in People With Bipolar Disorder
• 6-Month Open-Label Safety Study Of PD 0332334 In Elderly Patients With Generalized Anxiety Disorder (GAD)
• Treatment of Panic Disorder Among Individuals Consulting Emergency Departments for Non Cardiac Chest Pain
• Efficacy Study of Vortioxetine (Lu AA21004) in Adults With Major Depressive Disorder
• A 52-Week Open-Label Safety Study of PD 0332334 in Subjects With Generalized Anxiety Disorder (GAD)
• Olanzapine Given in Combination With Zonisamide SR to Prevent Weight Gain in Schizophrenic Subjects
• An Efficacy and Safety Study of Vortioxetine (Lu AA21004) in Treating Generalized Anxiety Disorder
• A Study of the Effects of a New Antidepressant Treatment (GSK561679) in Females With Major Depressive Disorder
• Efficacy of SEROQUEL in Selective Serotonin Reuptake Inhibitors (SSRI)-Resistant Major Depressive Disorder
• Allopurinol Maintenance Study for Bipolar Disorder
• Open Label Extension Assessing the Tolerability of BCI-024 in Combination With BCI-049 in Patients With Major Depressive Disorder (MDD)
• Study of Efficacy and Safety of Vortioxetine (Lu AA21004) in Treating Generalized Anxiety Disorder
• Efficacy of Vortioxetine (Lu AA21004) in Treating Generalized Anxiety Disorder
• Pilot Study of Minocycline (NPL-2003) in Adults With Obsessive-Compulsive Disorder (OCD)
• Ability of Aprepitant to Block Opioid Reward in Non-Dependent Opiate Abusers
• Methadone, Morphine, or Oxycodone in Treating Pain in Patients With Cancer
• Placebo Controled Clinical Trial Using Topiramate To Treat Posttraumatic Stress Disorder (PTSD) Patients.
• Org 25935 Versus Placebo as Augmentation to Cognitive-behavioral Therapy to Treat Panic Disorder (P05705)
• Treatment of Schizoaffective Disorder Using Mifepristone
• Lamictal as Add-on Treatment for Bipolar I Disorder in Pediatric Patients
• Open-Label, Chronic Exposure, Safety Study of CLONICEL (Clonidine HCl Sustained Release) in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
• Comparison of Effects Between Conventional Dose and High Dose Escitalopram on Clinical Improvement in Patients With Obsessive-compulsive Disorder
• Staccato Loxapine in Agitated Patients With Bipolar Disorder
• Disulfiram Combined With Lorazepam for Alcohol Dependence and Anxiety Disorder
• American Ginseng in Treating Patients With Fatigue Caused by Cancer
• Minimizing Doses of Antipsychotic Medication in Older Patients With Schizophrenia.
• Autologous Peripheral Blood Stem Cell Transplant for Neurologic Autoimmune Diseases
• Anticholinergic Burden in Schizophrenia
• Clinical Study Assessing a New Scale to Measure Onset of Action in Generalized Anxiety Disorder
• A Study to Evaluate Effectiveness and Safety of Prolonged Release OROS Methylphenidate in Adults With Attention Deficit Hyperactivity Disorder
• Efficacy and Tolerability Study of Betahistine to Ameliorate Antipsychotic Associated Weight Gain
• Treatment Youth With Obsessive-Compulsive Disorder
• Safety and Tolerability of Vortioxetine (Lu AA21004) in Adults With Major Depressive Disorder
• Safety and Efficacy Study of ISIS 301012 (Mipomersen) Administration in High Risk Statin Intolerant Subjects
• Aripiprazole in Children and Adolescents With Chronic Tic Disorder or Tourette's Disorder
• Trial of Hydrocortisone for Post-Traumatic Stress Disorder (PTSD)
• Efficacy and Safety Study of a Combination Product [Drug:BCI-024 (Buspirone) and Drug:BCI-049 (Melatonin)] to Treat Major Depressive Disorder (MDD)
• A Study of MK0777 Gel Extrusion Module (GEM) in the Treatment of Outpatients With Generalized Anxiety Disorder (0777-019)
• A Neuroimaging and Epigenetic Investigation of Antidepressants in Depression
• Pharmacological Treatment of Generalized Anxiety Disorder in the Elderly
• A Long Term Study of a Medication for Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)
• The Use of Cyclokapron for Treatment and Management of Women With Bleeding Disorders
• Observational Study on the Efficacy and Safety of NovoSeven® During "Real-life" Usage in Germany
• Open-label Safety Extension Study of 2.5, 5 and 10 mg of Vortioxetine (Lu AA21004) in Long-term Treatment of Major Depressive Disorder in Adults
• An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
• Further Studies of Attention Deficit Disorder - Residual Type (RT)
• Quetiapine in Co-Morbid Depressive and Anxiety Disorders
• Pilot Evaluation of Atomoxetine on Attention Deficit Hyperactivity Disorder (ADHD) Symptoms in Adolescents With Cannabis abusE
• Long Term Safety and Tolerability Study of ABT-089 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)
• Study of Preladenant for the Treatment of Antipsychotic Induced Movement Disorders in Participants With Schizophrenia (Study P04628)
• Randomized, Double-Blind, Placebo Controlled Study of Vilazodone's Efficacy, Safety, and Biomarkers of Response in Major Depressive Disorder (MDD)
• Schizophrenic Patients in Integrated Care
• Group Cognitive Behavioral Therapy Versus Fluoxetine for Obsessive-Compulsive Disorder: a Practical Trial
• The Role of GABA and Neurosteroids in Premenstrual Dysphoric Disorder
• A Study Of Sertraline Compared With Paroxetine In The Treatment Of Panic Disorder
• Ziprasidone for Severe Conduct and Other Disruptive Behavior Disorders
• Memantine Treatment for Obsessive-compulsive Disorder and Generalized Anxiety Disorder
• Efficacy and Safety of Vortioxetine (Lu AA21004) in Treating Adults With Major Depressive Disorder
• Efficacy and Safety of Vortioxetine (Lu AA21004) in the Treatment of Patients With Major Depressive Disorder
• Quetiapine Fumarate (Seroquel) as Mono-Therapy or Adjunct to Lithium in the Treatment of Patients With Acute Mania in Bipolar Disorder
• Quetiapine Extended Release (XR) in Bipolar Patients With Comorbid Generalized Anxiety Disorder (GAD)
• Pioglitazone for the Treatment of Major Depressive Disorder Comorbid With Metabolic Syndrome
• Study Evaluating Desvenlafaxine Succinate Sustained-Release Tablets (DVS SR) In The Treatment Of Child and Adolescent Outpatients With Major Depressive Disorder
• Escitalopram in Adult Patients With Major Depressive Disorder
• Effectiveness of Lithium Plus Optimized Medication in Treating People With Bipolar Disorder
• Study of Aripiprazole to Reduce Medical Risks in Bipolar Disorder
• Study to Evaluate the Efficacy and Safety of Aripiprazole Administered With Lithium or Valproate Over 12 Weeks in the Treatment of Mania in Bipolar I Disorder
• Drug Treatment Validation of Functional Magnetic Resonance Imaging in Generalized Anxiety Disorder
• Bioavailability Study of Ondansetron 16 mg Orally Disintegrating Tablets Under Fasting Conditions
• Efficacy and Safety of DOV 21,947 in the Treatment of Major Depressive Disorder
• Bioavailability Study of Ondansetron 24 mg Orally Disintegrating Tablets Under Fasting Conditions
• A 10-week Study Evaluating the Efficacy and Safety of PD 0332334 for the Treatment of Generalized Anxiety Disorder (3)
• A 10-week Study Evaluating the Efficacy and Safety of PD 0332334 in Patients With Generalized Anxiety Disorder (2)
• A 10-week Study Evaluating the Efficacy and Safety of PD 0332334 in Patients With Generalized Anxiety Disorder (1)
• A 12-Week, Placebo Controlled Trial of Ziprasidone as Monotherapy for Major Depressive Disorder
• Safety and Efficacy of LibiGel® for Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women
• Bioavailability Study of Ondansetron Orally Disintegrating Tablets Under Fasting Conditions
• Bioavailability Study of Torsemide Tablets Under Fasting Conditions
• Bioavailability Study of (Buspar) Buspirone HCl Tablets Under Fasting Conditions
• Bioavailability Study of Doxycycline Monohydrate Capsules and Monodox Under Fasting Conditions
• Bioavailability Study of Tramadol/APAP Tablets Under Fasting Conditions
• Bioavailability Study of Propranolol Under Fasting Conditions
• Bioequivalence Study of Cabergoline Tablets and Dostinex Under Fasting Conditions
• Bioavailability Study of Leflunomide Tablets Under Fed Conditions
• Bioavailability Study of Clonazepam ODT Under Fasting Conditions
• Bioavailability Study of Oxandrolone Tablets Under Fasting Conditions
• Bioequivalence Study of Cabergoline Tablets and Dostinex Under Fed Conditions
• Bioavailability Study of Tramadol/APAP Tablets Under Fed Conditions
• Bioequivalence Study Doxycycline Tablets and Monodox Capsules Under Fasting Conditions
• Bioavailability Study of (Buspar) Buspirone HCl Tablets Under Fasting and Fed Conditions
• Bioavailability Study of Doxycycline Monohydrate Capsules and Monodox Under Fasting and Fed Conditions
• Bioavailability Study of Clonazepam Tablets Under Fasting Conditions
• Bioavailability Study of Propranolol Under Fed Conditions
• A Study of the Safety and Tolerability of Oral Ziprasidone in Children and Teens With Psychotic Disorders
• A Study of the Efficacy and Safety of Ziprasidone for the Treatment of Acute Exacerbation of Schizophrenia or Schizoaffective Disorder
• A Study of the Effects of Ziprasidone for the Treatment of Schizophrenia or Schizoaffective Disorder in Patients Who Were Switched From Other Antipsychotic Drugs
• Effectiveness of Propranolol For Treating People With Post-Traumatic Stress Disorder
• Randomized, Controlled, Double Blind Trial of Eszopiclone for Insomnia Associated With Schizophrenia
• Memantine and Cognitive Dysfunction in Bipolar Disorder
• A Study of the Efficacy and Safety of Ziprasidone in Patients With Acute Exacerbation of Schizophrenia or Schizoaffective Disorder
• A One Year Open Label Study Assessing the Safety and Tolerability of Vilazodone in Patients With Major Depressive Disorder (MDD)
• Study to Investigate Effect of Sildenafil on Clitoral Engorgement as Measured by Magnetic Resonance Imaging (MRI) in Pre-menopausal Women With Female Sexual Arousal Disorder
• Safety and Tolerability Study of ABT-089 in Children With Attention-Deficit/Hyperactivity Disorder (ADHD)
• Safety, Tolerability and Efficacy Study of ABT-089 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)
• Nonmyeloablative Allo SCT for the Treatment of Hematologic Disorders
• Atomoxetine Asian Study in Adult Subjects With Attention-Deficit/Hyperactivity Disorder (ADHD)
• Ziprasidone in the Treatment of Borderline Personality Disorder
• A Study to Evaluate the Use of Extended Release Alprazolam in the Treatment of Adolescents With Panic Disorder
• Randomised Placebo-controlled Duloxetine-referenced Efficacy and Safety Study of 2.5, 5 and 10 mg of Vortioxetine (Lu AA21004) in Acute Treatment of Major Depressive Disorder
• A Study to Assess the Long-term Use of Alprazolam Extended Release (XL) in the Treatment of Adolescents With Panic Disorder
• A Study To Assess the Safety of Extended Release Alprazolam for the Treatment of Adolescents With Panic Disorder or Anxiety With Panic Attacks
• Study of Lamotrigine Treatment of Affective Instability in Borderline Personality Disorder
• Ziprasidone Augmentation of SSRIs for Patients With Major Depressive Disorder (MDD) That do Not Sufficiently Respond to Treatment With SSRIs
• Virtual Reality & D-cycloserine (DCS) for Posttraumatic Stress Disorder (PTSD)
• Double Blinded, Placebo-Controlled Trial of Paliperidone Addition in SRI-Resistant Obsessive-Compulsive Disorder
• A 6-Month Efficacy and Safety Study of Org 50081 in Adult Patients With Chronic Primary Insomnia (21106/P05701/MK-8265-002)
• Psychotherapy and Pharmacotherapy in Dissociative Disorders
• An Eight-week Study of Saredutant and Paroxetine as Combination Treatment for Major Depressive Disorder
• Phase 2a Study of Safety and Tolerability of SPN-810 in Children With ADHD and Persistent Serious Conduct Problems
• Nicotine Patch Pretreatment for Smoking Cessation in PTSD
• Safety and Efficacy Evaluation Of Pregabalin (Lyrica) With Patients With Generalized Anxiety Disorder
• Ziprasidone in Pediatric Bipolar Disorder
• Treatment of Outpatients With Severe Asthma and Moderate or Severe Major Depressive Disorder
• A Study of Varenicline for Prevention of Relapse to Smoking in Patients With Schizophrenia or Bipolar Disorder
• Safety and Effectiveness Study of BCI-540 Versus Placebo in the Treatment of Major Depressive Disorder With Concomitant Anxiety
• Combined Treatment for Generalized Anxiety Disorder (GAD)
• A Study of Quetiapine SR (Seroquel SR) to Treat SSRI-Resistant, Comorbid Panic Disorder Patients
• Citicoline for Bipolar 1 Disorder and Cocaine Dependence
• Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) In The Treatment Of Child And Adolescent Outpatients With Major Depressive Disorder
• Study of Aripiprazole to Treat Children and Adolescents With Autism
• Safety and Efficacy of Olanzapine in the Long-term Treatment for Bipolar I Disorder, Depressed
• Open Label Seroquel (Quetiapine) Study for Treatment Resistant Functional Bowel Disorder
• Does Sleep Quality Change After Switch From Wellbutrin SR to Wellbutrin XL in Patients With Major Depressive Disorder?
• Effect of Quetiapine on Sleep Architecture in Bipolar Depression and Major Depressive Disorder
• Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects
• ERP N1 as a Treatment Predictor of Generalized Anxiety Disorder
• Safety and Efficacy of LibiGel® for the Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women
• Study to Assess the Efficacy and Safety of Levetiracetam for the Treatment of Social Anxiety Disorder (Generalized Type)
• Treatment of Mood and Marriage Study (TOMMS)
• Safety and Efficacy of LibiGel® for Treatment of Hypoactive Sexual Desire Disorder in Postmenopausal Women
• Dose Finding Study in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)(174007/P05805/MK-8777-003)
• Functional MRI Evaluation of the Effect of Citalopram in Autism Spectrum Disorders
• Neurofunctional and Neurochemical Markers of Treatment Response in Bipolar Disorder
• Study to Assess the Safety and Efficacy of ISIS 301012 (Mipomersen) in Homozygous Familial Hypercholesterolemia
• Efficacy and Safety of Topiramate in the Treatment of Sleep-Related Eating Disorder
• A Multicenter, Investigative Study of the Safety and Efficacy of Extended Administration of Aripiprazole in Combination With Mood Stabilizer for the Treatment of Patients With Bipolar Disorder Experiencing a Manic or Mixed Episode
• A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group-comparison Trial of Aripiprazole in the Treatment of Patients With Bipolar Disorder Experiencing a Manic or Mixed Episode
• A Multicenter Investigative Study of the Safety and Efficacy of Long-term Administration of Aripiprazole in Combination With Mood Stabilizer for the Treatment of Patients With Bipolar Disorder Experiencing a Manic or Mixed Episode
• A Multicenter, Placebo-controlled, Double-blind Investigative Extension Trial of the Safety and Efficacy of Aripiprazole in the Treatment of Patients With Bipolar Disorder Experiencing a Manic or Mixed Episode
• Special Investigation Of J Zoloft For Panic Disorder Patients
• Dose-finding Study With Lu AA24530 in Major Depressive Disorder
• Cognitive Enhancement in Bipolar Disorder
• FMRI Study of Brain Response Before and After Lithium Treatment in People With Bipolar Disorder
• Ramelteon as an Adjunct Therapy in Non-Diabetic Patients With Schizophrenia
• Exploratory Study to Evaluate the Effect of SYN111 (Rufinamide) in Patients With Generalized Anxiety Disorder (GAD)
• Flexible Dose Titration Add-on Study to Treat Major Depressive Disorder
• A Preliminary Study of Sustained-Release Bupropion for Smoking Cessation in Bipolar Affective Disorder
• Fluoxetine for Obsessive-Compulsive Disorder in Children and Adolescents With Bipolar Disorder
• Omega-3 Fatty Acid Adjunctive to Open-Label Aripiprazole for the Treatment of Bipolar Disorder in Children and Adolescents
• Invega (Paliperidone) for the Treatment of Mania in Children and Adolescents Ages 6-17 With Bipolar Disorder
• Memantine and Cognitive Dysfunction in Bipolar Disorder
• Add-On Ramelteon in Bipolar I Disorder With Clinically Significant Sleep Disturbance
• A Safety, Efficacy and Tolerability Study of SEP-225289
• Modafinil, Sleep, and Cognition in Cocaine Dependence
• The Role of Dopamine Metabolism in the Antidepressant Effects of Sleep Deprivation and Sertraline in Depressed Patients
• An Open-Label Trial Measuring Satisfaction And Convenience Of Two Formulations Of Lamotrigine In Subjects With A Mood Disorder
• Quetiapine SR and Divalproex Sodium ER in the Treatment of Anxiety in Bipolar Disorder With Panic Disorder and/or GAD
• Allogeneic SCT Of Pts With SCID And Other Primary Immunodeficiency Disorders
• Reduced Intensity Preparative Regimen Followed by Stem Cell Transplant (FAB)
• A Study of the Effectiveness and Safety of Two Doses of Risperidone in the Treatment of Children and Adolescents With Autistic Disorder
• Study of Maca Root to Treat Sexual Dysfunction Associated With the Treatment Regimen for Bipolar Disorder in Females
• First Episode Schizophrenia and Cannabis-Related Disorder Study
• Alprostadil (FemLife Gel) in the Treatment of Female Sexual Arousal Disorder
• Adjunctive Topiramate for Treatment of Alcohol Dependence in Patients With Bipolar Disorder
• Does Risperidone Consta Reduce Relapse and Rehospitalization in Bipolar Disorder?
• The Use of Anticonvulsants for Treatment of Patients With Alcohol Dependence and Post Traumatic Stress Disorder
• Effect of Intranasal Insulin on Depressive Symptoms in Major Depressive Disorder
• Atomoxetine to Treat Korean Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD)
• A Safety and Effectiveness Study of JNJ-31001074 in Adults With Attention-Deficit/Hyperactivity Disorder.
• A Clinical Evaluation Of BW430C (Lamotrigine) In Bipolar I Disorder- Long-term Extension Of Study SCA104779 (NCT00550407) -
• A Study of Dex-methylphenidate Extended Release in Children (6-12 Years) With Attention-Deficit/Hyperactivity Disorder (ADHD)
• Quetiapine Augmentation Versus Clomipramine Augmentation of SSRI for Obsessive-compulsive Disorder Patients
• Effectiveness of Lithium and Valproate in Treating High-Risk Bipolar Disorder
• Evaluation of Efficacy and Safety of Long-acting Risperidone Microspheres in Patients With Schizophrenia or Other Psychotic Disorders When Switching From Typical Antipsychotic (Oral/Depot) or Atypical Oral Other Than Risperidone
• Double-Blind, Four Week Trial Of [S,S]-Reboxetine And Atomoxetine In Adults With Attention Deficit Hyperactivity Disorder.
• Efficacy and Safety Study of Org 50081 (Esmirtazapine) in Elderly Participants (P05709)
• A Long-Term Safety Study of Org 50081 (Esmirtazapine) in Elderly Outpatients With Chronic Primary Insomnia (176005/P05697/MK-8265-001)
• Secondary Prevention With Paroxetine vs. Placebo in Subthreshold Posttraumatic Stress Disorder (PTSD)
• Patient Tolerability Study of GSK163090
• A Long Term Study of Safety for Long Acting Injectable Risperidone in Patients With Schizophrenia or Schizoaffective Disorder.
• Clinical Evaluation of BRL29060A (Paroxetine Hydrochloride Hydrate) in Posttraumatic Stress Disorder (PTSD)
• Study Evaluating the Safety and Efficacy of CLONICEL® to Treat Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
• A 12-Week, Placebo Controlled Trial of Ziprasidone as Monotherapy for Major Depressive Disorder
• A Study To Compare The Putative Anxiolytic Effect Of 2 New Drugs In Subjects With Social Anxiety Disorder
• A Safety and Tolerability Study of ABT-089 in Children With Attention-Deficit/Hyperactivity Disorder (ADHD)
• Study of Adderall-XR for the Treatment of Adult Attention Deficit Hyperactivity Disorder and Cocaine Dependence
• Ramelteon for the Treatment of Insomnia and Mood Stability in Patients With Euthymic Bipolar Disorder
• Dose-Escalation Safety Study of HPN-100 to Treat Urea Cycle Disorders
• SA4503 8-Week Study in Major Depressive Disorder (MDD)
• Antibodies to Digoxin for Bipolar Disorder
• An Evaluation Of BW430C (Lamotrigine) Versus Placebo In The Prevention Of Mood Episodes In Bipolar I Disorder Patients
• The Effects of Atomoxetine on Cognition and Brain Function Based on Catechol-O-methyltransferase(COMT) Genotype
• Comparison of Atomoxetine Versus Placebo in Children With Attention-Deficit/Hyperactivity Disorder (ADHD)
• Abilify in Bipolar Disorder for 24 Weeks Treatment Effectiveness
• Abilify in Bipolar Disorder for 6 Weeks Treatment Effectiveness
• Donor Peripheral Stem Cell Transplant in Treating Patients With Advanced Hematologic Cancer or Other Disorders
• A 10-Week Study Evaluating the Efficacy And Safety of PD 0332334 for the Treatment of Generalized Anxiety Disorder
• A Pilot Study of Daytrana TM in Children With Autism Co-Morbid for Attention Deficit Hyperactivity Disorder (ADHD) Symptoms
• Paroxetine vs Placebo Combined With Aerobic Exercise or Relaxation in Panic Disorder
• Treatment of Patients With Anxiety Disorder (0777-022)
• N-Acetylcysteine Augmentation in Treatment-Refractory Obsessive-Compulsive Disorder
• Improving Diabetes Risk Factors in Persons With Schizophrenia or Bipolar Disorder by Switching to Ziprasidone
• Comparative Study Of Pregabalin And Gabapentin As Adjunctive Therapy In Subjects With Partial Seizures
• A Study Comparing Duloxetine and Placebo in Assessing Energy and Vitality in Major Depressive Disorder (MDD) Patients
• Impact of Attention Deficit/Hyperactivity Disorder and Substance Use Disorder on Motorcycle Traffic Accidents
• An Eight-Week Study to Evaluate the Efficacy and Safety of SR58611A in Elderly Patients With Generalized Anxiety Disorder
• Study to Measure the Safety of Paliperidone ER (Extended-release) in Patients With Liver Disease
• Generalized Anxiety Disorder Adjunct Study
• Nonmyeloablative Allogeneic Stem Cell Transplantation From HLA-Matched Unrelated Donor for the Treatment of Hematologic Disorders
• Treating Suicidal Behavior and Self-Mutilation in People With Borderline Personality Disorder
• A Study to Evaluate the Efficacy and Safety of Two Doses of PF-03654746 in Adults With Attention Deficit Hyperactivity Disorder (ADHD).
• An Eight-week Study of Saredutant and Escitalopram as Combination Treatment for Major Depressive Disorder
• Early Detection and Intervention for the Prevention of Psychosis
• Atomoxetine Phase 2 Study in Japanese Adult Patients With Attention Deficit/Hyperactivity Disorder (ADHD)
• Open-Label Study of Duloxetine in the Treatment of Children and Adolescents With Major Depressive Disorder
• A Safety and Efficacy Study of ABT-089 in Children With Attention-Deficit/Hyperactivity Disorder (ADHD)
• An Efficacy and Safety Study of Long-acting Risperidone in Participants With Schizophrenia or Schizoaffective Disorders Who Are Receiving Psychiatric Home Care Treatment
• Riluzole Augmentation in Treatment-refractory Obsessive-compulsive Disorder
• Effectiveness of Quetiapine XR on the Control of Symptoms of Manic Phase of Bipolar Disorder.
• An Investigation of the Sleep Architecture and Consequent Cognitive Changes in Olanzapine-Treated Depressed Patients
• Efficacy and Safety of Armodafinil for Adults With Excessive Sleepiness Obstructive Sleep Apnea/Hypopnea and Depression
• Levetiracetam in the Treatment of Patients With Premenstrual Dysphoric Disorder (PMDD)
• A Study to Determine Effective and Tolerable Titration Scheme for OROS-Methylphenidate in Children With Attention-deficit Hyperactivity Disorder
• Methylphenidate Study in Young Children With Developmental Disorders
• Baclofen-Amitriptyline Hydrochloride-Ketamine Gel in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
• Study on the Safety and Effectiveness of Risperidone Treatment of Acute Psychotic Patients
• Study of NPL-2003 in Adolescents With Obsessive Compulsive Disorder (OCD)
• Placebo-Controlled Study of ONO-2333Ms in Patients With Recurrent Major Depressive Disorder
• Pilot Study Examining Effect for Dextroamphetamine to Treat Cocaine Dependence Plus Attention-deficit Hyperactivity Disorder (ADHD)
• A Glutamate Transporter GLT1, in the Treatment of Bipolar Disorder
• Melatonin Metabolism Abnormality in Patients With Schizophrenia or Schizoaffective Disorder Treated With Olanzapine
• Omega-3 Fatty Acids as Adjunct Treatment for Major Depressive Disorder
• Study on the Safety of Risperidone on Obese or Overweight Patients With Schizophrenia
• Treatment Strategies for Children With Smith-Magenis Syndrome
• Ramelteon in the Treatment of Sleep and Mood in Patients With Seasonal Affective Disorder
• Equivalence of Generic Clozapine to Orally Dissolving Clozapine in Schizophrenia or Schizoaffective Disorder
• Aprepitant or Ondansetron in Treating Nausea and Vomiting Caused By Opioids in Patients With Cancer
• Treatment of Schizophrenia and Comorbid Cannabis Use Disorder: Comparing Clozapine to Treatment-as-Usual
• A Long-term Safety Study for Long-acting Injectable Risperidone in Schizophrenia or Schizoaffective Disorder Patients.
• Varenicline Adjunctive Treatment in Schizophrenia
• Safety and Efficacy Study of Oral Glycopyrrolate Liquid for the Treatment of Pathologic (Chronic Moderate to Severe) Drooling in Pediatric Patients 3 to 18 Years of Age With Cerebral Palsy or Other Neurologic Conditions
• Sarcosine or D-Serine Add-on Treatment for Chronic Schizophrenia
• A Study to Evaluate the Effectiveness and Safety of Extended-Release (ER) Paliperidone Compared With Placebo in Delaying the Recurrence of Symptoms in Bipolar I Disorder
• Open-label Study of Flexible-dose Paliperidone ER (Extended Release) to Treat Adolescent Schizophrenia.
• FAST-A Study to Evaluate the Efficacy and Safety of Quetiapin IR in Patients With Acute Psychosis
• Olanzapine Versus Comparator in the Treatment of Bipolar Disorder
• ABLE: Abilify in Bipolar Disorder for Long-term Effectiveness
• Nasal Carbon Dioxide (CO2)for the Treatment of Temporomandibular Disorders (TMD)Related Pain
• Clinical and Pharmacogenetic Study of Attention Deficit With Hyperactivity Disorder (ADHD)
• Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
• Safety and Tolerability of BL-1020 in Hospitalized Subjects With Chronic Schizophrenia or Schizo-Affective Disorder
• Open Label Extension of ISIS 301012 (Mipomersen) to Treat Familial Hypercholesterolemia
• Geodon in Weight Loss Study for Bipolar Disorders
• A Study for Patients With Attention-Deficit/Hyperactivity Disorder Treated With Atomoxetine
• A Study To Compare Emotional Changes In Subjects With Social Anxiety Disorder
• Efficacy and Safety of NS2359 in Adults With Attention Deficit Hyperactivity Disorder
• Efficacy, Safety and Tolerability of Agomelatine in the Prevention of Relapse of Major Depressive Disorder
• Using Drug Augmentation to Treat Obsessive Compulsive Disorder Patients Who Did Not Respond to Previous Treatment
• Propranolol in Post Traumatic Stress Disorder
• Donepezil Double Blind Trial for ECT Memory Disfunction
• Brain GABA Levels and Treatment Response in Major Depressive Disorder
• Duloxetine for the Treatment of Obsessive Compulsive Disorder (OCD)
• Topiramate for Treatment of Patients With Borderline Personality Disorder and Alcohol Dependence
• A Placebo- and Paroxetine-controlled Study of the Efficacy, Safety and Tolerability of Agomelatine (25 or 50 mg) in the Treatment of Major Depressive Disorder (MDD)
• Prevention of Mood Disorders by Folic Acid Supplementation
• A Study of SPD465 in Young Adult Drivers With Attention-Deficit Hyperactivity Disorder (ADHD) Using Driving Simulators
• RiSPECT: Risperdal Safety Protocol Evaluation Consta Treatment, a Post Authorization Safety Survey to Obtain Information on the Safety and Efficacy of Risperidone When Used in Routine Clinical Practice
• Rapid Versus Conventional Titration of Quetiapine in Schizophrenia/Schizoaffective Disorder
• Quetiapine for Bipolar Disorder and Alcohol Dependence
• Injectable Versus Oral Naltrexone Treatment of Alcohol Dependence In Serious Mental Illness (SMI)
• Injectable Naltrexone Treatment of Alcohol Dependence in Serious Mental Illness (SMI)
• A Study of Oral N-Acetylcysteine in Children With Autism Spectrum Disorders
• Study Evaluating DVS-233 for Treatment of Outpatients With Major Depressive Disorder
• St. John's Wort And Kava In The Treatment Of Major Depressive Disorder With Comorbid Anxiety
• The Effect of Agomelatine or Fluoxentine on Heart Rate Variability in Patients With Major Depressive Disorder
• Efficacy and Safety of Seroquel and Lithium as Monotherapy in Acute Mania Treatment in Bipolar Disorder Patients
• A Efficacy Study of PRX-00023 in Patients With Major Depressive Disorder
• A Study Comparing the Effect of Atomoxetine Versus Other Standard Care Therapy on the Long Term Functioning in Attention-Deficit/Hyperactivity Disorder (ADHD) Children and Adolescents
• A Safety and Tolerability Study of ABT-089 in Adults With Attention Deficit-Hyperactivity Disorder (ADHD)
• Escitalopram and Sleep Architecture in Patients With Major Depressive Disorder
• Aripiprazole in the Treatment of Post-Traumatic Stress Disorder Symptoms
• The Efficacy and Tolerability of Duloxetine for the Treatment of Panic Disorder
• Aripiprazole for the Treatment of Refractory Anxiety
• Efficacy of Omega-3 Fatty Acids on Borderline Personality Disorder
• Bortezomib in Treating Patients With Advanced Myeloproliferative Disorders
• A Study of Eszopiclone Co-administered With Venlafaxine in Subjects With Major Depressive Disorder and Insomnia
• Efficacy and Safety of SR58611A co-Administered With Escitalopram in Adults With Major Depressive Disorder
• Valproic Acid Sodium Salt in Bipolar Disorder
• Effects of Pentazocine Versus Lorazepam on Manic Symptoms
• Effect Of Nicotine on Neurocognitive Performance of Cigarette Smokers
• A Dose-Ranging Study of the Efficacy of ABT-894 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)
• Safety and Efficacy of Methylphenidate in Children With Attention-deficit Hyperactivity Disorder (ADHD)
• Pemetrexed Disodium in the Cerebrospinal Fluid of Patients With Leptomeningeal Metastases
• Safety and Efficacy Study of Lithium in Bipolar Disorder
• Open-label Ziprasidone Study for Psychosis Treatment in Adolescents
• Safety and Efficacy of GTS21 in Adults With Attention-deficit Hyperactivity Disorder
• Treatment of Schizophrenia With an Omega-3 Fatty Acid (EPA) and Antioxidants
• Open-Label Study of the Long Term Tolerability and Safety of Atomoxetine in Children With FASD and ADD/ADHD
• Assess the Effectiveness of Atomoxetine in Children With Fetal Alcohol Syndrome and ADD/ADHD
• Bioequivalence Study of Carbidopa/Levodopa/Entacapone Combination vs. Carbidopa/Levodopa Combination Plus Entacapone Under Fasting Conditions in Healthy Volunteers
• An Eight-week Study Evaluating the Efficacy of a 100mg Dose of Saredutant Once Daily, in Elderly Patients With Major Depressive Disorder
• Levetiracetam in Post-Traumatic Stress Disorder
• Study Of The Effects Of A New Antidepressant Therapy In Patients With Major Depressive Disorder (MDD)
• Pregabalin in the Treatment of Patients With Generalized Anxiety Disorder (GAD).
• Evaluation of Effectiveness and Safety of Flexible-dose Paliperidone Extended Release in Patients With Schizoaffective Disorder.
• A 10 Week Open-Label Pilot Study to Evaluate the Effectiveness and Safety of Memantine(Namenda) as Augmentation Therapy in Patients With Generalized Anxiety Disorder
• Efficacy, Safety and Tolerability of Agomelatine in the Treatment of Major Depressive Disorder
• Efficacy, Safety and Tolerability of Agomelatine in the Treatment of Major Depressive Disorder
• Effects of Methylphenidate on Cellular Abnormalities in Children With Attention Deficit Hyperactivity Disorder (ADHD)
• D-cycloserine for Major Depressive Disorder
• Neural Inhibition as a Mechanism of Nicotine Dependence Among Persons With Schizophrenia
• Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) vs. Escitalopram in Postmenopausal Women
• Comparison of Atomoxetine Versus Placebo in Children and Adolescents With ADHD and Comorbid ODD in Germany
• Adjunctive Glycine for Obsessive Compulsive Disorder
• A Study to Examine the Efficacy and Safety of Meridia® (Sibutramine Hydrochloride) in Binge-Eating Disorder
• Lithium Versus Paroxetine in Patients With Major Depression Who Have a Family History of Bipolar Disorder or Suicide
• Atomoxetine for Attention Deficit Hyperactivity Disorder in Adolescents With Substance Use Disorder
• Study to Determine Whether There Are Any Cognitive or Motor Effects From Taking the Medicine Risperidone.
• PROFILe3: Epidemiologic Survey in Patients With Schizophrenia or Schizoaffective Disorders
• Treatment Of Patients With Social Anxiety Disorder
• Cannabinoids in Bipolar Affective Disorder
• Evaluation of Effectiveness and Safety of Paliperidone Extended Release in Patients With Schizoaffective Disorder.
• The Effects of Pharmacotherapy on Brain Mechanisms Underlying Cocaine Dependence.
• Antidepressant Safety in Kids Study
• Effect of Ziprasidone on Glucose & Plasma Lipids in Diabetes (II) and Schizophrenia or Schizoaffective Disorder
• Topiramate vs. Placebo in Preventing Weight Gain in Bipolar Disorder Treated With Olanzapine
• Efficacy Study of Quetiapine Plus Topiramate for Reducing Cannabis Consumption and Bipolar Mania
• Efficacy of Sleep Interventions for Posttraumatic Stress Disorder (PTSD)
• A Dose-Ranging, Cross-over Study of the Safety and Efficacy of ABT-089 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)
• Cognitive Behavioral Therapy Versus Sertraline in the Treatment of Post-Traumatic Stress Disorder
• An Open-label Trial of Metformin for Weight Control of Pediatric Patients on Antipsychotic Medications.
• A Study to Evaluate the Efficacy and Safety of Risperidone for the Prevention of Mood Episodes in the Treatment of Patients With Bipolar I Disorder
• Taurine in Adolescents With Bipolar Disorder
• Efficacy and Safety Study of Seroquel SR in the Treatment of Generalised Anxiety Disorder
• Efficacy and Safety Study of Seroquel SR in the Treatment of Major Depressive Disorder
• Efficacy, Tolerability, and Safety of Once-Daily Atomoxetine Hydrochloride Versus Placebo in Russian Children and Adolescents With Attention-Deficit/Hyperactivity Disorder
• Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) In The Treatment Of Major Depressive Disorder
• Effectiveness of Sertraline and Cognitive Behavioral Therapy in Treating Pediatric Obsessive-Compulsive Disorder
• Atomoxetine Versus Placebo for Symptoms of Attention-Deficit/Hyperactivity Disorder (ADHD) in Children and Adolescents With Autism Spectrum Disorder
• A Pilot Study of Citicoline add-on Therapy in Patients With Bipolar Disorder or Major Depressive Disorder and Amphetamine Abuse or Dependence
• Mercury Chelation to Treat Autism
• Safety and Efficacy of MEM 1003 Versus Placebo for the Treatment of Patients With Bipolar I Disorder
• Ziprasidone for the Treatment of Generalized Anxiety in Patients With Bipolar Disorder
• Aripiprazole in the Treatment of Patients With Schizophrenia and Symptoms of Obsessive Compulsive Disorder (OCD)
• An Eight-week Study Evaluating the Efficacy and Tolerability of Two Doses of SSR149415 in Outpatients With Generalized Anxiety Disorder
• Effects of Armodafinil on Cognition for Patients With Schizophrenia or Schizoaffective Disorder
• A Placebo-Controlled Trial of D-Cycloserine and Exposure Therapy for Combat-PTSD
• STAR*D Alcohol: Treatment of Depression Concurrent With Alcohol Abuse
• Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) Versus Placebo in Peri- and Postmenopausal Women
• Treatment With Risperidone Long Acting Injectable (RLAI) in an Early Phase of Psychosis
• Efficacy and Safety of Pregabalin vs Placebo for Generalized Anxiety Disorder (GAD) Symptoms in Subjects Discontinuing Benzodiazepine Treatment and Remaining 6 Weeks on Study Medication, Free From Benzodiazepine Use.
• A Local Register Study For Major Depression Of Paroxetine Controlled Release
• A Study of Eszopiclone in Subjects With Insomnia Related to Major Depressive Disorder
• Study Evaluating the Effects of DVS SR and Duloxetine on the Pharmacokinetics of Desipramine in Healthy Subjects
• Study of Aripiprazole in the Treatment of Serious Behavioral Problems in Children and Adolescents With Autistic Disorder (AD)
• Low-dose Cortisol in Chronic Posttraumatic Stress Disorder
• Measure Liver Fat Content After ISIS 301012 (Mipomersen) Administration
• Selective Estrogen Receptor Modulators - A Potential Treatment for Psychotic Symptoms of Schizophrenia
• An Eight-Week Study Evaluating the Efficacy of Two Fixed Doses (250 mg Twice Daily and 100 mg Twice Daily) of SSR149415 in Patients With Major Depressive Disorder
• Biological Markers of Response to Treatment in Major Depressive Disorder
• Duloxetine for Chronic Depression: a Double-blind Study
• An Open-Label Extension Study Of Lamotrigine In Subjects With Bipolar Disorder
• Guanfacine to Treat Borderline Personality Disorder
• Fludarabine Phosphate, Cyclophosphamide, and Total-Body Irradiation Followed by Donor Bone Marrow Transplant and Cyclophosphamide, Mycophenolate Mofetil, Tacrolimus, and Sirolimus in Treating Patients With Primary Immunodeficiency Disorders or Nonca
• An Eight-Week Study Evaluating the Efficacy and Tolerability of Two Doses of SSR149415 in Outpatients With Major Depressive Disorder
• A Definitive Estrogen Patch Study (ADEPT)
• Treatment of Prisoners With Attention Deficit Hyperactive Disorder in Trondheim Prison
• Study of 3,4-Methylenedioxymethamphetamine-assisted Psychotherapy in People With Posttraumatic Stress Disorder
• Pharmacology of Cognition in Schizotypal Personality Disorder
• Fluvoxamine Maleate in the Treatment of Obsessive-Compulsive Disorder: A Post-marketing Clinical Study in Children and Adolescents
• Trial of Seroquel SR for Alcohol Dependence and Comorbid Anxiety
• Efficacy of Seroquel SR in Combination With an Antidepressant in Treatment of Major Depressive Disorder
• Efficacy of Seroquel SR in Combination With an Antidepressant in Treatment of Major Depressive Disorder
• Clinical Trial of Dipyridamole in Schizophrenia
• Primary Care Intervention Strategy for Anxiety Disorders
• A Study of SR58611A in the Prevention of Depression Relapse in Patients With Major Depressive Disorder
• Study to Evaluate the Efficacy of Modafinil Treatment in Patients With Attention Deficit Hyperactivity Disorder (ADHD) Who Are Responders to Modafinil Treatment
• A Study of Aripiprazole in Patients With Bipolar I Disorder With a Major Depressive Episode
• Efficacy Study of Early Onset of Antipsychotic Drug Action in Schizophrenia
• Study of Aripiprazole in the Treatment of Children and Adolescents With Autistic Disorder (AD)
• An Open-label Study of NRP104 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
• A Placebo Controlled Trial of the Dopamine D-2 Receptor Agonist Ropinirole in Treatment of 60 Patients With Refractory Bipolar Depression.
• Study to Assess the Safety and Efficacy of NRP104 in Adults With Attention-Deficit Hyperactivity Disorder (ADHD)
• Study of Aripiprazole in the Treatment of Children and Adolescents With Autistic Disorder (AD)
• fMRI Study Comparing BOLD Activation Patterns Using GW679769 In Subjects With Social Anxiety Disorder
• An Open-Label Trial of Memantine in the Treatment of Binge Eating Disorder
• Acamprosate in Alcoholics With Comorbid Anxiety or Depression
• Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo & Active Control in Generalized Anxiety Disorder
• Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo in Generalized Anxiety Disorder
• Sarcosine (N-Methylglycine) Monotherapy for Schizophrenia
• Atomoxetine in the Treatment of Binge Eating Disorder
• Mitochondrial Dysfunction in the Pathophysiology and Treatment of Bipolar Disorder
• A Safety and Effectiveness Study of Methylphenidate HCl Extended-release Tablets in Adults With Attention Deficit Hyperactivity Disorder
• A Long-Term Safety Study to Evaluate Methylphenidate HCL Tablets at Multiple Dose Levels in Adults With Attention Deficit Hyperactivity Disorder
• Efficacy and Safety of Quetiapine Fumarate Sustained Release (SEROQUEL SR) in the Treatment of Major Depressive Disorders
• Efficacy and Safety of Quetiapine Fumarate Sustained Release (SEROQUEL SR) in Combination With an Antidepressant in the Treatment of Major Depressive Disorders
• Aripiprazole Used as Dual Therapy in the Treatement of Patients With Chronic Stable Schizophrenia or Schizoaffective Disorder.
• Open Label Study of Lithium Plus Extended-Release Carbamazepine (ERC-CBZ) for Rapid Cycling Bipolar Disorder
• ELB139 Given Orally to Patients With Concurrent Panic Disorder, Challenged by CO2 Inhalation After a Single Dose and One Week of Treatment
• Efficacy and Safety Study of Seroquel SR in the Treatment of Generalized Anxiety Disorder
• Drug-drug Interaction Study of Aripiprazole and Lamotrigine in Patients With Bipolar Type I Disorder
• Efficacy of Atomoxetine on Psychosocial Function of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD)
• Effectiveness of Baclofen in the Treatment of People With Bulimia Nervosa or Binge Eating Disorder
• Addition of Quetiapine in Obsessive Compulsive Disorder - Westenberg Study
• Orexigenic Therapy With Delta-9-tetrahydrocannabinol in Advanced Cancer Patients With Chemosensory Abnormalities - a Pilot Study
• Effectiveness of the Screen, Test, Immunize, Reduce Risk, and Refer (STIRR) Intervention for People With Both a Mental and Substance Abuse Disorder
• Sexual Functioning Study With Antidepressants
• Optimizing Response in Psychosis Study
• The Effect of Intranasal Insulin on Neurocognitive Function in Euthymic Patients With Bipolar Disorder
• Body Mass Index (BMI) and Metabolic Changes Following Switch to Aripiprazole From Olanzapine, Risperidone and Quetiapine
• A Study to Evaluate the Efficacy and Safety of Flexible Doses of Extended-release (ER) Paliperidone Compared With Flexible Doses of Quetiapine and Placebo in Patients With Bipolar I Disorder
• A Study to Evaluate the Efficacy and Safety of Adjustable Doses of Extended-release (ER) Paliperidone Compared With Placebo, in Combination With Lithium or Valproate, to Treat Manic and Mixed Episodes in Patients With Bipolar I Disorder
• An Open-Label Trial of Aripiprazole in Autism Spectrum Disorders
• Open Label, Multicentre Extension Study of Protocol 42603ATT3002 to Evaluate Safety of Prolonged Release OROS Methlyphenidate in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
• Safety and Effectiveness of Sustained Release Bupropion in Treating Individuals With Schizophrenia Who Smoke
• Use of Quetiapine as an Add on Therapy in the Treatment of Post Traumatic Stress Disorder
• Does The Addition Of Divalproex Sodium ER To An Atypical Antipsychotic Drug (APD) Improve Cognition And Psychopathology In Outpatients With Schizophrenia (SCH) Or Schizoaffective Disorder (SAD)?
• Tolerability and Efficacy of High Dose Escitalopram for the Treatment of Obsessive-Compulsive Disorder (OCD)
• Aripiprazole Associated With Methylphenidate in Children and Adolescents With Bipolar Disorder and ADHD
• An Effectiveness and Safety Study of CONCERTA* vs. Immediate Release Methylphenidate (IR MPH) in Attention Deficit Hyperactivity Disorder Children
• Comparing the Effect of Under the Tongue Olanzapine Versus Swallowed Olanzapine on Body Mass Index (A Ratio of Weight to Height)
• Efficacy of Quetiapine in Generalised Social Anxiety Disorder
• Study Evaluating the Efficacy and Safety of Desvenlafaxine Tablets in Adult Outpatients With Major Depressive Disorder
• A Study to Evaluate the Efficacy and Safety of Three Fixed Doses of Extended-release Paliperidone in Subjects With Bipolar I Disorder
• Augmentation Study of Levetiracetam in Obsessive Compulsive Disorder
• Atomoxetine for Children With Acquired Attentional Disorders Following Completion of Chemotherapy for ALL
• High Dose of Quetiapine in Treating Subjects With Treatment Refractory Schizophrenia or Schizoaffective Disorder
• A Study of How Long it Takes a Patient to Relapse After Switching From an Oral Antipsychotic to One of Two Doses of Long-acting Risperidone Injections in Patients With Schizophrenia or Schizoaffective Disorder
• Quetiapine Augmentation for Treatment-resistant PTSD
• Treatment of Heroin and Cocaine With Methadone Maintenance and Contingency Management
• PET Neuroimaging of [11C]Mirtazapine
• Anticonvulsant Mood Stabilizers, Antipsychotic Drugs and the Insulin Resistance Syndrome
• Estimating and Reducing the Cardiovascular Risk of Patients With Schizophrenia Drugs From Lipid Measures and Ischemic Electrocardiographic Changes
• Study of Amantadine for Weight Stabilization During Olanzapine Treatment
• A Double-blind, Group-comparison Study Using Zolpidem (Myslee) as a Comparative Drug in Patients With Insomnia
• Efficacy of a Triptan in the Treatment of Hostility and Aggression Among Convicts With a Psychiatric Treatment Order
• Photodynamic Therapy in Treating Patients With Precancerous Esophageal Conditions or Early Stage Esophageal Cancer
• Safety and Maintenance of Effect of Ziprasidone Plus a Mood Stabilizer in Bipolar I Disorder (Manic or Mixed)
• Lamotrigine add-on Therapy for Bipolar Disorder and Cocaine Dependency
• Levetiracetam Treatment of Panic Disorder and Lactate-Induced Panic Attacks
• Quetiapine Fumarate as Monotherapy in the Maintenance Treatment of Patients With Major Depressive Disorder
• Study of Divalproex Extended Release Monotherapy in Ambulatory Bipolar Spectrum Disorder With Moderate-to-Severe Hypomania or Mild Mania
• Study Evaluating Desvenlafaxine Sustained-Release (DVS-SR) in Adult Outpatients With Major Depressive Disorder
• Study of Quetiapine Monotherapy in Ambulatory Bipolar Spectrum Disorder With Moderate-to-Severe Hypomanic Symptoms or Mild Manic Symptoms
• Study of Risperidone Monotherapy in Ambulatory Bipolar Disorder With Concurrent Moderately Severe Anxiety and Lifetime Panic or Generalized Anxiety Disorder
• Lamotrigine in the Treatment of Binge Eating Disorder Associated With Obesity
• A Phase IV Study of the Safety and Efficacy of Aripiprazole in Combination With Lamotrigine in the Long-Term Maintenance Treatment of Patients With Bipolar I Disorder With A Recent Manic or Mixed Episode
• A Study of EGb 761® (Tanakan®) in Dementia of Alzheimer Type Onset in Patients Suffering From Memory Complaints
• Sarcosine Preventive Therapy for Individuals At High Risk for Schizophrenia
• A Research Study to Compare the Treatments of a Combination of Elzasonan With Zoloft, to Zoloft Alone, or Placebo in People With Major Depressive Disorder (MDD)
• Arsenic Trioxide, Ascorbic Acid, Dexamethasone, and Thalidomide in Myelofibrosis/Myeloproliferative Disorder
• Depression And Bipolar Disorder
• A Study Of A New Medicine (GW679769) For The Treatment Of Social Anxiety Disorder
• Safety Study of Sodium Divalproate in Bipolar Disorder in Adolescents
• An Open-Label Study Of Lamictal In Neurotic Excoriation
• Brain Imaging and Mental Disorders of Aging Intervention
• An Eight-Week Study to Evaluate the Efficacy and Safety of SR58611A in Patients With Generalized Anxiety Disorder
• Efficacy and Safety of Olanzapine in the Extended Treatment for Manic or Mixed Episode of Bipolar I Disorder
• A Study of the Safety and Effectiveness of Risperidone Versus Placebo for the Treatment of Conduct Disorder in Children With Mild, Moderate, or Borderline Mental Retardation
• Trial to Compare Time to Response in the Symptoms of Anxiety to Concomitant Treatment With Niravam™ and an SSRI or SNRI to Treatment With an SSRI or SNRI Alone in Subjects With Generalized Anxiety Disorder or Panic Disorder
• Safety and Tolerability of Ziprasidone in Children and Adolescents With Bipolar I Disorder (Manic or Mixed)
• Effectiveness of Levetiracetam in the Treatment of Body Dysmorphic Disorder
• Memantine Augmentation in Obsessive-Compulsive Disorder
• ADH.E.R.E.: Therapeutic ADHerence and Treatment Strategies: A Mental Health Registry
• Randomized, Placebo-controlled Trial of an AMPAkine in Major Depressive Disorder
• Effect of Growth Hormone in Children With Growth Hormone Deficiency
• Combined Treatment for Alcohol-Dependent Individuals With PTSD
• Treatment of Patients With Alcoholism and Attention Deficit Disorder
• Prazosin vs. Paroxetine in Combat Stress Symptoms in OIF/OEF Returnees
• A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Children With Autistic Disorder and Other Pervasive Developmental Disorders (PDD)
• Study of Aripiprazole in Patients With Bipolar I Disorder
• Baclofen Effects on Smoking Urge and Withdrawal
• D-Cycloserine Augmentation of Exposure and Response Prevention Treatment for Obsessive-Compulsive Disorder
• Safety and Efficacy of Ziprasidone in Children and Adolescents With Bipolar I Disorder (Manic or Mixed)
• A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Manic Episodes Associated With Bipolar I Disorder
• DBT and Escitalopram in Borderline Personality Disorder
• A Prospective Study of Risperdal (Risperidone) for the Treatment of Behavioral Disorder Following Psychological Therapy for Challenging Behavior in Learning Disabled Children
• Efficacy and Safety of Quetiapine Compared With Valproate in the Treatment of Patients With Bipolar Disorder and Rapid Cycling
• Quetiapine Augmentation in Severe Obsessive Compulsive Disorder
• A Study of the Effectiveness and Safety of Risperidone Compared With Placebo in the Treatment of Manic Episodes Associated With Bipolar I Disorder, and the Maintenance of Anti-manic Effectiveness of Risperidone Compared With Haloperidol
• A Study of the Effectiveness and Safety of Risperidone as add-on Therapy to Mood Stabilizers in the Treatment of Manic Episodes Associated With Bipolar Disorder
• A Comparison of Risperidone With Haloperidol in Patients With Schizophrenia and Schizoaffective Disorder
• Omega-3 Fatty Acids in Children and Adolescents With Bipolar Disorder
• Efficacy and Safety of SR58611A in Patients With a Generalized Anxiety Disorder
• Quetiapine (Seroquel) Maintenance Treatment in Early Onset Bipolar Spectrum Disorders
• Pergolide for Cognitive Symptoms in Schizotypal Personality Disorder
• Riluzole to Treat Child and Adolescent Obsessive-Compulsive Disorder With or Without Autism Spectrum Disorders
• A Study of the Effectiveness and Safety of Risperidone Versus Placebo as add-on Therapy to Mood Stabilizers, in the Treatment of Manic Episodes Associated With Bipolar Disorder.
• A Study of the Safety and Effectiveness of Risperidone for the Treatment of Conduct Disorder and Other Disruptive Behavior Disorders in Children Ages 5 to 12 With Mild, Moderate, or Borderline Mental Retardation
• An Effectiveness and Safety Study of CONCERTA® (Methylphenidate Hydrochloride) in the Treatment of Adolescents With Attention Deficit Hyperactivity Disorder
• A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Manic or Mixed Episodes Associated With Bipolar I Disorder
• Psychosocial and Medication Treatment for Anxiety in Alcoholism
• Female Orgasmic Disorder (FOD) and Wellbutrin XL
• A Study To Evaluate PRX-00023 In Patients With Generalized Anxiety Disorder (GAD)
• Study to Evaluate the Likeability, Safety, and Abuse Potential of NRP 104 in Adults With Histories of Stimulant Abuse
• Safety, Tolerability and Abuse Liability Study of Intravenous NRP104 in Adults With Stimulant Abuse Histories
• Paroxetine for Comorbid Social Anxiety Disorder and Alcoholism
• A Trial Comparing Risperidone Long-Acting Injection With Oral Antipsychotic in the Treatment of Early Psychosis
• A Randomized, Open-label Trial of Long-acting Injectable Risperidone Versus Oral Antipsychotic Medication in Patients With Bipolar Disorder
• CONCERTA® (Methylphenidate Hydrochloride) as add-on Therapy in the Treatment of Adult Major Depressive Disorder.
• A Study of the Effectiveness and Safety of Prolonged-release Methylphenidate Hydrochloride in Adult Patients With Attention Deficit/Hyperactivity Disorder.
• CONCERTA (OROS Methylphenidate Hydrochloride) for the Treatment of Attention Deficit Hyperactivity Disorder in Adults
• Fluoxetine in Pediatric Body Dysmorphic Disorder
• Study Evaluating DVS-233 SR in Elderly Outpatients With Major Depressive Disorder
• Open Label Trial of Aripiprazole in Children and Adolescents With Tourette's Disorder
• A Study of the Effectiveness and Safety of Topiramate in the Treatment of Patients With Bipolar Disorder
• A Follow-up Study to Assess Safety and Tolerability of Galantamine Treatment in Individuals With Mild Cognitive Impairment
• Escitalopram Combination Comparison Study for Adult Patients With Major Depressive Disorder
• Study Evaluating Venlafaxine ER in Children and Adolescents With Social Anxiety Disorder
• An Open-label Extension Study to Evaluate the Safety and Tolerability of Licarbazepine 750-2000 mg/d in the Treatment of Manic Episodes of Bipolar I Disorder
• Topiramate Versus Placebo as add-on Treatment in Patients With Bipolar Disorder in the Outpatient Setting
• Managing Temporomandibular Disorder (TMD) Symptoms
• Evaluation of the Usefulness to Doctors of the Risperdal Consta Treatment Guidebook Over a Three-month Period During Which Adult Patients With Schizophrenia or Schizoaffective Disorder Are Switching From Daily Doses or Risperidone Tablets to Long-ac
• A Study of the Safety of Risperidone in the Treatment of Children and Adolescents With Conduct and Other Disruptive Behavior Disorders
• A Study Comparing the Efficacy of Long-acting Injectable Risperidone and Olanzapine Tablets in the Treatment of Patients With Schizophrenia or Schizoaffective Disorder
• A Study of the Efficacy and Safety of Risperidone in the Prevention of Relapse in Children and Adolescents With Conduct and Other Disruptive Behavior Disorders
• Evaluation of the Efficacy and Safety of Risperidone Injections Given Once a Month to Adults With Schizophrenia or Schizoaffective Disorder
• A 10-Week Study for Efficacy and Safety Study of Gabitril in the Treatment of Adults With Generalized Anxiety Disorder
• A 10-Week Efficacy and Safety Study for of Gabitril in the Treatment of Adults With Generalized Anxiety Disorder
• A 10-Week Efficacy and Safety Study of Gabitril in the Treatment of Adults With Generalized Anxiety Disorder
• Safety and Efficacy of Eszopiclone in Patients With Generalized Anxiety Disorder
• Wellbutrin XL, Major Depressive Disorder and Breast Cancer
• Evaluate the Safety of GABITRIL in Adults With Generalized Anxiety Disorder
• A Double-Blind Randomized Placebo Controlled Study of Quetiapine for the Treatment of Depression in Adolescents With Bipolar Disorder
• Quetiapine for Cocaine Use and Cravings
• Treatment With Ziprasidone for Schizophrenia Patients With Obsessive Compulsive Disorder (OCD)
• An Open-label Extension Study to Evaluate the Safety and Tolerability of Licarbazepine in the Treatment of Manic Episodes of Bipolar I Disorder.
• Medication Strategies for Treating Aggressive Behavior in Youth With Attention Deficit Hyperactivity Disorder
• Integrated Treatment for Cocaine and Mood Disorders - 1
• Quetiapine Fumarate (SEROQUEL) in the Treatment of Adolescent Patients With Schizophrenia and Bipolar I Disorder
• A Randomized Control Trial Comparing Quetiapine to Risperidone in Bipolar Disorder With Stimulant Dependence
• Safety Study of Galantamine in Tic Disorders
• Safety Study of ORG 34517 for Major Depression With Psychotic Features
• Prophylactic Effect of Lamotrigine Compared With Lithium in Bipolar Disorder
• Wellbutrin XL for Dysthymic Disorder
• The Effects of Aripiprazole on Patients With Metabolic Syndrome
• A Study To Investigate The Antidepressant Effect Of Lamotrigine In Patients With Bipolar Disorder Using Lithium
• Treatment of MDEs During the Course of Psychotic Disorders With Duloxetine
• Lamictal As Add on Treatment in Mixed States of Bipolar Disorder
• Study Comparing Patients Taking Olanzapine and Patients Taking Aripiprazole on Learning of Vocational Skills
• Naltrexone for Bipolar Disorder and Alcohol Dependence
• An Add-On Trial of Quetiapine in Patients With Bipolar Disorder and Cocaine Dependence
• Pregnenolone Trial for Depression in Bipolar Disorders or Recurrent Major Depressive Disorder With Substance Abuse
• A Comparative Study of New Medications for Psychosis in Adolescents
• Depakote ER in Borderline Personality Disorder
• An Evaluation of Divalproex vs. Olanzapine for Alcohol Abuse Relapse Prevention in Patients With Bipolar Disorder
• A Study of Quetiapine for the Treatment of Mood Disorders in Adolescents
• Zonegran in the Treatment of Binge Eating Disorder Associated With Obesity
• An Open-Label Trial of Aripiprazole in Children and Adolescents With Bipolar Disorder
• Placebo Controlled Trial of Valproate and Risperidone in Young Children With Bipolar Disorders
• Escitalopram in the Treatment of Dysthymic Disorder, Double Blind
• Cognitive-Behavioral Therapy and Escitalopram for Generalized Anxiety Disorder(GAD)
• Disulfiram for Treating Cocaine Dependence in Individuals Maintained on Methadone
• Atomoxetine for Treating Cocaine Abuse in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
• Effectiveness of ATMX in Treating Adolescents With ADHD and SUD
• Effects of Transdermal Nicotine on Smoking, Craving and Withdrawal in People With Schizophrenia
• Neuropsychological Functioning in Children With Attention-Deficit/Hyperactivity Disorder.
• Efficacy and Safety of Aripiprazole in Patients With Schizophrenia or Bipolar Disorder
• Safety Study of the Drug RG1068 in Patients With Obsessive Compulsive Disorder
• D-serine for Posttraumatic Stress Disorder Treatment
• Quetiapine in Social Anxiety Disorder
• Paroxetine-CR to Treat Post-Traumatic Stress Disorder (PTSD) Symptomatic After Initial Exposure Therapy
• Geodon for the Treatment of Refractory Social Anxiety Disorder
• Study to Evaluate the Safety and Efficacy of GABITRIL Treatment in Adults With Generalized Anxiety Disorder.
• Methylene Blue for Cognitive Dysfunction in Bipolar Disorder
• A Study to Determine the Efficacy and Safety of 2 Doses of Org 34517 as Adjunctive Therapy in Subjects With Psychotic Major Depression (28130)(P05845)
• Efficacy and Safety of Asenapine Using an Active Control in Subjects With Schizophrenia or Schizoaffective Disorder (25517)(P05935)
• Efficacy and Safety of Asenapine Using an Active Control in Subjects With Schizophrenia or Schizoaffective Disorder (25520)(P05846)
• Topiramate Augmentation in the Treatment of Obsessive-Compulsive Disorder
• Bipolar Disorder Research Study for Ages 12 and Older
• A Study of the Effectiveness and Safety of Topiramate in the Treatment of Moderate to Severe Binge-eating Disorder Associated With Obesity
• Study To Evaluate The Effects Of Gabitril™ In Patients With Social Anxiety Disorder
• Geodon (Ziprasidone) for Posttraumatic Stress Disorder
• Abilify Therapy for Reducing Comorbid Substance Abuse
• Seroquel Therapy for Substance Use Disorders Comorbid With Schizophrenia
• Topiramate in the Treatment of Posttraumatic Stress Disorder in Civilians
• Risperidone vs. Paroxetine for Panic Attacks
• Clinical Estradiol Trial in Women With Schizophrenia
• The Use of Selective Estrogen Receptor Modulators in the Treatment of Schizophrenia- a Pilot Study
• Anti-Estrogens - A Potential Treatment for Bipolar Affective Disorder in Women?
• A Study of the Cataractogenic Potential of Seroquel and Risperdal in the Treatment of Participants With Schizophrenia or Schizoaffective Disorder
• Metabolic Effects of Antipsychotics in Children
• Safety & Efficacy Study Using Topiramate in Posttraumatic Stress Disorder
• Effective Measurement of Risperidone Treatment Outcome for Persons With Borderline Personality Disorder
• Placebo Controlled Trial of Depakote ER in Alcohol Dependent Patients With Mood and/or Anxiety Symptoms
• The Effect of Testosterone on Mood and Quality of Life
• Prazosin vs Paroxetine in Combat Stress-Related Post-Traumatic Stress Disorder (PTSD) Nightmares & Sleep Disturbance
• Indicated Prevention of Psychotic Disorders With Low-dose Lithium
• Comparison of Combination Olanzapine+Lithium or Chlorpromazine+Lithium in Treatment of First Manic Episode With Psychotic Features
• Safety And Efficacy Study Of Depakote ER To Treat Pediatric Bipolar Disorder
• Safety And Efficacy Study Of Ziprasidone In Pediatric Psychotic Illness
• A Study of Sertraline and Early Alprazolam XR Administration Versus Sertraline Only in Panic Disorder Patients
• A Study of Aripiprazole in Children and Adolescents With Aspergers and Pervasive Developmental Disorder.
• A Double-Blind, Placebo-Controlled Study of Galantamine to Improve Cognitive Dysfunction in Bipolar Disorder
• A Study for the Treatment of Mania Associated With Bipolar I Disorder in Children and Adolescents
• Evaluate the Safety of Depakote Extended Release Tablets in the Treatment of Mania Associated With Bipolar Disorder in Children and Adolescents
• Study Comparing Venlafaxine vs. Paroxetine in Panic Disorder
• Lithium and Divalproex for the Treatment of Comorbid Rapid Cycling Bipolar Disorder and Substance Abuse Disorder
• Aripiprazole in Late Life Bipolar Disorder
• Study of Aripiprazole (Abilify) Versus Placebo in Children With Subsyndromal Bipolar Disorder
• An Italian Study of the Efficacy of Atomoxetine in the Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD) and Comorbid Oppositional Defiant Disorder (ODD).
• Efficacy and Safety of Atomoxetine in Children With Recent Diagnosis of Attention-Deficit/Hyperactivity Disorder (ADHD)
• Comparison of Atomoxetine and Placebo in Children With Attention-Deficit/Hyperactivity Disorder (ADHD) and/or Reading Disorder (RD)
• Open-Label Trial of Atomoxetine to Evaluate Academic Outcome in Children Ages 8-11 Years With Attention Deficit/Hyperactivity Disorder
• An Open-Label Study of Atomoxetine in Adolescents With Attention-Deficit/Hyperactivity Disorder
• Comparison of Atomoxetine and Placebo in Children and Adolescents With ADHD and ODD
• An Open-Label Study of Atomoxetine in Children With Attention-Deficit/Hyperactivity Disorder
• Long-Term Study of Atomoxetine in Children With Attention-Deficit/Hyperactivity Disorder (AD/HD)
• Atomoxetine Versus Placebo in Children With Attention Deficit/Hyperactivity Disorder (ADHD)
• A Functional Outcomes Study With Atomoxetine-Hydrochloride and Placebo in Adults With Attention-Deficit/Hyperactivity Disorder
• Placebo-Controlled Study of Atomoxetine Hydrochloride in the Treatment of Adults With ADHD and Comorbid Social Anxiety Disorder
• A Randomized, Double-Blind Comparison of Placebo and Atomoxetine Hydrochloride Given Once a Day in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)
• Safety Study of Olanzapine and a Comparator in Patients With Schizophrenia and Schizoaffective Disorder
• A Neuroimaging Investigation of Brain Activity in Major Depressive Disorder and Bipolar Disorder
• Study to Determine the Efficacy and Safety of Adjunctive Topiramate in the Treatment of Obsessive-Compulsive Disorder
• Determining the Safety and Effectiveness of Olanzapine in Children and Adolescents
• Prazosin for Treating Noncombat Trauma Post-Traumatic Stress Disorder
• Effectiveness of Long-Term Versus Short-Term Treatment of Generalized Anxiety Disorder With Venlafaxine XR
• Sertraline in Generalized Social Phobia With Co-Occurring Anxiety and Mood Disorders
• Efficacy of Adding Topiramate to Current Treatment in Refractory Obsessive Compulsive Disorder (OCD)
• Concerta in the Treatment of ADHD in Youth and Adults With Bipolar Disorder
• Risperidone Versus Olanzapine for Mania in Preschool Children 4 to 6 Years of Age With Bipolar Disorder
• Ziprasidone for the Treatment of Mania in Children and Adolescents With Bipolar Disorder
• Bupropion SR for Major Depression and Depression NOS in Children and Adolescents With Bipolar Disorder
• Quetiapine for Mania In Preschool Children 4 to 6 Years of Age With Bipolar Disorder
• Equetro for the Treatment of Mania in Children Ages 6-12 With Bipolar Disorder
• Lamotrigine for the Treatment of Mania in Youth Ages 6-17 With Bipolar Disorder
• Aripiprazole for the Treatment of Mania in Children and Adolescents With Bipolar Disorder
• Study of Depakote ER for the Treatment of Mania in Children Ages 6-12 With Bipolar Disorder
• Effects of Risperidone and Olanzapine on Patients With Schizophrenia, Schizoaffective Disorder, Major Depression or Bipolar Disorder
• Improving Symptoms of Schizophrenia and Schizoaffective Disorder by Supplementing Medications With Pravastatin
• Treatment of Geriatric Bipolar Mood Disorders: A Pilot Study
• L-Carnosine for Bipolar I Disorder
• Risperdal Consta for Bipolar Disorder
• Aripiprazole for the Treatment of Schizophrenia With Co-Morbid Social Anxiety
• Stem Cell Transplant for Immunologic or Histiocytic Disorders
• T-Cell Depletion and Stem Cell Transplant for Immune Deficiencies and Histiocytic Disorders
• Lamotrigine Monotherapy in Pediatric Bipolar Disorder
• Alcoholism and Schizophrenia: Effects of Clozapine
• Panic Disorder and Cardiac Risk
• Study of Safety and Efficacy of Antihemophilic Factor/Von Willebrand Factor Complex in Surgical Subjects With Von Willebrand Disease (vWD)
• A Study of Risperidone Monotherapy in Bipolar Anxiety
• Decreasing Risk of Coronary Artery Disease in Schizophrenia by Omega-3 Fatty Acid Supplementation
• Pharmacogenetics of Risperidone in Children With Pervasive Developmental Disorder (PDD)
• Treatments for Psychogenic Nonepileptic Seizures (NES)
• Effect And Safety Of Ziprasidone Compared To Other Atypical Antipsychotic Drug In Schizophrenic Patients
• Effect of Propranolol on Preventing Posttraumatic Stress Disorder
• Prescription Opioid Effects in Abusers Versus Non-Abusers
• Risperidone in the Treatment of Psychotic-like and Deficit Symptoms of Schizotypal Personality Disorder
• Efficacy of Quetiapine in the Treatment of Patients With Schizophrenia and a Comorbid Substance Use Disorder
• Escitalopram as a Mood Stabilizer for Bipolar II Disorder
• The Efficacy and Safety of Oral Oxcarbazepine 300-1200 mg/Day as Adjuvant Therapy in the Treatment of Adolescents With Impulsivity and Aggressive Behavior in Conduct Disorder This Study is Not Being Conducted in the United States.
• The Efficacy and Safety of Oral Oxcarbazepine 300-1200 mg/Day as Adjuvant Therapy in the Treatment of Bipolar Disorder I or II This Study is Not Being Conducted in the United States.
• Safety and Efficacy of SPD503 in Treating Attention-Deficit/Hyperactivity Disorder (ADHD) in Children Aged 6-17
• Safety and Tolerability of SPD503 and Psychostimulants in Children and Adolescents Aged 6-17 With Attention-Deficit/Hyperactivity Disorder (ADHD)
• Safety of SPD417 Combined With Other Psychotropic Medications in the Treatment of Bipolar I Disorder
• Effectiveness of Escitalopram in the Treatment of Body Dysmorphic Disorder
• Prevalence, Etiology and Therapy of Micturition Disorders of Children With a Mental and/or Motoric Disability
• Risperidone Pharmacokinetics in Children With Pervasive Developmental Disorder (PDD)
• Prevention of Post Traumatic Stress Disorder by Early Treatment
• Naltrexone Treatment of Alcohol Abuse in Schizophrenia
• Multicentre Trial to Evaluate the Safety and Efficacy of CP-316,311 in Major Depressive Disorder
• Atomoxetine for Treating Marijuana-Abusing Adolescents Who Have Attention Deficit Hyperactivity Disorder
• Combination of Disulfiram Plus Naltrexone to Treat Both Cocaine- and Alcohol-dependent Individuals - 1
• Modafinil and Naltrexone to Reduce Cocaine and Alcohol Dependence
• Fluoxetine to Reduce Cocaine Use in Cocaine and Opioid Addicts
• Levetiracetam for the Treatment of Alcohol Dependence and Anxiety
• Testosterone in Female Hypoactive Sexual Desire Disorder
• Progressively Decreasing Titration Schedules of Bifeprunox in Subjects With Schizophrenia or Bipolar Disorder
• Open Label Extension Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar I Disorder
• Nutrients and Hormones: Effects in Boys With Disordered Growth
• Clinical Effect Of Cross Titration Of Antipsychotics With Ziprasidone In Schizophrenia Or Schizoaffective Disorder
• Contingent Incentives Plus Bupropion for Smoking in People With Schizophrenia
• Methylphenidate Treatment for Cocaine Abuse and ADHD - 1
• Addition of Naltrexone to Methadone Taper
• Study Of Generalized Anxiety Disorder
• Study of BMS-562086 in the Treatment of Outpatients With Major Depressive Disorder
• 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Systemic Mastocytosis
• Augmenting Exposure Therapy With an N-Methyl-D-Aspartate (NMDA) Agonist for Panic Disorder
• Risperidone Long-acting Versus Oral Risperidone in Patients With Schizophrenia and Alcohol Use Disorder
• A United States Study of Corlux for Psychotic Symptoms in Psychotic Major Depression
• Trial of Olanzapine in Patients With Manic or Mixed Episode of Bipolar I Disorder
• An International Extension Study of Corlux for Recurrent Psychotic Symptoms in Psychotic Major Depression
• A United States Study of the Safety and Tolerability of Corlux for Psychotic Symptoms in Psychotic Major Depression
• A Medication Trial Combined With Behavior Therapy for Individuals With Obsessive-compulsive Disorder
• Naltrexone in Borderline Personality Disorder
• Duloxetine Compared With Placebo in the Prevention of Relapse in Generalized Anxiety Disorder
• A Comparison of Duloxetine Hydrochloride, Marketed Comparator, and Placebo in the Treatment of Generalized Anxiety Disorder
• A Comparison of Duloxetine Hydrochloride, Marketed Comparator, and Placebo in the Treatment of Generalized Anxiety Disorder
• Duloxetine Compared With Placebo in Patients With Generalized Anxiety Disorder
• Quetiapine Treatment for Symptoms Associated With Borderline Personality Disorder
• Trial of Paroxetine-CR for the Treatment of Patients With Post Traumatic Stress Disorder Remaining Symptomatic After Initial Exposure Therapy
• Eszopiclone for Sleep Disturbance and Nightmares in Post-Traumatic Stress Disorder
• St. John's Wort for the Treatment of Generalized Social Anxiety Disorder (GSAD)
• Therapies for Treatment-Resistant Panic Disorder Symptoms
• Escitalopram for the Treatment of Obsessive Compulsive Disorder (OCD)
• Aripiprazole in Children and Adolescents With Bipolar Disorder and Attention Deficit Hyperactivity Disorder (ADHD)
• Efficacy and Safety of Quetiapine Fumarate (SEROQUEL®) in the Treatment of Alcohol Dependency in Patients With Bipolar Disorder
• SSRI Administration to Reduce Acute Stress Disorder Symptoms and Prevent Depression and PTSD in Physical Trauma Victims
• Duloxetine for Social Anxiety Disorder: Prediction of Long Term Outcome
• Olanzapine Treated Adolescents With Schizophrenia or Bipolar I Disorder
• Combination of Paroxetine CR and Quetiapine for the Treatment of Refractory Generalized Anxiety Disorder
• Treatment and Management of Women With Bleeding Disorders
• Safety and Efficacy Study in the Treatment of Intestinal Problems Associated With Autism
• Aripiprazole in Children and Adolescents With Bipolar I Disorder
• Clinical Trial of a Nutritional Supplement in Adults With Bipolar Disorder
• Comparison of Escitalopram Combination in Adult Patients With Major Depressive Disorder
• Study of Escitalopram in Adult Patients With Major Depressive Disorder
• Efficacy, Safety and Tolerability of XBD173 in Patients With Generalized Anxiety Disorder
• Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar Disorder
• Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar Disorder
• Efficacy & Safety of Seroquel Plus Mood Stabilizer in the Maintenance of Bipolar I Disorder
• The Safety and Efficacy of Escitalopram in Pediatric Patients With Major Depressive Disorder
• A Long-Term Study Continuing on From Study 04-001-01 of an Experimental Medication in Adults With Anxiety Disorder
• An Evaluation of the Safety and Efficacy of Memantine in Patients With Acute Mania Associated With Bipolar I Disorder
• Duloxetine Versus Placebo in the Prevention of Recurrence of Major Depressive Disorder
• Drug Therapy for Generalized Anxiety Disorder Among the Elderly
• A Study of Aripiprazole in Patients With Major Depressive Disorder
• Photodynamic Therapy Using Silicon Phthalocyanine 4 in Treating Patients With Actinic Keratosis, Bowen's Disease, Skin Cancer, or Stage I or Stage II Mycosis Fungoides
• Study Of GW679769 In Major Depressive Disorder
• Role of Substance P in Post-Traumatic Stress Disorder
• Efficacy of High Dose Olanzapine for the Treatment of Schizophrenia and Schizoaffective Disorder
• Herbal Treatment for Attention Deficit Hyperactivity Disorder (ADHD)
• Risperidone Treatment for Military Service Related Chronic Post Traumatic Stress Disorder
• Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar Disorder
• Experimental Medication For the Treatment of Generalized Anxiety Disorder
• A Study of Adjunctive Aripiprazole in Patients With Major Depressive Disorder
• A Study of Adjunctive Aripiprazole in Patients With Major Depressive Disorder
• A Long-Term Study of Aripiprazole in Patients With Major Depressive Disorder
• Effects of Aripiprazole in Overweight Patients Treated With Olanzapine for Schizophrenia or Schizoaffective Disorder
• Study Comparing Adjunctive Risperidone Versus Placebo in Major Depressive Disorder That Is Not Responding to Standard Therapy
• A Study of Effectiveness and Safety of Risperdal CONSTA Added to Usual Treatment in Patients With Bipolar Disorder Who Have Frequent Mood Episodes.
• Olanzapine vs. Comparator and Placebo in the Treatment of Patients With Bipolar I Disorder
• A Study of Aripiprazole in Patients With Bipolar I Disorder With a Major Depressive Episode
• Interactions Between Cocaine and Ethanol and Disulfiram - 1
• Major Depressive Disorder In The Elderly
• Study Evaluating DVS-233 SR in Adult Outpatients With Major Depressive Disorder
• Olanzapine in Patients With Borderline Personality Disorder
• Study Evaluating DVS-233 SR And Venlafaxine ER In Adult Outpatients With Major Depressive Disorder
• MDMA-Assisted Psychotherapy in People With Posttraumatic Stress Disorder
• Comparison of Continuing Olanzapine to Switching to Quetiapine in Overweight or Obese Patients With Schizophrenia and Schizoaffective Disorder
• Treatment of Menstrually Related Disorders With Continuous v. Interrupted Oral Contraceptives
• Evaluation of Substance P Neurotransmission in Panic Disorder by PET Imaging of NK1 Receptors With [18F]SPA-RQ
• Open-Label Study of Intramuscular Olanzapine Depot in Patients With Schizophrenia or Schizoaffective Disorder
• Efficacy and Safety of Olanzapine in Patients With Borderline Personality Disorder
• Study Evaluating DVS-233 SR and Venlafaxine ER in Adult Outpatients With Major Depressive Disorder
• Study Comparing Risperidone vs Placebo as add-on Therapy in Patients With Generalized Anxiety Disorder Who Are Sub-optimally Responding to Standard Therapy.
• Efficacy and Safety of Seroquel Plus Mood Stabilizer in the Maintenance of Bipolar I Disorder
• Study of Aripiprazole in Patients With Bipolar I Disorder With a Major Depression Episode
• RUPP PI PDD: Drug and Behavioral Therapy for Children With Pervasive Developmental Disorders
• Armodafinil (CEP-10953) for Treatment of Narcolepsy, Obstructive Sleep Apnea/Hypopnea Syndrome, or Chronic Shift Work Sleep Disorder
• Study to Determine the Effectiveness of Risperidone in Bipolar Disorder in Children and Adolescents
• Study Evaluating DVS-233 SR In Adult Outpatients With Major Depressive Disorder
• Study Evaluating DVS-233 SR In Adult Outpatients With Major Depressive Disorder
• A 6 Week Study to Determine the Effectiveness of R228060 in Adult Subjects With Major Depressive Disorder
• Study Evaluating DVS-233 SR In Adult Outpatients With Major Depressive Disorder
• Duloxetine Compassionate Use in Patients Who Have Completed a Previous Neuroscience Duloxetine Clinical Trial
• Total-Body Irradiation, Fludarabine, and Alemtuzumab Followed By Stem Cell Transplant in Treating Patients With Myeloproliferative Disorder, MS, AML, or CML
• Propranolol for the Treatment of Acute Stress Disorder
• Depression Study In Elderly Patients
• An Outpatient Study of the Effectiveness and Safety of Depakote ER in the Treatment of Mania/Bipolar Disorder in Children and Adolescents
• Comparison of Psychological and Pharmacological Treatments for Pain Due to Temporomandibular Joint Disorder (TMD)
• Study Evaluating DVS-233 in Adult Outpatients With Major Depressive Disorder
• Efficacy and Safety of Two Atypical Antipsychotics vs. Placebo in Patients With an Acute Exacerbation of Either Schizophrenia or Schizoaffective Disorder
• Substance Dependent Teens - Impact of Treating Depression Study 1 - 1
• An Inpatient Study of the Effectiveness and Safety of Depakote ER in the Treatment of Mania/Bipolar Disorder
• An 8 Week Depression Study In Adults Diagnosed With Major Depressive Disorder
• An 8 Week Study Of Adults Diagnosed With Major Depressive Disorder
• An 8 Week Study Of Depression In Adults Diagnosed With Major Depressive Disorder
• Bipolar Disorder Study for Men and Women
• Cholinergic Modulation of Condition and Emotion in Mood Disorders: Functional Neuroimaging Studies
• Riluzole to Treat Depression in Bipolar Disorder
• Combination Chemotherapy and Antithymocyte Globulin in Reducing Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplantation For Myelodysplastic Syndrome or Myeloproliferative Disorder
• Child and Adolescent Anxiety Disorders (CAMS)
• Evaluation of Stress Disorders
• Olanzapine Versus Placebo in the Treatment of Mania in Adolescents With Bipolar I Disorder
• Major Depressive Disorder Study In Adults
• Treatment and Outcome of Early Onset Bipolar Disorder
• Treatment of Patients With Major Depressive Disorder With MK0869 (0869-062)(COMPLETED)
• Long Term Treatment of Patients With Major Depressive Disorder With MK0869 (0869-065)(COMPLETED)
• Stem Cell Transplant for Patients With Blood Malignancy Using Donors and Less Toxic Chemotherapy With CAMPATH 1H
• Attention-Deficit Hyperactivity Disorder (ADHD) Study With Adults
• A Study Of A New Medicine (GW597599B) For The Treatment Of Major Depressive Disorder
• Nicotine Patch for Nicotine Dependence in Individuals With Schizophrenia or Schizoaffective Disorder - 1
• Brain Receptor Function in Post-Traumatic Stress Disorder
• Prevention of Seasonal Affective Disorder
• Optimizing Electroconvulsive Therapy for Depression
• Study Evaluating Venlafaxine ER in Patients With Panic Disorder
• A Study of the Effectiveness and Safety of Risperidone to Augment SSRI Therapy in Patients With Treatment-resistant Depression
• Lorazepam-Induced Toxicity in the Aged
• Relapse Prevention for Bipolar Type-II Disorder
• The Assessment of a Weight-Gain Agent for the Treatment of Olanzapine-Associated Anti-Obesity Agent in Patients With Schizophrenia, Schizophreniform Disorder, Schizoaffective Disorder, and Bipolar I Disorder
• Treatment of Patients With Major Depressive Disorder With MK0869 (0869-073)
• Study Evaluating Venlafaxine ER in Adults With Panic Disorder
• A Study on the Safety and Efficacy of Topiramate in the Treatment of Patients With Bipolar I Disorder
• Clozapine vs. Placebo in Treatment-Refractory Bipolar Disorder in Children and Adolescents
• Duloxetine Versus Placebo in the Prevention of Relapse of Major Depressive Disorder
• A Study to Evaluate the Safety and Effectiveness of Topiramate Compared to Placebo in the Treatment of Patients With Bipolar I Disorder
• St. John's Wort Vs. Placebo in Obsessive-Compulsive Disorder.
• Treatment of Patients With Major Depressive Disorder With MK0869 (0869-061)
• Treatment of Patients With Major Depressive Disorder With MK0869 (0869-060)(COMPLETED)
• A Study on the Safety and Efficacy of Topiramate in the Treatment of Patients With Bipolar I Disorder
• Treatment of Patients With Major Depressive Disorder With MK0869 (0869-068)(COMPLETED)
• Treatment of Patients With Major Depressive Disorder With MK0869 (0869-059)
• Treatment of Patients With Major Depressive Disorder With MK0869 (0869-066)(COMPLETED)
• Treatment of Patients With Major Depressive Disorder With MK0869 (0869-063)
• CAFE Comparison of Atypicals in First Episode of Psychosis
• Olanzapine Versus Active Comparator in the Treatment of Bipolar I Disorder
• A Study of Cabergoline for the Treatment of Cocaine Dependence - 1
• Reserpine for the Treatment of Cocaine Dependence - 1
• Clonidine in Attention Deficit Hyperactivity Disorder (ADHD) in Children
• Evaluation of Clonazepam and Paroxetine for Panic Disorder With Depression
• Atomoxetine to Treat Adolescents With Coexisting Alcohol and Other Substance Use Disorder and ADHD
• Study of Fluoxetine in Adults With Autistic Disorder
• Methylphenidate in Children and Adolescents With Pervasive Developmental Disorders
• Clonazepam and Paroxetine for Rapid Treatment of Post-Traumatic Stress Disorder
• Clinical Trial of Fluoxetine in Anxiety and Depression in Children, and Associated Brain Changes
• Methylphenidate Raclopride Positron Emission Tomography (PET) Test - 11
• Prepulse Inhibition of Startle in Cocaine Dependence - 7
• Methylphenidate in the Treatment of Cocaine Dependent Patients With Adult Attention Deficit Hyperactivity Disorder - 5
• Nefazodone in the Treatment of Cocaine Dependence and Depression - 4
• Buprenorphine Dose Escalation Trial for Treatment of Non-Dependent Opiate Users - 2
• Buprenorphine/Naloxone for Opiate-Dependence Treatment - 1
• Fludarabine Phosphate and Total-Body Radiation Followed by Donor Peripheral Blood Stem Cell Transplant and Immunosuppression in Treating Patients With Hematologic Malignancies
• Treatment of Youth With ADHD and Anxiety
• Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)
• Oregon Center for Complementary and Alternative Medicine in Neurological Disorders
• Omega-3 Fatty Acids in Bipolar Disorder
• Total-Body Irradiation Followed By Cyclosporine and Mycophenolate Mofetil in Treating Patients With Severe Combined Immunodeficiency Undergoing Donor Bone Marrow Transplant
• Treatment for Alcoholism and Post-Traumatic Stress Disorder (Naltrexone)
• Glycine to Treat Psychotic Disorders in Children
• Treatment of Depression in Youth With Bipolar Disorders
• Randomized Study of Cognitive-Behavioral Therapy vs Imipramine and Their Combination for Panic Disorder
• Study of Fluoxetine in Patients With Depersonalization Disorder
• Phase II Double-Blind, Placebo-Controlled Study of the Reinforcing Effects of Alprazolam in Patients With Anxiety
• Phase II Randomized Study of Intravenous Versus Oral Clomipramine in Patients With Obsessive Compulsive Disorder
• 12-O-Tetradecanoylphorbol-13-acetate in Treating Patients With Hematologic Cancer or Bone Marrow Disorder
• Topical Use of 4,4'-Dihydroxybenzophenone-2,4-Dinitrophenylhydrazone (A-007) in the Treatment of Advanced Malignancies Including Kaposi's Sarcoma and Lymphoproliferative Disorders
• Treatment of Childhood Onset Psychiatric Disorders With Intravenous Immunoglobulin (IVIg)
• Amoxicillin for the Treatment of Pediatric Autoimmune Disorders Associated With Streptococcal Infections
• Comparison of Clozapine vs Olanzapine in Childhood-Onset Psychotic Disorders
• Treatment of Mid-Life-Related Mood Disorders
• Acute Effectiveness of Additional Drugs to the Standard Treatment of Depression
• New Drugs in the Treatment of Mood Disorders
• A Pilot Study of the Combination of Retinoic Acid and Interferon-Alpha2a for the Treatment of Lymphoproliferative Disorders in Children With Immunodeficiency Syndromes
• Preventive Measures for Childhood-Onset Obsessive-Compulsive Disorder and Tic Disorders (PANDAS Subgroup)
• Omega-3 Fatty Acids in the Treatment of Bipolar Disorder: A Double-Blind, Placebo-Controlled Trial
• Cooperative Study of Factor VIII Inhibitors
• Drug Treatment for Alcoholics With Post-Traumatic Stress Disorder
• Treatment for Anxiety in Children
• Multimodal Treatment Study of Children With Attention Deficit and Hyperactivity Disorder (MTA)
• Long-Term Lithium Treatment for Aggressive Conduct Disorder
• Treatment of Obsessive-Compulsive Disorder (OCD) in Children
• Fluoxetine vs EMDR to Treat Post-Traumatic Stress Disorder (PTSD)
• Cognitive and Drug Therapy for Drug-Resistant Depression
• Treatment of Obsessive-Compulsive Disorder
• Maintenance Therapies in Bipolar Disorders
• Treatment of Panic Disorder: Long Term Strategies
• Evaluation of Lofexidine for Treatment of Opioid Withdrawal - 7
• Buprenorphine Maintenance for Opiate Dependence - 6
• Evaluation of L-alpha-acetylmethadol (LAAM) in Methadone Patients - 5
• Effects of Buprenorphine and Naloxone in Opiate Addicts - 4
• Evaluation of Lofexidine for Treatment of Opioid Withdrawal - 3
• Trial of Buprenorphine/Naloxone for Opiate Dependence - 2
• Effects of Dextromethorphan on Opioid Tolerance in Methadone Patients - 1
• Buprenorphine Maintenance Dose Schedule and Treatment Setting - 2
• Buprenorphine Maintenance Dose Schedule and Treatment Setting - 1
• Early Phase II Trials for Cocaine Medication Development - 1
• Combining Behavioral Treatment With Agonist Maintenance - 1
• Naltrexone as Adjunct in Alcoholic Cocaine Dependent Patients - 4
• Dextroamphetamine as Adjunct in Cocaine/Opiate Dependent Patients - 3
• Dextroamphetamine as an Adjunct in Cocaine Treatment - 1
• Novel Medications for Opiate Detoxification - 4
• Disulfiram for Cocaine-Alcohol Abuse - 3
• Flupenthixol and Haloperidol for Treating Cocaine Abuse Schizophrenics - 9
• A Laboratory Model for Heroin Abuse Medications - 8
• Early Phase II Trials for Cocaine Medication Development - 1
• New Approaches to Cocaine Abuse Medications (A) - 6
• Pergolide Treatment for Substance Abusers - 4
• Cocaine Abuse and Attention Deficit Disorder - 3
• Subjective/Psychomotor/ Effects of Combined Alcohol & Nitrous Oxide - 16
• Effects of Combined Alcohol and Nitrous Oxide Intake - 15
• Effects of Combined Sevoflurane and Nitrous Oxide Inhalation - 14
• Effects of Alcohol History on Effects of Sevoflurane and Nitrous Oxide - 13
• Effects of Behavioral Contingencies on Effects of Nitrous Oxide - 12
• Sevoflurane vs Nitrous Oxide Inhalation at Subanesthetic Concentrations - 11
• Role of Instructions in Nitrous Oxide Effects and Choice - 10
• Effects of Alcohol History on Effects of Nitrous Oxide - 9
• Reinforcing Effects of Brief Exposures to Nitrous Oxide - 8
• Differential Acute Tolerance Development to Effects of Nitrous Oxide - 7
• Isoflurane at Subanesthetic Concentrations - 6
• Effects of Nitrous Oxide: A Dose-Response Analysis - 5
• Lack of Acute Tolerance Development to Effects of Nitrous Oxide - 4
• Effects of Subanesthetic Concentrations of Isoflurane/Nitrous Oxide - 3
• Cold Water Immersion Modulates Reinforcing Effects of Nitrous Oxide - 2
• Effects of Subanesthetic Concentrations of Nitrous Oxide - 1
• Evaluation of a Desipramine Ceiling in Cocaine Abuse - 1
• Carbamazepine Treatment of Cocaine Dependence - 1
• Combined Buprenorphine and Behavioral Treatment With and Without Contingent Reinforcement on Opioid and Cocaine Abstinence. - 22
• Pharmacotherapy and Intensive Treatment - 2
• Pharmacotherapy and Intensive Treatment of Drug Abuse - 1
• Buprenorphine Maintenance for Cocaine Abusing Opioid Addicts - 1
• The Effects of Sex Hormones on Cognition and Mood in Older Adults